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Abstract
There is a constant demand for enormous numbers of high quality hepatocytes in the
fields of cell transplantation, pharmacotoxicology, tissue engineering, and bioartificial
assist devices. The scarcity of viable hepatocytes necessitates the use of suboptimal
sources including damaged donor organs that are not transplantable. Many of these
organs have potentially reversible pathologies however, that could be treated via ex vivo
perfusion thereby increasing their cell yield. With the intent to translate organ recovery
by perfusion into the clinic, we engineered a very simple room temperature-operated ex
vivo organ perfusion system to test a rat liver model of uncontrolled non-heart beating
donors. Seventeen times as many hepatocytes were recovered from livers exposed to
an hour of warm ischemia (WI, 34*C) compared to untreated WI livers in only 3 hours of
perfusion. Further, fresh liver hepatocyte yields were also increased by 32% post-
perfusion, demonstrating that both damaged and healthy donor livers could benefit from
this methodology. A linear correlation between cell yield and tissue ATP content was
established. This enables an accurate prediction of cell recovery during preservation and
can be used as a direct measure of organ viability and the trajectory of organ recovery
during perfusion resuscitation. Further, a strong correlation between perfusion flow rate
and cell yield was also established supporting the use of flow rates as low as possible
without causing hypoperfusion or oxygen deprivation. Morphologically and functionally,
perfusion-isolated hepatocytes generally performed comparably or better than fresh
hepatocytes in cell suspension and plate culture. Cumulatively, these findings strongly
support the ubiquitous use of organ perfusion systems in the clinic for optimal
enhancement of donor grafts.
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Chapter 1: Introduction
There is a multi-billion dollar demand for viable organs in the fields of organ
transplantation, cell-based therapeutics, basic research, toxicology and drug
development 5 . As hepatocyte transplantation emerges as a treatment alternative to
liver failure6 and bioartificial liver assist devices (BAL) enter clinical trials7, identifying
suitable sources of hepatocytes for these methods is becoming an immediate
bottleneck. The current donor shortage is severe; as few as 2% of waiting-list candidates
may receive an organ in any one year8. Hepatocytes subsequently derive largely from
untreated discarded organs that are severely compromised, resulting in low yields and
low viabilities9'10. Donor livers obtained after Cardiac Death (DCD) are the single largest
untapped human organ resource because of high incidents of primary non-function.
They are also the most likely to be completely restored if treated to be used for
transplantation" or as a source of hepatocytes'. In this work, we engineer a new
approach to enhancing organ viability of both healthy and ischemically damaged organs
through treatment with extracorporeal perfusion. Upon scaling these findings up to
human organs, the contribution will be significant in developing the practical resources
available for a highly desired supply of human hepatocytes14 . This enabling methodology
will impact all current fields of demand due to improved hepatocyte quality and function.
It will unfetter the development and clinical applicability of hepatocyte transplantation
and BAL methods, offering new treatment options to thousands of patients with liver
failure.
Hepatic Failure and Treatment Options. Approximately 30,000 patients die each year
from end-stage liver disease in the U.S. Approximately 80% of patients have
decompensated chronic liver disease and become too ill to tolerate liver transplantation.
The remaining 20% die of acute liver failure primarily due to ischemia/reperfusion injury,
alcoholic liver disease, viral hepatitis, idiosyncratic drug reactions, and acetaminophen
poisoning 5. Orthotopic liver transplantation is the only clinically proven effective
treatment for patients with end-stage liver disease. Unfortunately, it is both very costly
and limited by the shortage of organ donors. The number of patients on the liver
transplant waiting list in the U.S. stands at -17,000, with new additions of about 10,000
per year, while the number of transplanted livers is only -7,000 per year (UNOS OPTN
data as of July 2007). Furthermore, -2,500 patients per year die on the waiting list or
become too sick to transplant before a donor is found. Living and split liver donor
techniques may be promising alternatives, yet they have represented less than -5% of
the total number of transplants performed in the U.S.16, and present significant risks for
donors.
Xenotransplantation could provide a limitless supply of donor organs, but
previous attempts in humans resulted in hyperacute rejection and death17. Another
approach under consideration is hepatocyte transplantation, where one donor liver could
potentially treat several patients. This still incurs the need for immunosupression,
however, fresh cells are rare and the efficiency of engraftment is generally low,
particularly with cryopreserved cells. Further, an unpredictable lag time of as much as
48h before any clinical benefit occurs1 may be too long in a rapidly deteriorating patient.
Yet, this approach offers an attractive prospect for correcting non-acute conditions such
as genetic defects of the liver 9.
Extracorporeal BALs containing functioning viable hepatocytes could provide
temporary support for patients with fulminant hepatic failure and patients awaiting
orthotopic liver transplantation. Furthermore, since the liver has the ability to regenerate,
temporary support may obviate the need for transplantation in some patients, which
would reallocate donor livers as well as eliminate the need for life-long
immunosuppressive drugs that must be taken by all transplant recipients. Several
hurdles must be overcome for the development of BALs. Some of the issues that the
field continues to wrestle with are: (1) lack of reliable - and preferably human20 - cell
sources; and (2) deteriorating hepatocyte function in the bioreactor environment.
Quantifying Cell Requirements and Identifying Alternative Cell Sources. The cell
mass required to support an animal model of hepatic failure has not been systematically
determined. Prior studies have shown significant improvements in various parameters
using as low as 2-3% of the normal liver mass of the animal 21,22. Devices which have
undergone clinical testing have used 6x10 9 - 1x10 11 porcine hepatocytes 2 or 4x10
C3A cells 25. In a pig model of hepatic failure, a BAL containing as few as 6x10 8 pig
hepatocytes (about 3-5% of the liver mass) significantly improved survival 26
Clinical improvements have also been seen in hepatocyte transplantation studies
using less than 10% of the host's liver mass. Intrasplenic transplantation of 2.5x10 7
allogeneic rat hepatocytes (-5% of the liver mass in this model) prolonged the survival
and improved blood chemistry of anhepatic rats 27. In another study using reversibly
transformed human hepatocytes, 5x10 7 cells were injected intrasplenically into 90%
hepatectomized rats 28. In a recent study on humans with acute liver failure, intrasplenic
and intra-arterial injections of human hepatocytes (ranging from 109 - 4x1 010 per patient,
i.e. 1-10% of the total liver mass) transiently improved blood chemistry parameters and
brain function after a lag time of about 48 h, but did not improve survival 18. The lag time
before any benefit is observed may reflect the time required for the engraftment of the
cells in the host liver. Better survival of the injected cells may be possible if they were
seeded in prevascularized polymeric scaffolds 29. The relatively low number of
hepatocytes needed for a therapeutic benefit suggests the possibility that the
exogenously supplied hepatocytes may aid the regeneration of the native liver22 .
Assuming that the minimum cell mass necessary to support a patient undergoing acute
liver failure is about 5-10% of the total liver weight sets the requirement to about 1010
cells/BAL device for humans.
Recent clinical studies using extracorporeal liver perfusion strongly suggest that
human and baboon livers are superior to pig livers for treating acute liver with this
modality30. Human hepatocytes are therefore preferred for the clinical liver assist device;
however, they are scarce due to the competing demand of livers for orthotopic
transplantation as well as for hepatocyte transplantation. In BAL devices containing
human cells tested so far, only one used adult hepatocytes, while the remainder were
C3A hepatoma cells 25 31. One study suggests that C3A cells have lower levels of
P4501A1 activity, ammonia removal, and amino acid metabolism than adult porcine
hepatocytes 32. Furthermore, when using immortalized cell lines, there are concerns with
the possibility of transmission of tumorigenic products into the patient. Although porcine
cells are available in large quantities, they also pose risks of hyperacute rejection33 ,
transmission of zoonoses 34, and potential mismatch between pig and human liver
functions35. The first two could be addressed by dedicated breeding programs of
transgenic animals 36, but there is little known about the third factor.
The lack of availability of adult human hepatocytes would be solved if they could
be induced to replicate in vitro; however, this has not been conclusively reported yet.
Human hepatocyte cell lines have been developed via spontaneous transformation 37 as
well as via retroviral transfection of the simian virus 40 large T antigen 38. Reversible
transformation with the SV40 T antigen and Cre-Lox recombination has been used to
grow human hepatocytes in vitro 28. These cells, when transplanted into the spleen of
90% hepatectomized rats, improved biochemical and clinical parameters. However,
quantitative characterization of these cells in vitro suggests relatively low levels of
expression of liver-specific functions (Shinoda et al., unpublished data). While no one
has achieved the goal of generating a safe, fully functional yet clonal, immortalized, or
genetically engineered human cell that can be substituted for primary hepatocytes, new
promising avenues have arisen from recent studies with fetal hepatocytes 39-41 and stem
cells 4244. These approaches, however, are possibly decades away from clinical
application, and the availability of fetal and stem cells itself remains a controversial
issue.
Marginal Organs form a Major untapped Donor Organ Pool. Currently, the primary
source of donor livers is donors after brain death (DBD, formerly described as "heart-
beating cadavers") who have irreversible loss of brain function but have functioning
circulation and respiration. The most common cause of rejection from the donor pool
is hepatic steatosis, due to significantly decreasing graft survival rates . Based on prior
surveys, steatosis prevalence was evaluated to be 10-25% of all donated livers46'4 7, and
approximately 65% of donor livers that are rejected for transplantation are steatotic48 -
hence the potential pool of steatotic livers that could be transplanted is -1,000/year. The
second, potentially much larger alternative source is donors after cardiac death (DCD,
formerly described as "non-heart-beating cadavers")49. The use of DCD liver grafts,
which suffer from varying durations of ischemia, is considered an experimental
procedure50 , although the practice is much more common in kidney transplants51. The
total number of potential DCDs is estimated to exceed 6,000 annually". (A similar
ballpark estimate of 10-20% more livers is also given by White and Prasad, 2006). About
1,000 of these would be "controlled" according to 1995 Maastricht criteria, which means
they are obtained from hemodynamically stable individuals following a controlled clinical
death. In these cases, the ischemic time, hence damage to the organ, is limited, and
these organs are prime candidates for transplantation or as cell sources.
Based on the estimates in the literature as outlined above, the potential pool of DCD
livers is roughly twice the current demand (6,000 vs. 3,000). Therefore, the DCD organs
rejected for transplantation could easily match the need as sources of human
hepatocytes for other treatment modalities, such as BAL devices, even if the yield of
viable cells obtained from these organs is only 5% of the total liver mass. Currently,
reports on yields from discarded donor organs indicate low retrieval. Alexandrova et.
al.53 reported a mean specific yield of 2.6-3.6 million cells per gram of liver tissue, with a
viability of 64%. Baccarini et. a 13 reported more than 7 million cells per gram liver tissue,
with a mean 73% viability. Hughes et al.9 obtained on average 2.2 106 cells/gram tissue
with 51 % viability from livers with an average of 15 minutes of warm ischemia and 13 hrs
of cold storage in University of Wisconsin (UW) solution. The results all demonstrate a
negative correlation between ischemic time and cell viability. The use of organs rejected
due to steatosis, cirrhosis and traumatic injury have been considered favorably as
sources of hepatocytes for in vitro 54-55 applications, as well as in limited clinical trials56
though with equally low yields. However, the estimated number of suitable livers is about
1,000 55, significantly less as compared to ischemic livers.
Ex vivo liver perfusion optimizes healthy and discarded donor organs. The current
gold standard for organ preservation is static cold storage (SCS) in University of
Wisconsin solution57 -61 and is based on the minimization of metabolism and enzymic
activity by temperature reduction. The logistical ease of use (placing the organ on ice
after flushing), rapid organ mobilization and transport has favored this modality for the
last 50 years. However, organ storage duration is limited by the gradual depletion of ATP
supplies6 2'63 which, combined with the inability to directly and objectively measure organ
function, favor the use of ex vivo machine perfusion. This is particularly relevant today as
the rising demands for viable organs necessitate the use of marginal or extended criteria
donors64'6 5, which do not fare as well under SCS conditions' 6 -70. Hypothermic machine
perfusion (HMP) simply circulates cold oxygenated UW solution through donor livers at
low flow rates and has demonstrated that the sustenance of tissue ATP levels reduces
cellular damage, enables longer storage times and improved graft performance upon
transplantation 71 ~74 . More recently, temperature-dependent differences have confirmed
that even better graft function occurs above 20*C75-77, thereby necessitating the use of
machine perfusion for optimal organ storage. Many groups favor creating an ex vivo
environment that mimics the in vivo state''' 67 because of several perceived advantages
of operating at normothermic conditions78-83 . The first and most significant is the proven
ability to recover ischemically damaged organs to transplantable state using
normothermic perfusion84-86. Though this has only been achieved in a very select
number of cases, the impact of this additional source of transplantable organs to the
critically limited donor pool will significantly enhance treatment options to thousands of
patients per annum14. Normothermic perfusion also enables the development of clinically
relevant metrics of organ viability prior to transplantation, from which it would be possible
to derive pathology-specific treatment protocols for optimal organ preservation. These
quantitative measures of organ stability, likelihood of primary non-function or delayed
graft function, and recovery to transplantable-state would replace subjective decision
making on questionable organs and dramatically improve the number of successful
outcomesso
Despite these promising results, they derive from animal models only and the desired
metrics are as yet ideals. Only in renal transplantation is machine perfusion
(hypothermic) an accepted clinical practice in a few centers around the country. Despite
increasing evidence that machine perfusion results in better grafts, early results that
were arguably biased in favor of static cold storage did not demonstrate significant
differences in preservation techniques8 7-90. Regarding human livers, only one report of
hypothermic machine perfusion has been published91.
Establishing organ perfusion as an accepted and standard methodology for all donor
organs depends on the development of highly reliable, automated, simple systems that
are comprehensively and accurately monitored using parameters that are tightly coupled
to organ function and transplantability.
Thesis Contributions. The intent of this thesis was to engineer practical ex vivo
perfusion systems that significantly enhance the current donor pool and eliminate the
hepatocyte shortage by optimizing discarded organs. A major expectation of this work
was to minimize the number of parameters required to establish the status of viability in
perfused organs. As the energy content of the organ is known to be critical to its
viability6 2, 92-95 , and the perfusate medium serves primarily as a reservoir of nutrients, the
approach taken in this work focuses on the hemodynamic parameters governing the rate
of nutrient flow into and out of the liver, enabling comprehensive metabolic analyses to
form the framework for perfusion optimization and control.
We begin with the development of a unique model that examines the metabolic
fluxes across rat livers in vivo. This provides us with a basis upon which to evaluate the
parameters of our perfusion systems. We measure 24 different extracellular metabolic
fluxes, including amino acids, glucose, urea, albumin, ketone bodies, blood gases, and
lactate and use them to estimate an additional 37 intracellular fluxes of intermediary
metabolism with a mass balance approach, or Metabolic Flux Analysis (MFA). These
data provide us with a comprehensive integrated snapshot of basic metabolism in a
healthy liver. We assess the validity of the model to reflect global changes in
metabolism by examining its ability to detect variations present in mild to moderate
hypermetabolism. We find that several features of this state of elevated resting energy
expenditure are accurately portrayed in an appropriately dose-dependent fashion.
We use this model to evaluate the impact of a simple ex vivo perfusion system
on normal liver function. We use these results to determine intrinsic shortcomings in the
perfusate that need to be altered in order to allow sustainable and physiological organ
function. The perfusion system is used as a technique to evaluate the same moderate
model of liver hypermetabolism analyzed in vivo. A comparison between in vivo vs. ex
vivo outcomes shows that the liver responds quickly and significantly to its new ex vivo
surroundings and does not accurately portray its in vivo metabolic rate during the first
hour of ex vivo perfusion. Rather, this first hour reflects an adjustment by the liver to its
new environment. Combined, these data provide the basis for the rational development
of a physiologically relevant perfusion system and an appreciation for the time to achieve
organ stability at 370C.
A normothermic extracorporeal liver perfusion (NELP) is established using a modified
cell culture medium as the perfusate, and erythrocytes as oxygen carriers to allow
physiological flow rates of oxygen delivery. A primary circuit contains the erythrocytes
which are adjusted to the optimal hematocrit with a dialyzer that forms the connection to
the second circuit and perfusate reservoir. The system is tested on fresh livers which are
perfused for 6 hours, an average static cold storage time, prior to transplantation into
syngeneic recipients. We show the animals survive beyond 1 month in good health.
We subsequently use the same perfusion system to evaluate whether ischemically
damaged livers can be recovered. Livers are exposed to a severe model of warm
ischemia (1 hr, 340C) and either experience 5 hours of static cold storage (SCS) or NELP
followed by transplantation. All recipients of NELP livers survive, while none who
received SCS do. We have not observed similar findings of recovery from such a severe
WI model in the literature, except by Sch6n et. al. who performed the experiments in a
porcine model85.
MFA is performed on the Fresh and WI livers in perfusion to evaluate the overall
performance of the organs in perfusion. The major differences between ischemic and
fresh liver metabolism is noted, time to recovery is suggested, and methods of improving
perfusion are discussed. Metabolites are generally assessed for linearity of uptake or
production, rates of change, substrate depletion and excessive presence driving fluxes
unnecessarily. The intrinsic differences between ischemic and fresh livers are observed
and suggestions for treatment protocols specific to WI recovery are suggested.
A series of steps are undertaken to simplify the perfusion system based on the MFA
findings. We first reduce temperature to reduce oxygen demand; we choose room
temperature because this has shown both viable livers and allows the obviation of a
heating or cooling system. No significant differences are observed between livers
perfused at 370C, 300C and 200C either during perfusion or after transplantation.
Further, oxygen uptake rate by livers at room temperature is less than the oxygen that is
supplied through solution alone if a 95%02/5%C02 mixture were to be used. Animals
survive in good health beyond 1 month. Using hepatocyte isolation as an endpoint to
allow greater quantification of differences observed, differences in duration of perfusion
are examined. It is determined that full and optimum recovery of ischemically damaged
hepatocytes occurs within 2-3 hours of perfusion, which also concurs with the
aforementioned MFA findings.
An asanguineous perfusate is subsequently prepared, the heating apparatus
removed and the circuit reduced to a primary loop only, comprising a reservoir, a pump,
an oxygenator and a bubble trap prior to entering the liver in its chamber. Fresh livers
are perfused with and without heparin pretreatment and no significant differences in cell
yield and viability are observed.
Using a significantly simplified perfusion system, fresh livers are perfused for 3 hours
(3hrRT), as are warm ischemic livers (WI+3hrRT) and subsequently the hepatocytes are
isolated. The yield and viability is compared to fresh and warm ischemic livers without
perfusion treatment, reflecting a normal isolation and the current discarded donor
isolation. The results demonstrate that there is a complete recovery to fresh liver cell
yield in WI+3hrRT livers suggesting 60 minutes of WI in a rat model does not induce a
catastrophic degree of tissue damage and is generally reversible. Equally interesting is
the observation that 3hrRT livers have a significantly higher cell yield than either fresh or
WI+3hrRT livers and may relate to a period of ischemic preconditioning prior to inception
of ex vivo perfusion. The cells procured from perfusion function equally or better than
fresh livers in cell suspension and plate culture. We show that there is a significant linear
correlation between cell yield post-Percoll purification and the ATP content of the organ
tissue, normalized to total protein. This is the first time the relation between energy
status and hepatocyte outcome has been so strongly correlated and enables the
development of an objective marker of organ viability. A second correlation is observed
between cell yield and final perfusate flow rate. The correlation is significantly linear in
3hrRT livers, less so in WI+3hrRT livers; both groups demonstrate cell yield is enhanced
at very low flow rates. Cumulatively, these data provide us with the next iterative steps
for future improvement of the perfusion system, including ischemic preconditioning if
appropriate, vasodilation, thrombolytics and an artificial oxygen carrier6'97.
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Chapter 2: In vivo Metabolic Analysis of the Rat Liver
In this study, we develop an approach to evaluate the in vivo hemodynamic
parameters of the rat hepatic blood supply and its major metabolic constituents
for the purposes of establishing a platform upon which to base ex vivo perfusion
parameters, and compare subsequent systems' performance. To investigate the
validity of the model, we extensively compare our normal liver findings with
current literature, and then develop a cohesive map of metabolic interactions
using metabolic flux analysis (MFA). This tool allows us to portray a snapshot in
time of organ metabolism and integrate our findings to appreciate large pathway
activity such as gluconeogenesis, the pentose phosphate pathway, the urea and
TCA cycles. To evaluate the sensitivity of the model to metabolic disturbances, we
compare healthy liver metabolism to mild and moderate degrees of
hypermetabolism. It is well known that thermal injury induces a hypermetabolic
response that increases with the severity of injury. Sprague Dawley rats receive a sham,
20% or 40% total body surface area burn. The products of in vivo concentration
measurements and flow rates, normalized to each liver's weight provide 24 fluxes with
which to perform MFA, providing information regarding an additional 37 intracellular
fluxes. Burn injury induces a mild metabolic response in 20% TBSA burn injuries. The
primary finding is a reduction in hepatic gluconeogenesis, most likely in response to
hyperinsulinemia, and a shift in nitrogen balance, favoring the formation of albumin and
anaplerosis. A 40% TBSA burn injury, by contrast, causes significant metabolic
alterations. Despite hyperinsulinemia, gluconeogenic fluxes are increased by
significantly elevated lactate levels and increasing amino acid uptake, suggestive of
insulin resistance. Nitrogen uptake is increased 1.5 times compared to in vivo values,
with an increased and preferential use for anaplerosis; albumin production is reduced.
These results accurately and cumulatively reflect the gross expected outcomes of
hypermetabolism and provide new detailed insight as to the extent of hepatic reaction to,
and impact on, metabolism. This is the first MFA analysis of whole-organ metabolism
conducted on in vivo parameters and provides sufficiently useful data to enable
detection of even subtle degrees of metabolic disturbances.
RESULTS
To determine the effect of burn injury on hepatic metabolism, rats were subjected
to a dorsal burn corresponding to 20% of the total body surface area, or a combined
dorsal and ventral burn corresponding to a total body surface area of 40%. Three days
after burn, the animals were fasted overnight, and on the fourth day, portal vein and
hepatic artery flow rates were measured and blood samples were taken. Sham controls
consisted of rats that underwent the same procedures, but experienced an immersion in
water at 20*C.
Metabolite Concentration Analysis
Table 1 displays the group averages of the measured extracellular metabolite
concentrations in the portal vein (PV), hepatic artery (HA) and hepatic veins (SHVC) in
addition to the flow rates and liver weights. Additional relevant blood chemistry values
not used specifically for MFA are represented in Table 2. Nitrogen fluxes are accounted
for in Table 3.
There were no elevations in liver enzymes (ALT, AST and ALP) or total bilirubin' 2
amongst any of the vessels in all groups suggesting that no significant liver damage
occurred within four days of burn injury. Plasma creatinine and urea nitrogen values
remained within normal range for all rats suggesting unimpaired renal function due to
burn injury.
Flow rates generally increased in the portal vein and decreased in the hepatic artery
for burn groups compared to sham. Overall values ranged between 1.7-2.2ml/min/g liver
in the portal vein and 0.07-0.05ml/min/g liver in the hepatic artery for a cumulative inflow
of 1.77-2.25ml/min/g liver.
Trends common to all vessels likely signify the systemic impact due to burn. For
example, a significant decrease in albumin and total hemoglobin levels occurred equally
in both burn groups. Lactate levels were slightly decreased in the 20% TBSA burn group
but elevated 4-fold in the 40% TBSA burn group. This particular finding, combined with
reduced dissolved oxygen from low hemoglobin levels, low pH, and high carbon dioxide
values suggest a mildly acidotic state induced by the liver in 40% TBSA burn animals.
Obvious dose-dependent changes in concentrations were generally not observed.
The most apparent circumstance in which this occurred was a significant four-fold
increase in SHVC insulin levels (Table 2). There was also a dose-dependent systemic
decrease in VLDL and TG content reflected equally in all vessels (Table 2).
A general appreciation of amino acid metabolism was obtained by accounting for
nitrogen. At the bottom of Table 1 is a summation of the total circulating amino acid
nitrogen in each vessel. Arterial nitrogen, most representative of the systemic state of
the body, demonstrates a slight decline in total nitrogen compared to sham (-3.5% and -
1 % in 20% and 40% TBSA burns respectively). The burn groups had 13 out of 20 amino
acids with reduced trends compared to sham, except for arginine, ornithine and cysteine,
which were increased systemically, and histidine, valine, tyrosine and phenylalanine,
which were unchanged. In the PV, sham nitrogen content remained virtually unchanged
from the HA, however the burn groups demonstrated a dose-related increase from
intestinal contributions (3.3% and 8.9% in 20% and 40% TBSA burns respectively).
SHVC nitrogen content of the burn groups was generally 5% greater than in sham. All
groups had a SHVC nitrogen content significantly lower than either the HA or PV.
Nitrogen flux across the liver (Table 3) shows that 20% TBSA burn livers took up as
much nitrogen as sham livers but produced more albumin. 40% TBSA burn livers took
up the surplus nitrogen but did not alter albumin production; rather they increased their
urea nitrogen output suggesting the use of protein preferentially as an energy source.
In order to appreciate the effects of the liver on specific amino acids, influxes
(Table 4) and fluxes across the liver were calculated (Table 5). Influxes took the
combined contributions of the PV and HA into account, and estimated a total delivery
rate of each metabolite to the liver. The efflux subtracted from the influx provided the flux
across the liver. Though there were no significant differences in influx across any of the
groups, dose-dependent trends of increasing influxes were observed for all amino acids
except asparagine, aspartate, glutamate, glutamine, glycine, histidine, and serine, which
were similar across groups. Increased uptake from this list of amino acids represents
hepatic-specific requirements in the absence of mass-action driving fluxes. Glycine and
serine had systemically low concentrations and demonstrated a dose-dependent
significant increase in hepatic uptake. Glutamine and glutamate had systemically low
concentrations; their uptake by the liver was insignificantly and equally increased.
Asparagine and aspartate had systemically low concentrations. Here the flux across
livers with the smaller burn was reduced compared to sham while the 40% TBSA burn
fluxes were normal. Livers in the bigger burn group preferentially consumed more of
these amino acids thereby increasing the flux and significantly lowering the output
concentration. Histidine concentration did not vary with burn and its fluxes remained
within normal range. Systemically increased concentrations, and the only cases of
significantly increased HA concentrations in burn, were those of arginine, cysteine and
ornithine (40% TBSA burn only). These subsequently-increased influxes correlated
strongly with reduced fluxes across the burn liver groups. Conversely, increases in PV
concentrations outweighed concentration values in the HA that were within or below
normal range. This resulted in substantially increased fluxes across the liver for proline,
phenylalanine, lysine, alanine, threonine, and tyrosine. The BCAAs also had increasing
influx trends due to increased PV concentrations. All BCAA fluxes demonstrated a slight
upward trend in 20% TBSA burn compared with sham. In the 40% TBSA burn group
however, each BCAA differed: valine had a significantly reduced flux, isoleucine was
within normal range, and leucine was significantly increased. The resulting SHVC
concentration values were below normal for the glucogenic amino acids, normal for the
ketogenic ones and elevated for the BCAAs. To determine whether particular increases
in influxes were necessary to determine whether the liver would take up or release an
amino acid, ratios of burn influxes to sham influxes were calculated. These did not reveal
any correlations between change in influx and liver action in any of the groups.
TABLE 1. Measured In vivo Hepatic Blood Flow and Metabolite Concentrations
PARAMETER
Blood flow (ml/min)
Total Hemoglobin (g/dL)
Oxyhemoglobin (%)
Partial 02 tension (mmHg)
Partial CO2 tension (mmHg)
Dissolved 02 (mI0 2/1 00ml blood)
Total C02 (mmol/L)
pH
Glucose (mg/dL)
Lactate (mmol/L)
P -Hydroxybutyric acid (pmol/L)
Acetoacetic acid (pmol/L)
Urea nitrogen (mg/dL)
Albumin (g/dL)
Ammonia (pmol/L)
Alanine (pmol/L)
Arginine (pmol/L)
Ornithine (pmol/L)
Asparagine (pmol/L)
Aspartate (pmol/L)
Cysteine (pmol/L)
Glutamate (pmol/L)
Glutamine (pmol/L)
Glycine (pmol/L)
Histidine (pmol/L)
Proline (pmol/L)
Serine (pmol/L)
Methionine (pmol/L)
Threonine (pmol/L)
Valine (pmol/L)
Tyrosine (pmol/L)
Isoleucine (pmol/L)
Phenylalanine (pmol/L)
Leucine (pmol/L)
Lysine (pmol/L)
Sum Amino Acid Nitrogen (pmol/L)
SH
15
13,
24
27j
52
4.2
21
7.28
21
1.0
350
11
14
1.8
41
26
62
82
28j
13j
12
83
30
19
56
14
17
38
191
15
60
82
54
241
21
3E
SUPRAHEPATIC VENA CAVA
(SHVC, n=5)
AM 20% TBSA 40% TE
±7.4 20±9.1 20±6.
0.55 11±1.4 11±1.
±3.3 34±7.3 17±6.
0.63 41±16 21±6.
±5.9 48±7.8 67±5.
±0.5 5.2±1.2 2.7±1.
±2.8 22±1.9 25±0.4
+0.01 7.29±0.04 7.24±0.
)±57 165±33 144±1
L0.17 0.77±0.17 4.3±1.
±251 271±141 216±1
3±36 132±12 11±6f
±5.0 15±1.1 17±2.
0.17 1.2±0.11 1.2±0.
±3.4 29±12 19±5.
1±26 163±29 149±1
±1.5 198±30 199±2
±9.9 85±17 124±1
0.83 21±2.6 18±0.
0.88 11±2.6 8.3±0.
0.46 17±1.5 19±1.
±19 51±6.8 57±1
5±42 221±53 234±8
4±32 148±5.3 124±1
±6.6 50±10 60±7.
3±21 114±4.7 117±1
)±12 107±5.4 101±1
±1.1 32±1.9 34±1.
±24 167±37 158±7
3±54 191±21 205±1
±11 63±9.6 67±5.
±7.5 97±12 103±1
±2.8 52±7.7 51±2.
±35 266±33 240±4
)±42 201±33 207±2
83 3845 3873
Note:
Liver weights (g) in each group were SHAM: 9.4±0.76; 20% TBSA: 10.6±0.73; 40% TBSA:
9.83±0.35.
Bolded items are significantly different (p<0.05) from SHAM.
* indicates the value for 40% TBSA is significantly different (p<0.05) compared to 20% TBSA
burn
SA
2
2
1*
2
5*
1*
5*
02*
2
2*
89
0
09
7
1
3
1*
07
62
9
8
.6
4*
1
4
5
2
.5
8
5
1
9
1
4
TABLE I cont. Measured In vivo Hepatic Blood Flow and Metabolite
Concentrations
Blood flow (ml/min)
Total Hemoglobin (g/dL)
Oxyhemoglobin (%)
Partial 02 tension (mmHg)
Partial C02 tension (mmHg)
Dissolved 02 (mI0 2/100ml blood)
Total C02 (mmol/L)
pH
Glucose (mg/dL)
Lactate (mmol/L)
p -Hydroxybutyric acid (pmol/L)
Acetoacetic acid (pmol/L)
Urea nitrogen (mg/dL)
Albumin (g/dL)
Ammonia (pmol/L)
Alanine (pmol/L)
Arginine (pmol/L)
Ornithine (pmol/L)
Asparagine (pmol/L)
Aspartate (pmol/L)
Cysteine (pmol/L)
Glutamate (pmol/L)
Glutamine (pmol/L)
Glycine (pmol/L)
Histidine (pmol/L)
Proline (pmol/L)
Serine (pmol/L)
Methionine (pmol/L)
Threonine (pmol/L)
Valine (pmol/L)
Tyrosine (pmol/L)
Isoleucine (pmol/L)
Phenylalanine (pmol/L)
Leucine (pmol/L)
Lysine (pmol/L)
Sum Amino Acid Nitrogen (pmol/L)
SHAM
15±7.4
15±1.2
73±8.8
68±12
61±12
15±2.5
19±2.9
7.27±0.02
123±62
1.0±0.18
110±96
110±73
13±5.0
1.9±0.21
109±33
397±13
141±93
120±3.5
49±5.4
21±7.6
15±1.5
68±7.7
293±46
273±27
137±26
163±12
199±13
44±7.0
204±41
165±31
68±7.4
86±16
59±3.9
261±33
220±38
4880
Note:
Liver weights (g) in each group were SHAM: 9.4±0.76; 20% TBSA: 10.6±0.73; 40% TBSA:
9.83±0.35.
Bolded items are significantly different (p<0.05) from SHAM.
* indicates the value for 40% TBSA is significantly different (p<0.05) compared to 20% TBSA
burn
PORTAL VEIN
(PV, n=5)
20% TBSA
19±9.1
13±1.0
81±5.1
57±12
62±14
14±1.9
23±0.71
7.28±0.05
165±30
0.75±0.25
124±58
143±95
16±2.2
1.4±0.13
65±30
401±74
219±36
106±3.3
33±2.5
13±0.54
17±1.5
43±6.7
257±29
216±18
126±14
161±6.7
154±24
43±4.6
208±39
199±20
74±4.6
102±6.3
66±2.9
310±30
242±23
5039
40% TBSA
20±6.3
13±0.41
75±6.3
66±9.1
57±2.0
13±0.9
23±1.1
7.25±0.02
125±12*
4.9±0.84*
87±47
98±88
16±2.7
1.3±0.11
74±5.0
412±69
222±5.1
128±9.7*
31±0.65
13±3.0
17±0.82
53±16
255±5.03
213±25
148±10*
177±20
153±8.3
43±1.8
211±27
205±2.9
80±5.3
101±1.4
66±4.1
340±13
270±14
5313
TABLE I cont. Measured In vivo Hepatic Blood Flow and Metabolite
Concentrations
Blood flow (ml/min)
Total Hemoglobin (g/dL)
Oxyhemoglobin (%)
Partial 02 tension (mmHg)
Partial C02 tension (mmHg)
Dissolved 02 (ml0 2/100ml blood)
Total C02 (mmol/L)
pH
Glucose (mg/dL)
Lactate (mmol/L)
P-Hydroxybutyric acid (pmol/L)
Acetoacetic acid (pmol/L)
Urea nitrogen (mg/dL)
Albumin (g/dL)
Ammonia (pmol/L)
Alanine (pmol/L)
Arginine (pmol/L)
Ornithine (pmol/L)
Asparagine (pmol/L)
Aspartate (pmol/L)
Cysteine (pmol/L)
Glutamate (pmol/L)
Glutamine (pmol/L)
Glycine (pmol/L)
Histidine (pmol/L)
Proline (pmol/L)
Serine (pmol/L)
Methionine (pmol/L)
Threonine (pmol/L)
Valine (pmol/L)
Tyrosine (pmol/L)
Isoleucine (pmol/L)
Phenylalanine (pmol/L)
Leucine (pmol/L)
Lysine (pmol/L)
Sum Amino Acid Nitroqen (pmol/L)
SHAM
0.66±0.11
13±1.1
90±4.9
114±27
45±3.7
15±1.7
21 ±1.1
7.28±0.03
164±57
0.94±0.55
245±205
122±21
14±4.3
1.9±0.10
50±5.4
357±35
107±7.9
105±20
43±3.4
11±1.2
16±1.2
78±5.2
419±36
218±5.4
65±0.17
169±5.6
219±24
54±9.6
252±40
202±69
80±10
122±28
65±4.4
321 ±88
237±42
4809
HEPATIC ARTERY
(HA, n=5)
20% TBSA 4
0.46±0.05
12±0.94
92±0.92
115±15
52±11
16±1.1
20±1.9
7.29±0.04
141 ±28
0.55±0.16
62±23
101±67
13±1.7
1.1±0.14
38±1.4
302±14
195±37
117±1.8
35±2.3
8.6±3.7
21±0.7
46±12
359±29
187±17
59±5.4
147±14
159±9.6
42±4.1
221±23
193±22
89±1.6
106±11
63±2.0
276±33
193±18
4640
Note:
Liver weights (g) in each group were SHAM: 9.4±0.76; 20% TBSA: 10.6±0.73; 40% TBSA:
9.83±0.35.
Bolded items are significantly different (p<0.05) from SHAM.
* indicates the value for 40% TBSA is significantly different (p<0.05) compared to 20% TBSA
burn
0% TBSA
).46±0.27
9.9±1.2*
85±3.6*
96±13
48±1.1
12±1.6*
25±1.8*
7.25±0.02
144±18
3.5±0.6*
141±66
61±36
17±2.6*
1.3±0.17
23±2.4*
284±33
185±11
138±21
33±3.4
9.4±2.0
25±1.1*
45±9.0
405±15*
163±10*
67±3.5*
150±7.5
178±19
40±5.5
203±15
193±27
82±5.4*
100±19
67±1.1*
290±62
224±1*
4759
TABLE 2. Non-MFA In vivo Hepatic Blood Chemistry Values
PARAMETER
Insulin (ng/ml)
AST (u/L) (87-114)
ALT (u/L) (28-40)
ALP (u/L) (136-188)
Total Bilirubin (mg/dL) (0.1-1.0)
Creatinine (mg/dL) (0.5-0.6)
Cholesterol (mg/dL) (55-89)
HDL (mg/dL)
LDL (mg/dL)
VLDL (mg/dL)
Triacylglycerol (mg/dL) (62-92)
PARAMETER
AST (u/L) (87-114)
ALT (u/L) (28-40)
ALP (u/L) (136-188)
Total Bilirubin (mg/dL) (0.1-1.0)
Creatinine (mg/dL) (0.5-0.6)
Cholesterol (mg/dL) (55-89)
HDL (mg/dL)
LDL (mg/dL)
VLDL (mg/dL)
Triacylglycerol (mg/dL) (62-92)
PARAMETER
AST (u/L) (87-114)
ALT (u/L) (28-40)
ALP (u/L) (136-188)
Total Bilirubin (mg/dL) (0.1-1.0)
Creatinine (mg/dL) (0.5-0.6)
Cholesterol (mg/dL) (55-89)
HDL (mg/dL)
LDL (mg/dL)
VLDL (mg/dL)
Triacylglycerol (mg/dL) (62-92)
SH
(n=
1.1+
96±
48+
209±
0.32
0.25
62±
33±
28+
9±
37±
SH
(n=
95±
53±
231 ±
0.32i
0.21 j
68±
36±
26±
11
48±
SH
(n=
109±
55±
259±
0.32
0.21 j
72±
32±
30±
12+
51±
A (SHVC)SUPRAHEPATIC VENA CAV
(SHVC)
AM 20% TBSA
12) (n=12)
0.01 3.8±0.02
25.7 93±26.8
13.0 39±9.50
66.0 166±63.0
L0.06 0.31 ±0.03
L0.09 0.23±0.049
21.3 71±19.7
7.41 32±8.4
12.3 35±14.9
3.3 5±1.10
17.0 22±4.76
PORTAL VEIN
(PV)
AM 20% TBSA
12) (n=12)
30.0 110±2.36
15.1 47±7.20
81.7 188±86.9
0.06 0.34±0.05
0.03 0.22±0.04
20.0 86.4±18.6
3.15 42±10.5
11.1 37±12.2
4.47 6±1.33
23.8 27±8.15
HEPATIC ARTERY
(HA)
AM 20% TBSA
12) (n=12)
33.5 103±37.6
15.7 40±10.5
75.6 156±93.5
0.06 0.32±0.04
0.03 0.23±0.05
20.4 67±22.2
9.82 32±11.6
13.4 32±15.0
3.24 7±2.4
21.2 31±10.9
TBSA burn.
Note
Bolded items are significantly different (p<0.05) from SHAM.
* value for 40% TBSA is significantly different (p<0.05) compared to 20%
40% TBSA
(n=13)
4.5±0.02*
122±50.9
40±7.30
165±57.4
0.32±0.06
0.22±0.04
68±11.2
32±7.27
32±3.4
4±0.45
22±2.38
40% TBSA
(n=13)
47±45.4
43±7.92
198±58.9
0.32±0.06
0.21±0.03
82±8.50
35±3.56
41±6.94
5±1.03
24±4.80
40% TBSA
(n=13)
116±44.2
44±9.87
186±42.1
0.35±0.05
0.25±0.08
74±13.7
34±4.40
39±8.10
5±0.89
24±4.53
TABLE 3. Nitrogen Flux Across the Liver
Sham 20% TBSA 40%TBSA
Net Urea Nitrogen Output
(umol/min) 3.6 6.4 9
Net Albumin Nitrogen Output
(umol/min) 318 344 298
Net Amino Acid Nitrogen Uptake
(umol/min) 21 21 31
TABLE 4. Measured Influx Values
METABOLITE PV+HA
Total Oxygen (ml 02/min/g liver) 0.26±0.14
Albumin (g/min/g liver) 0.03±0.01
Lactate (mmol/min/g liver) 0.07±0.03
Glucose (mg/min/g liver) 1.81±0.68
Alanine (umol/min/g liver) 0.64±0.28
Ammonia (umol/min/g liver) 0.15±0.04
Arginine (umol/min/g liver) 0.25±0.25
Asparagine (umol/min/g liver) 0.08±0.04
Aspartate (umol/min/g liver) 0.03±0.01
Cysteine (umol/min/g liver) 0.02±0.01
Glutamate (umol/min/g liver) 0.11±0.04
Glutamine (umol/min/g liver) 0.48±0.2
Glycine (umol/min/g liver) 0.43±0.17
Histidine (umol/min/g liver) 0.22±0.13
Isoleucine (umol/min/g liver) 0.15±0.08
Leucine (umol/min/g liver) 0.44±0.22
Lysine (umol/min/g liver) 0.36±0.18
Methionine (umol/min/g liver) 0.07±0.03
Ornithine (umol/min/g liver) 0.19±0.09
Phenylalanine (umol/min/g liver) 0.09±0.04
Proline (umol/min/g liver) 0.26±0.1
Serine (umol/min/g liver) 0.32±0.15
Threonine (umol/min/g liver) 0.33±0.14
Tyrosine (umol/min/g liver) 0.11±0.06
Valine(umol/min/g liver) 0.28±0.16
Note
In vivo influx is the combined portal vein (PV) and hepatic artery (HA) contribution to that flux.
"Perfusion" is calculated according to the initial portal perfusate influx.
TABLE 5. Measured In vivo Metabolic Fluxes Across the Liver.
METABOLITE
Oxygen uptake
Carbon Dioxide output
Glucose output
Lactate uptake
Acetoacetate output
p-Hydroxybutyrate output
Urea output
Ammonia uptake
Alanine uptake
Arginine uptake
Ornithine uptake
Asparagine uptake
Aspartate uptake
Cysteine output
Glutamate output
Glutamine uptake
Glycine uptake
Histidine uptake
Proline uptake
Serine uptake
Methionine uptake
Threonine uptake
Valine uptake
Tyrosine uptake
Isoleucine uptake
Phenylalanine uptake
Lysine uptake
Leucine uptake
SHAM
(umol/hr/g)
249±132
216±30
93±37
5.6±2.6
-1.3±0.6
21 ±16
28±23
6.2±1.7
13±6.0
3.6±5.1
3.4±0.9
2.0±1.1
0.5±0.4
0.2±0.0
0.8±1.3
2.0±2.5
5.4±1.2
8.0±5.3
0.7±2.9
2.7±1.7
0.8±0.1
1.2±4.0
0.8±0.4
1.0±1.1
-0.2±0.7
0.5±0.4
1.5±0.4
-0.2±3.5
Note
Values in bold are significantly different from sham group (p<0.05)
*Values significantly different from 20% TBSA group (p<0.05)
20% TBSA
(umol/hr/g)
247±15
191 ±228
28±17
-7.3±7.0
1.1±2.7
11±17
25±38
5.3±0.6
24±10
2.3±1.8
2.6±2.5
0.9±0.2
0.2±0.3
0.0±0.1
1.1±1.1
4.0±4.4
7.1±2.5
8.0±3.8
4.8±1.4
4.8±1.6
0.9±0.4
2.4±4.9
1.2±2.8
1.0±0.4
0.5±1.3
2.2±0.6
5.1±5.7
3.1±3.1
40% TBSA
(umol/hr/g)
404±148*
291±20
124±135
87±67*
-5.5±10
8.7±9.1
76±34
6.6±1.6
31 ±8.0
2.8±3.1
0.1±2.0
1.6±0.4*
0.5±0.3
-0.3±0.1*
1.0±3.4
3.2±0.5
9.2±2.6
11±3.3
6.9±3.4
6.4±2.7
1.1±0.4
6.0±3.2
-0.1±0.4
1.5±0.3
-0.3±0.1
2.0±1.0
8.3±5.3
13±7.0*
Metabolic Flux Analysis
A total of 28 fluxes across the liver were calculated from the measured
metabolite concentrations, flow rates and liver weights from each rat and averaged
(Table 5). MFA then estimated the unmeasured internal metabolic fluxes Tables 6 and 7)
using the measured external fluxes. The significant results are mapped in Figs 1-6.
Figure 1 represents cumulatively how fluxes in each major pathway were altered (amino
acid metabolism, gluconeogenesis, TCA cycle, lipid metabolism, oxidative
phosphorylation, and urea cycle). The results show a significant reduction in
gluconeogenesis for 20% burn in contrast to a significant increase in 40% burn. Dose
dependent responses are seen in increased amino acid metabolism, and the reduced
uptake of fatty acids and glycerol. In all other circumstances, the 40% TBSA burn group
has increased fluxes compared to 20%, which approximates sham. Only the PPP
suggests an increase in 20% burn compared to 40% burn and sham.
The metabolic flux distributions are depicted as comparisons of the 20% TBSA and
40% TBSA burn groups to the sham controls in Figures 2 and 3, respectively. The 20%
TBSA burn group demonstrated few significant overall changes compared to sham
(Figure 2). The most prominent finding was a major reduction in gluconeogenesis,
despite being fasted, which favors an increase in this pathway. The concentration of
glucose exiting the liver was low, but within range of sham values. The impact of
reduced gluconeogenesis on oxidative metabolism was to retain TCA fluxes at sham
values, but fluxes feeding into the TCA cycle were smaller or diverted. The hydrolysis of
asparagine to aspartate and ammonia, for example, was significantly reduced, while
acetoacetate production increased (p<0.1), a pathway that is favored when the
concentration of acetyl CoA exceeds the oxidative capacity of the TCA cycle. Pyruvate
tended to be redirected elsewhere, such as to the production of lactate, the plasma
concentration of which was reduced systemically. Fluxes contributing to the PPP tended
to increase, which coincided with previous results on burn metabolism using isolated
perfused rat livers 3. Though insignificant, amino acid metabolism was generally
increased throughout (Table 6) except for asparagine, aspartate, ornithine, arginine and
cysteine which were either decreased or unchanged.
By contrast, the 40% TBSA burn group showed a significant increase in
gluconeogenesis (Figure 3); again the glucose concentration levels were lower, but
within range of sham upon exiting the liver. Lactate conversion to pyruvate was
significantly increased as was the uptake of several gluconeogenic amino acids. In
addition, increased uptake of ketogenic amino acids lysine and leucine occurred,
resulting in a direct increase of glutamate fueling of the TCA cycle, and a subsequent
increase in acetoacetate production. The urea cycle fluxes, as well as the fluxes
connecting it to the TCA cycle were all significantly upregulated. The pentose phosphate
pathway coincided with sham results.
Figure 4 illustrates the differences in hepatic metabolism of the two burn models.
Here it can be appreciated that the energy requirement of the 40% TBSA burn is
significantly increased compared to a 20% TBSA burn, with enhanced contributions to
the TCA cycle deriving from lactate, acetyl-CoA and amino acids. The consequences of
producing more ATP were twice as much oxygen consumption and carbon dioxide
output, and three times as much urea output compared to a 20% TBSA burn. Pathways
common to both burn groups were significant dose-dependent increases in uptake of
proline, phenylalanine and alanine (Table 6; p<0.01 in 20% TBSA burn).
TABLE 6. Balanced Metabolites for MFA
Glucose-6-P
Fructose-6-P
Fructose-1, 6-P2
Glyceraldehyde-3-P
PEP
Pyruvate
Oxaloacetate
NADH
Acetyl-CoA
Citrate
alpha-Ketoglutarate
Succinyl-CoA
Fumarate
FADH2
Malate
Arginine
Ornithine
NH4+
Citrulline
Aspartate
Alanine
Glutamate
Serine
Cysteine
Glycine
Propionyl-CoA
Acetoacetate
Acetoacetyl-CoA
02
Tyrosine
Ribulose-5-P
Ribose-5-P
Xylulose-5-P
Erythrose-4-P
C02
TABLE 7. Effect of burn injury on metabolic fluxes based on in situ (in vivo) and perfused liver data.
# REACTION
1 Glucose 6-phosphate ++ Glucose
2 Fructose 6-phosphate <-+ Glucose 6-phosphate
3 Fructose 1,6-Bisphosphate <-+ Fructose6-phosphate
4 2 Glyceraldehyde 3-P <-+ Fructose 1,6-Bisphosphate
5 Phosphoenolpyruvate + NADH +-*Glyceraldehyde 3-P
6 Oxaloacetate <-+ C02 +Phosphoenolpyruvate
7 Pyruvate + C02 <-+ Oxaloacetate
8 Lactate <-* Pyruvate + NADH
9 Acetyl-CoA + Oxaloacetate --+Citrate
10 Citrate <-+ 2-oxo-Glutarate + NADH + C02
11 2-oxo-Glutarate -> Succinyl-CoA + NADH + C02
12 Succinyl-CoA <-+ FADH2 +Fumarate
13 Fumarate <-+ Malate
PATHWAY
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Lactate metabolism & TCA cycle
Lactate metabolism & TCA cycle
Lactate metabolism & TCA cycle
Lactate metabolism & TCA cycle
Lactate metabolism & TCA cycle
Lactate metabolism & TCA cycle
IN VIVO FLUX DATA
(umol/h/g liver)
20% 40%
SHAM TBSA TBSA
(n=5) (n=5) (n=5)
93±37 28±17 124±135
99±86 58±30 129±101
66±28 29±17 112±64
57±26 27±18 108±55
95±33 39±34 205±105*
90±32 37±35 203±100*
31±18 13±30 151±70*
5.6±2.6 -7.0±7.0 87±67*
68±47 68±11 120±53
75±46 70±12 123±52
92±45 84±11 148±53
102±44 89±11 153±58
140±47 118±34 235±75
Malate *-+ Oxaloacetate + NADH
Arginine -+ Ornithine + Urea
Ornithine + C02 + NH4 +-*Citrulline
Citrulline + Aspartate --*Arginine + Fumarate
Arginine uptake
Ammonia Output
Ornithine Output
Citrulline Output
Alanine -+ Pyruvate + NH4 + NADH
Alanine Output
Serine -- Pyruvate + NH4
Serine Uptake
Cysteine -* Pyruvate+ NH4 + NADH
Cysteine Output
Lactate metabolism & TCA cycle
Urea cycle
Urea cycle
Urea cycle
Aminoacid metabolism
Urea cycle
Urea cycle
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
145±47
28±23
34±19
28±20
3.6±5.1
-6.2±1.7
-3.4±0.9
5.6±5.2
13±6.7
-13±6.2
6.8±11
2.7±1.7
0.8±3.7
0.2±0.0
120±32
25±38
32±32
27±32
2.3±1.8
-5.3±0.6
-2.6±2.5
4.6±3.1
21 ±11
-24±10
1.6±18
4.8±1.6
-2.8±5.9
0±0.1
238±80
76±34
75±29
73±29
2.8±3.1
-6.6±1.6
-0.1±2
2.2±4.3
33±9
-31±8
25±16
6.4±2.7
3.3±5.4
-0.3±0.1
Threonine -+ NADH + Glycine +Acetyl-CoA
Glycine <-+ C02 + NH4 +NADH
Glycine Uptake
Valine + 2-oxo-Glutarate -* Glutamate + propionyl-CoA
+ 3 NADH +FADH2 + 2 C02
Isoleucine + 2-oxo-Glutarate -> Glutamate + propionyl-
CoA + Acetyl-CoA + 2 NADH + FADH2 +C02
Leucine + 2-oxo-Glutarate -> Glutamate + NADH +
FADH2 Acetoacetate + Acetyl-CoA
Propionyl-CoA + C02 ->Succinyl-CoA
Lysine + 2 2-oxo-Glutarate -+ 2 Glutamate + 4 NADH
+ FADH2 + 2CO2 + Acetoacetatyl-CoA
Phenylalanine + 02 -> Tyrosine
Tyrosine + 2 02 -+NH4 + C02 + Fumarate +
Acetoacetate + NADH
Tyrosine Output
Glutamate <-+ 2-oxo-Glutarate + NADH +NH4
Glutamate Output
Glutamine -* Glutamate + NH4
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
1.2±4
4.2±8.2
5.4±1.2
0.8±0.4
-0.2±0.7
-0.2±3.5
5.1±2.0
1.5±0.4
0.5±0.4
3.7±3.7
-1.0±1.1
15±7.5
0.8±1.3
2.0±2.5
2.4±4.9
1.3±13
7.1±2.5
1.2±2.8
0.5±1.3
3.1±3.1
3.6±3.4
5.1±5.7
2.2±0.6
0.1±5.4
-1±0.4
27.4±13.7
1.1±1.1
4±4.4
6±3.2
18±11
9.2±2.6
-0.1±0.4
-0.3±0.1
5.4±0.1
2.5±6.1
4.6±2.2
2±1
6.4±6.8
-1.5±0.3
37±9
1±3.4
3.2±0.5
Proline +0.5 02-+ Glutamate + 0.5 NADH
Histidine -+ NH4 +Glutamate
Methionine + Serine -+ Cysteine + NADH + Propionyl-
CoA + C02
Aspartate+->Oxaloacetate + NH4 +NADH
Aspartate Uptake
Asparagine -+ Aspartate + NH4
Palmitate-- 8 Acetyl-CoA +7 FADH2 + 7 NADH
2 Acetyl-CoA <-+ Acetoacetyl-CoA
Acetoacetyl-CoA -+ Acetoacetate
Acetoacetate Output
Acetoacetate + NADH <-+b-Hydroxybutyrate
NADH + 0.5 02 -- NAD
FADH2 + 0.5 02 -- FAD
02 Uptake
Glucose 6-phosphate-+ 2 NADPH + C02 +Ribulose 5-
P
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Aminoacid metabolism
Lipid, glycerol, fatty acid
metabolism
Lipid, glycerol, fatty acid
metabolism
Lipid, glycerol, fatty acid
metabolism
Lipid, glycerol, fatty acid
metabolism
Lipid, glycerol, fatty acid
metabolism
Oxygen uptake and electron
transport
Oxygen uptake and electron
transport
Oxygen uptake and electron
transport
PPP
0.7±2.9
8.0±5.3
0.8±0.1
-24±17
0.5±0.4
2.0±1.1
11.1±7
11±16
15±16
-1±1
21±16
302±181
182±87
249±132
14±90
4.8±1.4
8±3.8
0.9±0.4
-30±26
0.2±0.3
0.9±0.2
8.5±4.2
2.9±19
8.6±18
1.1±2.7
11±17
327±31
158±25
247±15
32±31
6.9±3.4
10.7±3.3
1.1±0.4
-68±24
0.5±0.3
1.6±0.4
11.8±8
-7.1±14
-1.6±13
2.2±0.7
8.7±9.1
527±205
245±97
404±148
9.4±134
Ribulose 5-P < Ribose 5-P
Ribulose 5-P < Xylulose 5-P
Ribose 5-P + Xylulose 5-P <-+ Fructose6-P + Erythrose
4-P
Erythrose 4-P + Xylulose 5-P <-+ Glyceraldehyde 3-P +
Fructose 6-P
C02 Output
PPP
PPP
PPP
PPP
Oxygen uptake and electron
transport
3±30
18±61
10±30
15±31
216±30
Note
Bolded items are significantly different (p<0.05) from SHAM.
* indicates the value for 40% TBSA is significantly different (p<0.05) compared to 20% TBSA burn.
10±11
24±19
12±10
14±9.1
191±19
2.3±47
10±81
5.6±40
8.2±36
291±20
5.0 -
4.5 Sham
E 0 20% TBSA Burn
4--040% TBSA Burn
9)3.5(0
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LL
0.5
0.0
Amino acids Gluconeogenesis Lactate & TCA Lipid, Glycerol, Oxygen Uptake & PPP Urea cycle
(1 0x)* cycle Fatty Acids Electron
Transport
* Significantly different from sham-burn group (p<0.05).
** Significantly different from 20% TBSA burn group (p<0.05).
Figure 1: Summary of the effects of burn injury on the major pathways in the hepatic metabolic network. Values shown are the
averages of all fluxes in each pathway group, which were then normalized to the sham group. Pathways (from Table 6) are grouped
as follows: Gluconeogenesis: #1-7, Lactate metabolism and TCA cycle: #8-14, Oxidative phosphorylation: #53-55, 61. Pentose
phosphate pathway: #56-60. Amino acid metabolism: #18, 21-47, Urea cycle: #15-17, 19-20, Lipid metabolism: #48-52.
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Figure 2: Flux directions reflect 20% TBSA results vs. sham controls. Red = Upregulated. Blue = Downregulated, Green = Reversed.
Glicose +- d lcoe6 -56 -9RbloeS
2 68 67
Fre
Figure 3: Flux directions reflect 40% TBSA results vs. sham controls. Red = Upregulated. Blue = Downregulated, Green = Reversed.
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Figure 4: Flux directions reflect 40% vs. 20% TBSA burns. Red = Upregulated. Blue = Downregulated, Green = Reversed.
DISCUSSION
This investigation has examined the in vivo metabolic alterations in a rat model of
a 20% and 40% TBSA burn. Although this was a terminal procedure not amenable to
serial measurements, it provided the advantage of quantitatively characterizing the entire
central carbon and nitrogen metabolism at once. Subsequently, this is the first MFA
evaluation of in vivo data, and it has enabled us to connect the multiple alterations in
metabolic pathways at the whole-organ scale to produce a comprehensive hepatic-
specific map of the impact of thermal injury on metabolism. These results suggest that
MFA is an appropriate methodology for organ-scale analyses. General pathway
responses to metabolite-specific changes for a given burn severity may facilitate
targeted treatment considerations.
An initial assessment of the validity of our measured metabolite concentrations
and their trends in response to burn injury was made by comparison to published
literature. Plasma metabolite values for sham rats were found to be within the normal
range of venous and arterial blood measurements in several reports 149. Flow rate
values compared favorably with a total inflow of 1.74±0.2ml/min/g in normal livers
observed by Daemen et al 10. Both groups demonstrated a trend to increase portal flow
and decrease arterial flow for ultimately insignificant increases in total hepatic blood flow
. Overt hepatic and renal damage was negated by normal liver function tests,
creatinine and urea nitrogen values 13. Fluxes across the liver were subsequently
calculated.
The most pronounced observation in this analysis is the distinctly different
responses in gluconeogenesis by the burn groups, which is most likely related to the
dramatic increases in insulin levels observed. As the liver extracts insulin, the
measurements obtained in the SHVC may only reflect as little as 40% of the amount
delivered to it 14. Glucose production in the 20% TBSA burn group was substantially
reduced. Oxaloacetate, the conduit to forming phosphoenolpyruvate (Flux #6) was half
the value of the sham control. Oxaloacetate flux from pyruvate occured at a tenth of the
rate in sham and was 65 times smaller than in a 40% TBSA burn. Oxaloacetate
formation from malate occured at the normal rate (Flux #14), but was largely shunted
into the production of aspartate (Flux #45) thereby likely explaining the reduction in
asparagine uptake in this group. While some liver sensitivity to insulin appeared to be
retained in the 20% TBSA group, thereby minimizing its glucose output, the 40% TBSA
burn group demonstrated resistance to insulin by comparison. Despite even higher
insulin levels than the 20% TBSA burn group, the bigger burn group responded with
significantly increased gluconeogenesis, likely exacerbated upon fasting to increase the
systemically low glucose concentrations. MFA has enabled the pinpointing of the
multiple carbon sources mobilized for this increase (Table 6).
Increased insulin levels have been extensively associated with burn injury and
insulin resistance 1416. A regression analysis of several parameters including insulin,
glucagon, cortisol and triglycerides, demonstrated that in patients with low severity of
injury (no fatalities, average TBSA -37%), insulin was strongly correlated to glucose
regulation without significant interplay of other factors 17. Increased insulin release may
in part be associated with the increase in certain circulating amino acids, notably
arginine (Table 1), which is known to be a particularly strong stimulus for insulin
production and release 18 and is present in 2-3 times the concentration of sham values.
This alteration in amino acid concentration occurs in the larger context of increased
catabolism of skeletal muscle postburn which is thought to contribute 70-80% of whole
body insulin stimulated glucose uptake 19.
Impaired insulin signaling may also be related to dysregulation of fat metabolism
and in particular the development of "ectopic" fat stores in the liver and muscle 20
Reduced hepatic VLDL-TG release and fatty acid oxidation (Tables 2, 6) is known to
occur in burn injury 21 and is observed in both burn groups. These measurements
demonstrate a similarly strong dose-dependent response to burn severity as insulin. It
has been proposed that this subsequent intracellular accumulation of fat, possibly
contributing to liver enlargement seen here and in other reports of burn injury 2, may
adversely impact the normal insulin signaling response to increased metabolic demand.
A complete nitrogen balance could not be performed in this analysis but general
trends can be appreciated from the cumulative amino acid nitrogen concentration in
plasma (Table 1). In the PV, both burn groups have an increase in total nitrogen due
largely to intestinal contributions of arginine, lysine, phenylalanine, cysteine, the
branched chain amino acids, and ornithine in 40% TBSA burns. Plasma nitrogen in the
HA, representative of systemic circulating values, is slightly reduced compared to sham,
which occurs despite increased protein catabolism 24. In all groups, hepatic nitrogen
uptake occurs such that the exiting nitrogen concentrations are significantly lower than in
either PV or HA. Burn groups have on average 5% more nitrogen in the SHVC than
sham. Table 3 shows that for a 20% TBSA burn, total nitrogen uptake is comparable to
sham. The use of this nitrogen however, favors an increase in albumin production. The
40% TBSA burn group responds to the increased available amino acids in the PV,
however, the increased urea nitrogen output in this group suggests it is likely that the
primary use of amino acids at this time in severe burn recovery is devoted to production
of energy 25 and other acute phase proteins rather than albumin production, which
remains low 26. Albumin, a negative acute phase protein, is reduced systemically to the
same degree in both burn groups 27,28. The combined effects of increased catabolic rate,
altered metabolism and a substantially increased transcapillary rate commonly seen in
burn injury are known to contribute to plasma albumin reduction to varying degrees 29,30
Particular amino acids and their trends were further analyzed and compared to
other studies in both rats and humans. Cynober et. al. 31 analyzed venous blood
samples on fasted humans at Day 4 post-burn. They found that alanine, glutamate,
glutamine, glycine, proline, and serine were all significantly reduced below normal, while
the BCAAs, tyrosine, and lysine were within normal range. Ornithine was within normal
range, but then increased several days after burn. These concurred with our SHVC
values. By contrast, they found an increase in phenylalanine, and no changes in
methionine, asparagine and aspartate; we observed these trends only in the PV but not
for asparagine which was reduced systemically. Cynober et. al. point out that
phenylalanine is degraded primarily in the liver; from our flux analysis and concentration
results we have no increase in tyrosine as a result nor an increase in phenylalanine
suggesting unimpaired metabolism for this amino acid. Arterial plasma values for amino
acids were obtained by Aulick, Snelling and Groves from the legs of patients with a
range of burn severites 32-. There was general agreement amongst all studies and ours
that aspartate, glutamate, glutamine, glycine, proline, serine, and threonine were
decreased, while histidine was unchanged, and that in general, tyrosine, isoleucine,
leucine and lysine were within normal range. Our results found a decline in alanine
which agreed with Aulick's results but Snelling and Grove found it to be
unchanged/increasing. Methionine and asparagine were decreased, while phenylalanine
was normal in rats but, as in Cynober's results, these values were normal and increased
in humans respectively. Valine in rats was normal while it varied in humans. Overall,
human trends in amino acids illustrate a general increase in circulating phenylalanine,
associated with increased proteolysis in the periphery 32,35, while in rats, sampling the
aorta does not appear to have accumulated a significant increase at this point in the
circulation; it is only apparent in the PV. Rats have a systemic depletion of asparagine
and methionine in burns which does not appear to be the case in humans. Other trends
in concentration appear to be fairly comparable across species.
Amino acids that were preferentially taken up by the liver despite low circulating
concentrations include glycine and serine, amino acids that can be produced
interchangeably. From the flux results in Table 6, it would appear that glycine production
is likely favored over serine in both burn groups. This is seen directly through an
increase in glycine uptake (Flux #30) and production from threonine (Flux #28) resulting
in an increase in glycine breakdown to produce NADH (Flux #29). Indirectly, serine
uptake increases (Flux #25) but a disproportionate amount, if any, is converted into
pyruvate (Flux #24) suggesting an alternative fate for serine not captured in this MFA
model. Karner et. al. 9 suggested that glycine in rats is an important source of free
nitrogen, replacing the role of glutamine in humans 24, and is rapidly consumed in burn
injury in rats. Further, our results suggest that a correlation may exist between increased
HA concentrations of amino acids and reduced hepatic fluxes. A converse correlation
may also exist between increased PV content and a general increase in fluxes across
the liver, demonstrating a mass-action driving effect. This has already been observed in
the liver-specific degradation of phenylalanine. It is also particularly true for alanine,
which has been well-documented as being a major source for gluconeogenesis in
critically ill patients ". In both burn groups, alanine represents the largest amino acid flux
at an uptake rate 2-3 times the value observed in sham. Less often reported but
following a similar trend are proline and leucine, both of which appear to contribute
substantially in a severe burn to the formation of glutamate (Flux #33 and #42) and the
latter to acetyl-CoA (Flux #33) despite normally having minimal impact on liver
metabolism as a BCAA 18. Histidine appears to play no significant role in burn recovery.
The effect of increasing the burn size to 40% TBSA further enhanced the overall amino
acid metabolism (as seen in Figure 1), and more of the individual amino acid flux
increases reached statistical significance (as seen in Figure 3). These results are
consistent with a prior study reporting that 20% and 40% TBSA burns in rats cause
dose-dependent increases in the activity of the hepatic amino acid transporter system A
36, which is one of the major cellular transport mechanisms of alanine and other neutral
amino acids.
Increased production of lactate post thermal injury due to poor wound perfusion
is well-understood 37 and forms an important gluconeogenic precursor in 40% TBSA
burn livers. In addition to consuming at least double the amount of oxygen as any other
group, poor perfusion and impaired oxygenation may be limiting metabolism in the
bigger burn animals. Total hemoglobin reduction, a typical consequence of heat-induced
erythrocyte damage 1 appears to be critically reduced resulting in limited and
potentially inadequate oxygen supply. Though oxygen delivery is not significantly
different compared to either sham or 20% TBSA burn, most likely due to the
compensatory increase in PV flow rate, the oxygen efflux appears to be exhausted and
may be limiting the actual requirement. The results concur with the observed increase in
TCA cycle fluxes in the 40% TBSA burn group (Figures 1 and 3), which are expected to
generate the majority of the reducing equivalents (NADH and FADH 2) used as
substrates for the electron transport chain. These findings are consistent with prior
studies in rats and humans showing that burn injury increases whole-body resting
energy expenditure 39,40. Here we demonstrate the extent to which the liver is
responsible for this energy increase.
In summary, we have performed the first in vivo metabolic flux analysis of the
liver to characterize the hepatic metabolic response to experimental burn injury. We
found that within 4 days post-burn significantly different metabolic changes in the liver
result depending on burn severity. In a rat dorsal burn (20% TBSA) injury model, the
response was mild and likely primarily impacted by elevated insulin levels curtailing
gluconeogenesis. In a dorsal and ventral burn (40% TBSA) model, widespread changes
were observed aimed at increasing gluconeogenesis, and resisting insulin. The
responses included increased lactate, acetyl-CoA and amino acid utilization that
increased the TCA cycle, electron transport chain activity, and urea output. These
results agree with numerous reports in the literature regarding the changes brought
about by burn injury and, with the use of MFA, have illustrated the importance of specific
metabolites and pathways to burn recovery.
METHODS
Burn Injury Protocol
Male CD rats (Charles River Laboratories, Wilmington, MA) weighing 270-300g (n>5
for each group) were housed in a temperature- (250C) and light-controlled room (12-h
light-dark cycle). The animals were cared for in accordance with the National Research
Council guidelines. Experimental protocols were approved by the Subcommittee on
Research Animal Care, Committee on Research, Massachusetts General Hospital.
Water and rat chow were provided ad libitum. Animals were individually housed and
allowed to adjust to their new surroundings for at least 2 days prior to inception of the
experiment. On Day 0, rats were randomized into three groups and anesthetized with an
intraperitoneal injection of ketamine (62.5 mg/kg of body weight) and xylazine (12.5
mg/kg of body weight). The dorsum of each rat was shaved with clippers, and those
receiving a 40% total body surface area (TBSA) burn also had their abdomens shaved.
The area to be burned was carefully marked. A full-thickness burn covering -20% of the
TBSA was administered through a 10-s immersion in boiling water 41; the remaining 20%
burn on the abdomen was administered through a 5-s immersion in boiling water 42
Sham-treated animals were handled identically, except that room temperature water was
used. Animals were then immediately resuscitated with an intraperitoneal saline injection
(2.5 ml/kg per rat/%TBSA) and allowed to recover in individual cages. Animals were
weighed every 24 hours and food consumption was monitored.
Measurement of Hepatic Flow Rates and Blood Sampling
It has been shown that whole-body parameters of hypermetabolism post-burn injury,
including heart rate and temperature, are elevated and/or stable at Day 4 for rats of this
age {lzamis, 2009 #54. Subsequently, on the third day following the burn injury, all rats
were fasted overnight in preparation for blood sampling on the fourth day. This also
coincided with the time point of ex vivo liver perfusions that were performed in earlier
studies 4344 enabling the comparison of in vivo and ILP results. Fasting served the dual
purpose of providing a baseline measurement of the absolute rate of protein breakdown
in the body by which to compare trauma-induced catabolism, and creating a
gluconeogenic state for unidirectional fluxes in the MFA model.
On Day 4 each rat was anesthetized with ketamine (62.5mg/kg) and xylazine
(12.5mg/kg) and the abdomen was shaved from sternum to groin. A transverse
abdominal incision was made and the xyphoid process clamped and retracted to expose
the proximal abdominal contents. The intestines were moved aside and the caudal lobes
of the liver gently elevated to reveal the portal triad. A perivascular ultrasonic flow-probe
(Transonic Systems, Ithaca, NY) provided flow rates for the portal vein (PV) and hepatic
artery (HA); acoustic resolution was improved with the use of lubricant gel. The sum of
flow rates into the liver was assumed to equal the flow rate out via the suprahepatic vena
cava (SHVC).
Following flow rate measurements, a removable clamp was placed on the inferior
hepatic vena cava, immediately distal to the liver, and caudal to the renal and adrenal
vasculature. After a few minutes, gentle retraction of the liver revealed a markedly
reduced SHVC blood volume. A 23G heparinized syringe was used to withdraw -1 ml of
blood at the point of confluence of the hepatic veins into the SHVC. This technique did
not cause extraneous blood loss. The clamp was carefully removed and then placed on
the portal vein proximal to the liver. A 23G heparinized syringe was used to withdraw -1
ml of blood from the vein under high pressure. The site was clamped again to prevent
exsanguination post-sampling. To obtain a hepatic artery measurement, the abdominal
aorta was rapidly isolated caudal to its bifurcation into the common iliacs and
catheterized with a heparinized 18G catheter, again -1 ml was collected. The liver was
excised and a wet weight obtained.
Metabolite Analyses
All blood samples were immediately evaluated for blood gases () and subsequently
analyzed for multiple metabolites using a rapid-assay device (Comprehensive Metabolic
and Lipid Plus panels, Piccolo, Abaxis). The remaining blood was spun down at 3000 x g
and the plasma frozen at -800C. The samples were later analyzed for glucose, insulin,
lactate, urea, albumin, acetoacetate and p-hydroxybutyrate, using biochemical assays,
and amino acid composition (automated high-performance liquid chromatography
system, Waters Co., Milford, MA) as described elsewhere .
Data Preprocessing
An outlier analysis was performed for each variable utilizing box-and-whisker
diagrams in MATLAB (The Mathworks, Natick, MA); this resulted in deletion of less than
1% of data. The missing extracellular metabolite concentrations were replaced by the
median of the measurements from the other animals from each group, which is a
standard procedure in data mining analysis 46. Fluxes were calculated as:
SHVC SHVC -FPVCPV -FHACHA
where F is the flow rate and c is the concentration for metabolite i in the designated
vessel (SHVC, PV, or HA). A second outlier analysis was performed for the fluxes, and
58 fluxes out of 405 total were deleted. The average value for each flux (for each group)
was calculated for use in MFA, as discussed below.
Metabolic Flux Analysis (MFA)
MFA is based on fitting the measured set of fluxes to a stoichiometric model for the
hepatic metabolic reaction network developed previously {Lee, 2000 #22}. This model
captures the main biochemical reactions involved in central carbon and nitrogen
metabolism under fasting conditions. Fasting is used to deplete glycogen stores so that
glucose output reflects de novo gluconeogenesis without the confounding effects of
glycogen breakdown. Furthermore, under this condition pyruvate dehydrogenase is
inhibited, such that both glycogenolysis and pyruvate dehydrogenase fluxes can be set
equal to zero. The mathematical model uses a total of 35 metabolites (Table 4) and 61
chemical reactions (Table 6), and was implemented and solved using MATLAB software
as described previously 4.
The model estimates otherwise inaccessible intracellular reaction fluxes by
performing a mass balance around each intracellular metabolite using measured
extracellular fluxes. Assuming steady-state conditions (intracellular concentrations of
metabolites are constant), these mass balances reduce to a system of linear equations.
Briefly, the sum of fluxes to and from a metabolite or its "pool" is assumed to be zero:
S.v = 0 (1)
where the matrix S contains the stoichiometric coefficients of the biochemical reactions
in the hepatic metabolic network. Each element Sij of S is the coefficient of metabolite i in
reaction j, and each v1 of vector v is the net flux or conversion rate of reaction j. Equation
1 is separated into measured (vm) and unknown fluxes (vu), as well as the matrices
containing stoichiometric coefficients of known (Sm) and unknown reaction (Su) fluxes, as
follows:
SU= - Sm.vm (2)
The measured fluxes represent rates of uptake or release of extracellular metabolites
and by solving Equation 2 they also give estimates of unknown intracellular fluxes.
MFA was performed on each individual rat's data, and the results from all the rats in
each group pooled to determine average ± standard deviation. The validity of the
statistical model was confirmed via the test of Wang and Stephanopoulos 47, at a
threshold of p<0.05. This method statistically tests for the presence of gross errors that
are inconsistent with other measurements, which lead to the violation of the pseudo
steady-state assumption. Moreover, in the event of such errors, it can be used to identify
the artifactual/erroneous measurements that lead to these inconsistencies. This
approach was used to identify and eliminate several gross errors in the data.
Statistics
Comparisons were performed using ANOVA and 2-tailed Student's t-tests. p<0.05
was the criterion used for statistical significance.
ACKNOWLEDGEMENTS
This work was supported by the Shriners Hospitals for Children (8640, 8450, 8460,
8490, 8496, 8503) and the National Institutes of Health grant# DK080942.
REFERENCES
1. Giknis, M.L.A., Clifford, C.B. Clinical Laboratory Parameters for Crl: CD(SD)
Rats. (2006).
2. Vollmar, B., Pradarutti, S., Richter, S., Menger, M.D. In vivo quantification of
ageing changes in the rat liver from early juvenile to senescent life. Liver 22, 330-
341 (2002).
3. Lee, K., Berthiaume, F., Stephanopoulos, G.N., Yarmush, D.M., Yarmush, M.L.
Metabolic Flux Analysis of Postburn Hepatic Hypermetabolism. Metabolic
Engineering 2, 312-327 (2000).
4. Daull, P., Blouin, A., Cayer, J., Beaudoin, M., Belleville, K., Sirois, P., Nantel, F.,
Chang, T.M.S., Battistini, B. Profiling Biochemical and Hemodynamic Markers
Using Chronically Instrumented, Conscious and Unrestrained Rats Undergoing
Severe, Acute Controlled Hemorrhagic Hypovolemic Shock as an Integrated in-
vivo Model System to Assess New Blood Substitutes. Vascular Pharmacology
43, 289-301 (2005).
5. Jin, G., Kataoka, Y., Tanaka, M., Mizuma, H., Nozaki, S., Tahara, T., Mizuno, K.,
Yamato, M., Watanabe, Y. Changes in Plasma and Tissue Amino Acid Levels in
an Animal Model of Complex Fatigue. Nutrition 25, 597-607 (2009).
6. Milakofsky, L., Hare, T., Miller, J. M., Vogel, W. H. Rat Plasma Levels of Amino
Acids and Related Compounds During Stress. Life Sciences 36, 753-761 (1984).
7. Moslen, M.T., Kanz, M.F., Bhatia, J., Smith, C.V., Rassin, D.K. Biliary glutathione
and some amino acids are markedly diminished when biliary pressure is
elevated. Experimental and Molecular Pathology 61, 1-15 (1994).
8. Yokoyama, T., Banta, S., Berthiaume, F., Nagrath, D., Tompkins, R.G., Yarmush,
M.L. Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a D-
galactososamine-induced rat liver failure model. Metabolic Engineering 7, 88-103
(2004).
9. Karner, J., Roth, E., Funovics, J., Hanusch, J., Walzer, L., Adamiker, D., Berger,
A., Meissl, G. Effects of burns on amino acid levels in rat plasma, liver and
muscle. Burns 11, 130-137 (1984).
10. Daemen, M.J.A.P., Thijssen, H.H.W., van Essen, H., Vervoort-Peters, H.T.M.,
Prinzen, F.W., Struyker Boudier, H.A.J., Smits, J.F.M. Liver Blood Flow
Measurement in the Rat. Journal of Pharmacological Methods 21, 287-297
(1989).
11. Wilmore, D.W., Goodwin, C.W., Aulick, L.H., Powanda, M.C., Mason, A.D., Pruitt,
B.A. Effect of injury and infection on visceral metabolism and circulation. Annals
of surgery 192, 491-504 (1980).
12. Carter, E.A., Tompkins, R.G., Burke, J.F. Hepatic and intestinal blood flow
following thermal injury. J Burn Care Rehabil. 9, 347-350 (1988).
13. Jeschke, M.G. The hepatic response to thermal injury: Is the liver important for
postburn outcomes? Mol Med 15, 337-351 (2009).
14. Carter, E.A., Burks, D, Fishcman, A.J., White, M., Tompkins, R.G. Insulin
resistance in thermally-inured rats is associated with post-receptor alterations in
skeletal muscle, liver and adipose tissue. International Journal of Molecular
Medicine 14, 653-658 (2004).
15. Frayne, K.N. Effects of burn injury on insulin secretion and on sensitivity to
insulin in the rat in vivo. Eur J Clin Invest 5, 331-337 (1975).
16. Childs, C., Heath, D.F., Little, R.A., Brotherston, M. Glucose metabolism in
children during the first day after burn injury. Arch Emerg Med 7, 135-147 (1990).
17. Volenec, F.J., Clark, G.M., Mani, M.M., Kyner, J., Humphrey, L.J. Metabolic
profiles of thermal trauma. Ann Surg 190, 694-698 (1979).
18. Champe, P.C., Harvey, R.A., Ferrier, D.R. Biochemistry, (Lippincott Williams &
Wilkins, Baltimore, 2005).
19. DeFronzo, R.A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., Felber, J.P. The
effect of insulin on the disposal of intravenous glucose. Results from indirect
calorimetery and hepatic and femoral venous catheterization. Diabetes 30, 1000-
1007 (1981).
20. Cree, M.G., Wolfe, R.R. Postburn trauma insulin resistance and fat metabolism.
Am J Physiol Endocrinol Metab 294, 11-19 (2007).
21. Morio, B., Irtun, 0., Herndon, D.N., Wolfe, R.R. Propranolol decreases
splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate
diet. Ann Surg 236, 218-225 (2002).
22. Barrow, R.E., MIcak, R., Barrow, L.N., Hawkins, H.K. Increased liver weights in
severely burned children: comparison of ultrasound and autopsy measurements.
Burns 30, 565-568 (2004).
23. Mittendorfer, B., Jeschke, M.G., Wolf, S.E., Sidossis, L.S. Nutritional hepatic
steatosis and mortality after burn injury in rats. Clin Nutr 17, 293-299 (1998).
24. Goldstein, S.A. The effects of injury and sepsis on fuel utilization. Annu. Rev.
Nutr. 9, 445-473 (1989).
25. Wolfe, R.R. Regulation of skeletal muscle protein metabolism in catabolic states.
Curr Opin Clin Nutr Metab Care 8, 61-65 (1981).
26. Hiyama, D.T., von Allmen, D., Rosenblum, L., Ogle, C.K., Hasselgren, P.O.,
Fischer, J.E. Synthesis of albumin and acute-phase proteins in perfused liver
after burn injury in rats. J Burn Care Rehabil. 12, 1-6 (1991).
27. Rosenoer, V.M., Oratz, M., Rothschild, M.A. Albumin Structure, Function and
Uses, (Oxford: Pergamon, 1977).
28. Sheridan, R.L., Prelack, K., Cunningham, J.J. Physiologic hypoalbuminemia is
well tolerated by severely burned children. The Journal of Trauma: lnjury,
Infection and Critical Care 43, 448-452 (1997).
29. Don, B.R., Kaysen, G. Serum albumin: relationship to inflammation and nutrition.
Semin Dial. 17, 432-437 (2004).
30. Fleck, A., Raines, G., Hawker, F., Trotter, J. Wallace, P.I., Ledingham, I.M.,
Calman, K.C. Increased vascular permeability: a major cause of
hypoalbuminaemia in disease and injury. Lancet 1, 781-784 (1985).
31. Cynober, L., Dinh, F.N., Blonde, F., Saizy, R., Giboudeau, J. Plasma and urinary
amino acid pattern in severe burn patients - evolution throughout the healing
period. The American Journal of Clinical Nutrition 36, 416-425 (1982).
32. Aulick, L.H., Wilmore, D.W. Increased peripheral amino acid release following
burn injury. Surgery 85, 560-565 (1979).
33. Snelling, C.F.T., Woolf, L.I., Groves, A.C., Moore, J.P., Duff, J.H. Amino acid
metabolism in patients with severe burns. Surgery 91, 474-481 (1982).
34. Groves, A.C., Moore, J.P., Woolf, L.I., Duff, J.H. Arterial plasma amino acids in
patients with severe burns. Surgery 83, 138-143 (1978).
35. Kinney, J.M., Elwyn, D.H. Protein metabolism and injury. Ann Rev Nutr 3, 433-
466 (1983).
36. Lohmann, R., Souba, W., Zakrzewski, K. & Bode, B. Stimulation of rat hepatic
amino acid transport by burn injury. Metabolism 47. 608-616 (1998 ).
37. Wolfe, R.R. Acute versus chronic response to burn injury. Circ Shock 8, 105-115
(1981).
38. Palmieri, T.L., Caruso, D.M., Foster, K.N., Cairns, B.A., Peck, M.D., Gamelli,
R.L., Mozingo, D.W., Kagan, R.J., Wahl, W., Kemalyan, N.A., Fish, J.S., Gomez,
M., Sheridan, R.L., Faucher, L.D., Latenser, B.A., Gibran, N.S., Klein, R.L.,
Solem, L.D., Saffle, J.R., Morris, S.E., Jeng, J.C., Voigt, D., Howard, P.A.,
Molitor, F., Greenhalgh, D.G. Effect of blood transfusion on outcome after major
burn injury: a multicenter study. Crit Care Med 34, 1602-1607 (2006).
39. Jeschke, M., Herndon, D. & Barrow, R. Insulin-like growth factor I in combination
with insulin-like growth factor binding protein 3 affects the hepatic acute phase
response and hepatic morphology in thermally injured rats. Ann Surg 231, 408-
416(2000).
40. Jeschke, M.G., Mlcak, R.P., Finnerty, C.C., Norbury, W.B., Gauglitz, G.G., Kulp,
G.A., Herndon, D.N. Burn size determines the inflammatory and hypermetabolic
response. Crit Care 11, R90 (2007).
41. Carter, E.A., Derojas-Walker, T., Tami, S., Tannebaum, S.R., Yu, Y.M.,
Tompkins, R.G. Nitroc oxide production is intensely and persistently increased in
tissue by thermal injury. Biochem J 304(1994).
42. Baskaran, H., Yarmush, M.L., Berthiaume, F. Dynamics of Tissue Neutrophil
Sequestration after Cutaneous Burns in Rats. Journal of Surgical Research 93,
88-96 (2000).
43. Banta, S., Yokoyama, T., Berthiaume, F., Yarmush, M.L. Effects of
dehydroepiandrosterone administration on rat hepatic metabolism following
thermal injury. Journal of Surgical Research 127, 93-105 (2005).
44. Lee, K., Berthiaume, F., Stephanopoulos, G.N., Yarmush, D.M., Yarmush, M.L.
Profiling of Dynamic Changes in Hypermetabolic Livers. Biotechnology and
Bioengineering 83, 400-415 (2003).
45. Arai, K., Lee, K., Berthiaume, F., Tompkins, R.G., Yarmush, M.L. Intrahepatic
Amino Acid and Glucose Metabolism in a D-Galactosamine-Induced Rat Liver
Failure Model. Hepatology 34, 360-371 (2001).
46. Witten, I.H. & Frank, E. Data Mining: Practical machine learning tools and
techniques, (Morgan Kaufmann, San Francisco, 2005).
47. Wang, N.S. & Stephanopoulos, G. Application of macroscopic balances to the
identification of gross measurement errors. 25, 2177-2208 (1983).
62
Chapter 3: Design of a Normothermic Extracorporeal Liver Perfusion
System (NELP)
In this chapter we describe the design and implementation of an ex vivo perfusion system that is
capable of successfully storing healthy transplantable livers for 6 hours.
The work described in section 3-2 was first published as part of:
Tolboom, H., Pouw, R., Uygun K., Tanimura, Y., Izamis, M.-L., et. al. A Model for Normothermic
Preservation of the Rat Liver. Tissue Engineering. (2007) 13, 2143-2151
The full publication is attached as Appendix 1.
3-1. MFA comparison of simple organ perfusion systems to in vivo parameters.
An in vivo model provides us with a basis upon which to establish a physiologically
relevant perfusion system. We devise a simple way of creating such a system by
comparing the metabolic profile of a preexisting design to those obtained in vivo and
accordingly adjusting the parameters to enable stable, long-term function. We begin with
a perfusion system used previously in our lab to evaluate liver metabolism. Its design is
representative of many currently employed perfusion systems that have varied very little since
Hems and Krebs' endorsed the use of Miller and Mortimore's designs2'3 in 1966 to study various
facets of liver physiology4 5 . Blood or components of blood were originally used but this practice
has fallen out of favor with some investigators' 7 because of the additional logistical complexity it
introduces as well as the likely extent to which it impacts metabolic measurements. The
perfusion system we start with therefore comprises a peristaltic pump to flow perfusate through
a jacketed oxygenator, heat exchanger, and bubble trap into the liver via the portal vein and out
via the suprahepatic vena cava back to the perfusate reservoir. The perfusate comprises a cell
culture medium that is oxygenated with 95%02/5%C02. Using MFA, we compare its metabolic
profile to in vivo results and arrive at the following major conclusions and requirements for a
successful normothermic perfusion system:
* We evaluate the use of the perfusion system as a technique to capture in vivo organ
metabolism by extrapolating observed metabolic rates in perfusion to appreciate
what they were in vivo, minutes earlier. We take healthy livers and the same model
of mild liver hypermetabolism (20% TBSA burn) and compare their metabolism using
ex vivo perfusion and in vivo results. The data show that the liver responds quickly
and significantly to its new ex vivo surroundings, suggesting that MFA cannot
accurately portray its in vivo metabolic rate during the first hour of perfusion if the
perfusate differs significantly from in vivo. This first hour reflects an adjustment by the
liver to its new environment and should be taken into account when evaluating ex
vivo organ stability.
* The metabolic rate of a normothermic perfusion requires a high oxygen delivery rate.
Flow rates in the absence of oxygen carriers must be increased to ensure adequate
oxygenation but at values 3x physiological, risk inducing mass-action effects that
drive fluxes inappropriately or cause liver damage. We propose the addition of
erythrocytes to the system to reduce flow rates to physiological values.
* To minimize the volume of erythrocytes used for both ethical and logistical reasons,
we propose the formation of a primary, erythrocyte-containing, circuit and a
secondary circuit connected to a perfusate reservoir.
* Communication between the circuits will be facilitated by a dialyzer with a cutoff
weight to exclude albumin. This will serve as the "kidney" of the system enabling
adequate mixing of nutrients and waste molecules from the primary to secondary
circu it.
* The use of erythrocytes will enable the use of a 21%02/5%C02 and balance nitrogen
gas mixture if it is determined that high oxygen tension is contributing to free radical
damage8.
" We propose the use of a perfusate medium more closely resembling in vivo
conditions and better suited to the culture of rat hepatocytes, such as phenol-red
Williams Medium E9.
* As bovine serum albumin is believed to be toxic to murine cells, we opt to exclude
this from the perfusate and initially supplement only with flash frozen and filtered
plasma from freshly drawn blood6 ' 0.
* To prevent significant leukocyte activation we propose the addition of the steroid
hydrocortisone, a common finding in cell culture medium. We also propose the
addition of penicillin and streptomycin to reduce bacterial contamination over long
perfusion times"
* A significant difference between perfused livers and in vivo livers appears to be
related to the inadequate presence of insulin in perfusate, or a high insulin/glucagon
ratio, which strongly impacts the utilization of substrates. We therefore also propose
the addition of insulin to perfusate.
Monitoring organ metabolism through ex vivo perfusion.
Much of the hypermetabolic response post-injury has been investigated through whole-
body responses, and protein turnover in skeletal muscle or the wound bed12 20. These findings
have captured the hyperdynamic circulatory changes, the increases in resting energy
expenditure, and the hypercatabolism of muscle tissue impacting the patient's overall nitrogen
balance, which form some of the distinguishing features of this disease state2-24. The need to
identify and pharmacologically target specific pathways involved in the cause-effect
relationships governing hypermetabolism has spurred multiple investigations into the role of the
liver in response to severe injury25 34 . Our lab has investigated ways in which the liver effects
changes in metabolism post-burn injury in a rat burn injury model using isolated organ perfusion
systems (ILP) 35 . The development of the metabolic flux analysis (MFA) model36 -38 enabled the
use of extracellular fluxes measured during ILP to estimate intracellular fluxes, and thereby
create a cohesive map of pathways that contributed to time-dependent changes in hepatic
metabolism 2 ,37-40. The benefits of using ILP systems are the high degree of control over liver
metabolism achieved by creating identical conditions of perfusate composition, temperature,
flow rate, etc. between experiments 41. Thus, hypermetabolic-induced differences would be best
appreciated as "intrinsic" changes in metabolism compared to sham.
However, the extent to which the ex vivo setup and perfusate conditions impact liver
metabolism, and subsequently the accuracy of ILP systems in depicting intrinsic metabolic
changes, has yet to be completely investigated. The "invasiveness" of the process of perfusion
is substantial. The animal must be heavily anesthetized, and access to the vasculature requires
the animal is sacrificed. The liver is subsequently exposed to an artificial perfusate that
inevitably differs significantly from blood incurring a response from the liver. The washout period
between time of cannulation and sample measurement may contain the most informative data
but is usually discarded because it is inherently noisy and difficult to capture. A rather
substantial assumption is therefore made that the metabolite trajectories measured every ten
minutes during the first hour of established perfusion are not significantly impacted by the liver's
new environment. In order to evaluate the validity of this assumption, we compiled a detailed
comparison of metabolic fluxes across livers in an ILP system versus livers in vivo using data
from prior studies42,43.
RESULTS
The results presented here are a meta-analysis of data obtained from healthy and
hypermetabolic livers examined in Izamis et. al.42 and Banta et. al.43. In each study, two groups
of rats were subjected to either a sham burn or a dorsal burn corresponding to 20% of the total
body surface area. Three days after burn, the animals were fasted overnight, and on the fourth
day, samples were taken either via ex vivo perfusion, or directly from the vasculature
representing the in vivo measurements.
Metabolic Flux Analysis: Isolated liver perfusion vs. in vivo
Intracellular fluxes were calculated using the MFA model of Lee et. al.3 with data
derived from the reported values measured in the isolated perfused rat liver study by Banta et.
al. 9 and the in vivo samples by Izamis et. al. .
The results of the MFA comparison between ILP and in vivo are presented in Table 1
while Figure 1 summarizes the differences of major grouped pathways. From Figure 1 we can
appreciate that perfusion significantly increased lipid metabolism, PPP activity, and
gluconeogenesis. Amino acid metabolism and urea output were also increased in perfusion
though this was not significant. Only lactate, TCA cycle, oxygen uptake and electron transport
activity tended to be equal or less than livers in vivo; they were not significantly different. Figure
2 illustrates in detail the MFA results comparing sham ILP to sham in vivo. Here we see that
perfusion causes a preferential uptake of certain amino acids: glutamine (Flux #41), which
results in an increased extracellular glutamate pool (Flux #40), asparagine (Flux #47), citrulline
(Flux #21), cysteine (Flux #26) and phenylalanine (Flux #36). While others, such as histidine
(Flux #43), glycine (Flux #30), and alanine (Flux #23), are utilized less, and arginine output
rather than uptake occurs (Flux #18). Perfusion creates a significantly elevated oxaloacetate
pool originating from increased carboxylation of pyruvate (Flux #7), fueled by increased lactate
and cysteine fluxes (Flux #8 and #26 respectively). This translates into an increased formation
of phosphoenolpyruvate (PEP, Flux #6) and aspartate, which in turn cause an increase in the
PPP and urea cycle respectively. Though fluxes through the gluconeogenic pathway are
increased as a consequence, glucose output is in fact reduced compared to in vivo, with
preference given to increasing the PPP instead. Oxaloacetate formation of aspartate is
significantly contributed to by asparagine, resulting in a significantly increased formation of
fumarate, an entry point into the TCA cycle, and arginine. Oxaloacetate entry into the TCA cycle
via citrate production is reduced in perfusion. Citrate formation is similarly bypassed by an
increased uptake of palmitate (Flux #48), which is preferentially used to produce ketone bodies
(Fluxes #51, and #52) via acetyl-CoA. This decrease in citrate formation combined with a
decreased succinyl-CoA formation via propionyl-CoA causes a significant reduction in the
majority of the TCA cycle. However, with the increased fumarate production and the increased
lactate flux, this average metabolic activity coincides with the seemingly unchanged values
compared to in vivo seen in Figure 1. Urea output is increased as arginine is metabolized or
released into the extracellular space. Ornithine and ammonia output occur rather than being
recycled to citrulline.
Hemodynamics and Perfusate Composition
Influxes were compared between in vivo and ILP sham groups to evaluate the impact of
perfusate composition and the rate of flow into the livers. Table 2 provides influx data in
columns 1 and 2 where column 1 is the combined in vivo influx obtained from both the portal
vein and hepatic artery, while column 2 is the initial perfusate influx values at t=0. Column 3 is
the ratio between perfusate and in vivo influxes. Columns 4 and 5 are the corresponding fluxes
across the livers and their ratio is expressed in column 6. A significantly higher inflow was used
in ILP of average 5.5ml/min/g liver, compared to the average 1.8ml/min/g liver observed in in
vivo conditions. This 3-fold difference enabled an oxygen delivery rate that was 40% of the in
vivo value though oxygen uptake rates were comparable between groups. Ammonia and
ornithine influxes were zero initially as they were not present in perfusate; they were observed
to accumulate in perfusate, a common occurrence that typically continues until in vivo values
are observed4 . Lactate was the only other metabolite with an influx ratio of less than 1, but it
was consumed at 16 times the rate of in vivo livers. High rates of lactate breakdown would
suggest increased gluconeogenesis, but by contrast reduced glucose output was observed in
perfusion. Glucose influx was 3-fold higher in perfusion than in vivo; there was no insulin in the
perfusate.
All other influxes were elevated 3-71 times in vivo values. A scatterplot of the ratios of
influxes and fluxes in Table 2 suggests a correlation suggesting that increasing influxes cause
higher fluxes, and vice versa, indicative of a response to a mass action by the liver (Figure 3).
Metabolic flux analysis: Burn vs. Sham
Figure 4 generalizes both the metabolic response to burn as it compares with sham, and
the significant differences between the in vivo and ILP burn groups. Overall, the trends
observed post-burn tend to agree between groups, such as an increase in amino acid
metabolism or a reduction in lipid metabolism however, the response by the ILP group seems
generally damped by comparison. This is particularly evident in that only the in vivo model is
capable of depicting any differences between sham and burn by a significantly reduced
gluconeogenesis pathway. Gluconeogenesis, the PPP and lipid metabolism continue to differ
significantly between ILP and in vivo post-burn suggesting livers respond very rapidly to the ex
vivo environment and that it tends to overwhelm the underlying pathology being investigated.
Figure 5 displays the MFA outcomes of sham vs. burn side by side for both in vivo and ILP and
shows that at this level of detail, both techniques estimate substantially different liver responses
to burn. It could be argued that both models demonstrate an increase in glutamate formation
though by different pathways; that acetoacetate production is favored over P-hydroxybutyrate;
and that reduced lactate in ILP ultimately suggests reduced gluconeogenesis as seen in vivo.
Figure 6 however demonstrates that ILP 20% TBSA burn livers have distinctly different
metabolisms from in vivo livers. Intrinsic differences between sham and burn are unlikely to be
distinguished in an organ largely impacted by a non-physiological perfusate stimulus.
Table 1: Effect of burn injury on metabolic fluxes based on in situ (in vivo) and perfused liver data.
IN VIVO FLUX
DATA
PERFUSED LIVER
DATA
REACTION
Glucose 6-phosphate <-+ Glucose
Fructose 6-phosphate <-+ Glucose 6-phosphate
Fructose 1,6-Bisphosphate <-+ Fructose6-phosphate
2 Glyceraldehyde 3-P <-+ Fructose 1,6-Bisphosphate
Phosphoenolpyruvate + NADH +-Glyceraldehyde 3-P
Oxaloacetate <-+ C02 +Phosphoenolpyruvate
Pyruvate + C02 <-+ Oxaloacetate
Lactate <-+ Pyruvate + NADH
Acetyl-CoA + Oxaloacetate -+Citrate
Citrate *-> 2-oxo-Glutarate + NADH + C02
2-oxo-Glutarate -> Succinyl-CoA + NADH + C02
Succinyl-CoA <-* FADH2 +Fumarate
PATHWAY
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Lactate metabolism
TCA cycle
Lactate metabolism
TCA cycle
Lactate metabolism
TCA cycle
Lactate metabolism
TCA cycle
Lactate metabolism
TCA cycle
Lactate metabolism &
TCA cycle
(umol/h/g
SHAM
(n=5)
93±37
99±86
66±28
57±26
95±33
90±32
31±18
5.6±2.6
68±47
75±46
92±45
102±44
liver)
20%
TBSA
(n=5)
28±17 a
58±30
29±17a
27±18
39±34a
37±35
13±30
-7.0±7.0a
68±11
70±12
84±11
89±11
(umol/h/g
SHAM
(n=5)
52±6 b
174±74
96±21
97±20 b
157±20 b
157±20 b
124±20 b
89±14 b
34±14
33±13
50±13
49±13 b
liver)'
20%
TBSA
(n=5)
51±11
201 ±48c
102±15*
102±15*
155±20 c
155±20 c
100±20 c
67±14 c
20±15*
20±14 c
49±14 c
50±14 c
13 Fumarate <-+ Malate 140±47 118±34 125±20 149±21
Malate +-+ Oxaloacetate + NADH
Arginine -> Ornithine + Urea
Ornithine + C02 + NH4 <-+Citrulline
Citrulline + Aspartate -->Arginine + Fumarate
Arginine uptake
Ammonia Output
Ornithine Output
Citrulline Output
Alanine -+ Pyruvate + NH4 + NADH
Alanine Output
Serine -+ Pyruvate + NH4
Serine Uptake
Cysteine -> Pyruvate+ NH4 + NADH
Cysteine Output
Threonine -+ NADH + Glycine +Acetyl-CoA
Glycine +-* C02 + NH4 +NADH
Glycine Uptake
Valine + 2-oxo-Glutarate --+ Glutamate + propionyl-CoA +
3 NADH +FADH2 + 2 C02
Lactate metabolism &
TCA cycle
Urea cycle
Urea cycle
Urea cycle
Aminoacid
metabolism
Urea cycle
Urea cycle
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
145±47
28±23
34±19
28±20
3.6±5.1
-6.2±1.7
-3.4±0.9
5.6±5.2
13±6.7
-13±6.2
6.8±11
2.7±1.7
0.8±3.7
0.2±0.0
1.2±4
4.2±8.2
5.4±1.2
0.8±0.4
120±32
25±38
32±32
27±32
2.3±1.8
-5.3±0.6
-2.6±2.5
4.6±3.1
21±11
-24±10
1.6±18
4.8±1.6
-2.8±5.9
0±0.1 a
2.4±4.9
1.3±13
7.1±2.5
1.2±2.8
125±20
59±17
42±15
6 9±15'
-16±7
7±1 b
11±5 b
-27±9 b
7±4
-2±2 b
21±10
6±4
7±3 b
_1 1b
-2±2
11±6
2±1 b
0±1 b
149±21
76±16*
61±15
92±16 *
-20±10c
9±3 c
11±8c
31±13 c
6±3 c
*2±2c
22±10
8±3
6±3 c
-1±0c
-1 ±1
11±7
4±1
0±1
Isoleucine + 2-oxo-Glutarate --> Glutamate + propionyl-
CoA + Acetyl-CoA + 2 NADH + FADH2 +C02
Leucine + 2-oxo-Glutarate -+ Glutamate + NADH +
FADH2 Acetoacetate + Acetyl-CoA
Propionyl-CoA + C02 ->Succinyl-CoA
Lysine + 2 2-oxo-Glutarate --+ 2 Glutamate + 4 NADH +
FADH2 + 2CO2 + Acetoacetatyl-CoA
Phenylalanine + 02 --* Tyrosine
Tyrosine + 2 02 -+NH4 + C02 + Fumarate +
Acetoacetate + NADH
Tyrosine Output
Glutamate <-+ 2-oxo-Glutarate + NADH +NH4
Glutamate Output
Glutamine -+ Glutamate + NH4
Proline +0.5 02-+ Glutamate + 0.5 NADH
Histidine -> NH4 +Glutamate
Methionine + Serine -> Cysteine + NADH + Propionyl-
CoA + C02
Aspartate<-0xaloacetate + NH4 +NADH
Aspartate Uptake
Asparagine -> Aspartate + NH4
Palmitate-+ 8 Acetyl-CoA +7 FADH2 + 7 NADH
2 Acetyl-CoA +-* Acetoacetyl-CoA
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Lipid, glycerol, fatty
acid metabolism
Lipid, glycerol, fatty
acid metabolism
-0.2±0.7
-0.2±3.5
5.1±2.0
1.5±0.4
0.5±0.4
3.7±3.7
-1.0±1.1
15±7.5
0.8±1.3
2.0±2.5
0.7±2.9
8.0±5.3
0.8±0.1
-24±17
0.5±0.4
2.0±1.1
11.1±7
11±16
0.5±1.3
3.1±3.1
3.6±3.4
5.1±5.7
2.2±0.6a
0.1±5.4
-1±0.4
27±14
1.1±1.1
4±4.4
4.8±1.4a
8±3.8
0.9±0.4
-30±26
0.2±0.3
0.9±0.2a
8.5±4.2
2.9±19
0±1
0±1
0± 2 '
2±2
3±1 b
8±3
0±2
20±8
7±1 b
16±8 b
2±2
1±1 b
1 ±0
-56±14 b
0±1
9±4'
22±3
69±10 ob
0±1
0±1
1±2
2±1
3±0 4
8±3
0±1
33±10
16 c, d
37±9 c,'d
3±1
1±1 4
1±0
-74±15c
-3+1 c,d
17±6 c
18±3 c
62±15 c
50 Acetoacetyl-CoA -+ Acetoacetate
51 Acetoacetate Output
52 Acetoacetate + NADH <-+b-Hydroxybut
53 NADH + 0.5 02 -> NAD
54 FADH2 + 0.5 02 -+ FAD
55 02 Uptake
56 Glucose 6-phosphate-> 2 NADPH + C
57 Ribulose 5-P <-+ Ribose 5-P
58 Ribulose 5-P < Xylulose 5-P
Ribose 5-P + Xylulose 5-P <-+ Fructos
59 P
Erythrose 4-P + Xylulose 5-P <-+ Gl
60 Fructose 6-P
61 C02 Output
Note
1 Data from ref. [39].
a,b Values different from in vivo sham, p<0.05
C Values different from in vivo 20% TBSA, p<0.05
d Values different from sham perfusion, p<0.05
yrate
02 +Ribulose 5-P
e6-P + Erythrose 4-
yceraldehyde 3-P +
Lipid, glycerol, fatty
acid metabolism
Lipid, glycerol, fatty
acid metabolism
Lipid, glycerol, fatty
acid metabolism
Oxygen uptake and
electron transport
Oxygen uptake and
electron transport
Oxygen uptake and
electron transport
PPP
PPP
PPP
PPP
PPP
Oxygen uptake and
electron transport
15±16
-1±1
21±16
302±181
182±87
249±132
14±90
3±30
18±61
10±30
15±31
216±30
8.6±18
1.1±2.7
11±17
327±31
158±25
247±15
32±31
10±11
24±19
12±10
14±9.1
191±19
71±10 0 b
18±5 b
60±8 b
236±48
204±25
240±34
121±75
40±25
79±51
40±26
39±27
217±80
64±15 4
27±14c
45±5 c'd
212±42 4
180±23
216±29
150±50 c
50±16c
100±34 4
50±170
50±170
236±47
300 -
U ILP
250 0 in vivo
200
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E
100 *
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0
Amino acids (10x)* Gluconeogenesis Lactate & TCA cycle Lipid, Glycerol, Fatty Oxygen Uptake & PPP Urea cycle
Acids Electron Transport
Figure 1: In vivo sham vs. ILP sham. A summary the major pathways in the hepatic metabolic network. Values shown are the
averages of all fluxes in each pathway group. Flux numbers (from Table 1) averaged in each group are as follows: Gluconeogenesis:
# 1-7. Lactate & TCA cycle: # 8-14. Oxidative phosphorylation: # 53-55, #61. Pentose phosphate pathway: #2, 3, 4, 5, 6. Amino acid
metabolism: #18, # 21-47. Urea cycle: # 15-17, #19-20. Lipid metabolism: #48-52. PPP: # 56-60. *lndicates significant differences
between in vivo and ILP response to burn (p<0.05).
Figure 2: Flux directions reflect ILP results vs. in vivo. Red = Upregulated. Blue = Downregulated, Green = Reversed.
Table 2: Perfusate Influxes vs. Fluxes Across the Sham Liver
PARAMETER
Total Oxygen
(ml 02/min/g liver)
Albumin (g/min/g liver)
Lactate (mmol/min/g liver)
Glucose (mg/min/g liver)
Alanine (umol/min/g liver)
Ammonia
Arginine
Asparagine
Aspartate
Cysteine
Glutamate
Glutamine
Glycine
Histidine
Isoleucine
Leucine
Lysine
Methionine
Ornithine
Phenylalanine
Proline
Serine
Threonine
Tyrosine
Valine
INFLUX
Perfusate
PV+HA Perfusate PV+HA
0.26±0.14
0.03±0.01
0.07±0.03
1.81±0.68
0.64±0.28
0.15±0.04
0.25±0.25
0.08±0.04
0.03±0.01
0.02±0.01
0.11±0.04
0.48±0.2
0.43±0.17
0.22±0.13
0.15±0.08
0.44±0.22
0.36±0.18
0.07±0.03
0.19±0.09
0.09±0.04
0.26±0.1
0.32±0.15
0.33±0.14
0.11±0.06
0.28±0.16
0.1
0.17
0.03
5.5
2.65
0
4.15
4.79
0.35
1.42
1.81
11.08
2.1
1.63
2.2
2.2
2.88
0.56
0
1.07
2.29
3.48
2.23
1.73
2.18
0.4
6
0.4
3
4
0
17
60
12
71
17
23
45
7
15
5
8
8
0
12
9
11
7
16
8
FLUX
in vivo ILP
249±132 240±30
5.6±2.6
93±37
13±6.0
6.2±1.7
3.6±5.1
2.0±1.1
0.5±0.4
0.2±0.0
0.8±1.3
2.0±2.5
5.4±1.2
8.0±5.3
-0.2±0.7
-0.2±3.5
1.5±0.4
0.8±0.1
3.4±0.9
0.5±0.4
0.7±2.9
2.7±1.7
1.2±4.0
1.0±1.1
0.9±0.4
89±14*
52±6.0*
1.6±2.2*
-6.8±1.1*
16±7.0*
8.6±4.4*
-0.2±0.5
1.4±1.2*
7.1±1.3*
16±8.0*
2.4±1.4*
0.8±1.0*
0.4±1.1
-0.4±0.8
1.8±1.7
0.8±0.4
-11±5.0*
3.2±1.0*
2.1±1.5
5.6±3.6
-2.3±1.7
-0.5±1.7
-0.4±0.9*
Perfusate
PV+HA
1
16
0.6
0.1
-1
4
4
-0.4
7
9
8
0.4
0.1
-2
2
1
1
-3
6
3
2
-2
-0.5
-0.4
Note
* Values significantly different from in vivo group (p<0.05)
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Figure 3: Scatterplot of the ratios of perfusate to in vivo influxes, and ILP to in vivo fluxes to
determine if the liver is responsive to mass action effects from its inflow values.
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Figure 4: In vivo burn vs. ILP burn. A summary of the major pathways in hepatic metabolism after a burn injury, normalized to their
sham values. *lndicates significant differences between in vivo and ILP response to burn (p<0.05). **lndicates a significant difference
between sham and burn.
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Figure 5: Flux directions reflect 20% vs. sham. A: ILP B: In vivo. Red = Upregulated. Blue=
Downregulated, Green = Reversed
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Figure 6: Flux direction reflects ILP 20% TBSA burn vs. in vivo. Red = Upregulated. Blue = Downregulated, Green = Reversed
DISCUSSION
The purpose of this study was to use a simple perfusion methodology as a basis for
engineering an enhanced system capable of supporting a viable organ stably for extended
periods of time. We took healthy livers and livers experiencing mild hypermetabolism (20%
TBSA burn) and compared their metabolic profiles using ex vivo perfusion and in vivo results.
The disparities between the groups yielded several important perfusion design considerations.
Evaluating the impact of a new ex vivo environment.
When evaluating the use of the perfusion system as a technique to capture in vivo organ
metabolism we observed that within minutes of perfusion inception the metabolic composition of
the perfusate had a profound impact on whole organ metabolism. A perfusate that is
significantly different from blood has multiple clinical consequences: It implies that the original
metabolic state of an organ, especially a diseased one, cannot be accurately gauged or
subsequently treated; metrics for long-term organ stability and viability must be perfusion
specific, and may not be limited to known metabolic parameters, frustrating the rapidity with
which this will be translated to clinical use; approximately an hour is required for the organ to
assume a new steady state in an ex vivo environment. A positive finding regarding non-
physiologically relevant perfusates is their apparent ability to dampen, or potentially obviate the
stimuli for, metabolic abnormalities. This may be useful in returning a liver to its metabolic
baseline, potentially even enabling self-repair mechanisms. If, in addition, it were possible to
altogether reduce metabolic activity pharmacologically, the synergistic effect may be to enable
very long stable storage times. Designing a truly physiological perfusate that imparts no
systemic effects on organ metabolism is an unlikely endeavor, but ensuring a quiescent
environment that optimizes organ energy status should be strived for.
Meeting the oxygen requirements of the ex vivo perfused liver.
The metabolic rate of normothermic perfusion would logically require a high oxygen
delivery rate. Flow rates in the absence of oxygen carriers must be increased to ensure
adequate oxygenation*4 but at values 3x physiological, they risk inducing mass-action effects
that drive fluxes inappropriately, consume resources unnecessarily, accumulate toxic
byproducts more rapidly, and ultimately impart detrimental mechanical stress on the liver.
Further, it has been suggested that the use of hyperbaric oxygen is ultimately damaging to the
ultrastructural components of hepatocytes, the mitochondria in particular8. We propose the
addition of erythrocytes to the system to reduce flow rates and oxygen tension to physiological
values. The use of erythrocytes however, introduces various levels of complexity to perfusion
design. The first is the ethical procurement of enough blood to prime the perfusion circuit; the
recommendation of a 10-20% volume of erythrocytes4 5'46 for a rat model requires the
exsanguination of 3 additional large rats for an 80ml perfusate volume, or the use of donated
blood for human livers. Which leads to the second issue of the effects of aging on the function of
the erythrocytes where the freshest possible are preferred, but are also the most metabolically
active 1,5,47,48. The issue of procurement therefore must also be considered and possibly
incorporated into the routine of the procedure. Normal erythrocyte loss of viability and
mechanical induction of lysis are feared to cause problems by varying hematocrit, causing
microemboli and possible cytotoxic effects. Further, a study by Mischinger et. al. 6 strongly
eschewed the use of erythrocytes demonstrating that even in their presence, the rate of oxygen
uptake by livers in perfusion gradually declined over time (60 minutes) prior to plateauing at
levels similar to asanguineous perfusates. It is of course entirely plausible that in the absence of
lipids in the perfusate, and the removal of any external demands on the organ, the metabolic
activity will be reduced enough to consider the removal of erythrocytes, however, none of these
studies advocated low perfusion rates which will certainly be deleterious over long perfusion
times45 at 370C. However, if the use of perfusion systems does not require function at
physiological temperatures to evaluate organ viability, then it is entirely feasible to consider the
removal of erythrocytes49 (at the increased risk of hyperbaric damage).
To minimize the volume of erythrocytes used for both ethical and logistical reasons, we
propose the formation of a primary, erythrocyte-containing, circuit and a secondary circuit
connected to a perfusate reservoir. Communication between the circuits will be facilitated by a
dialyzer with a cutoff weight designed to exclude albumin (<60kDa). This will serve as the "renal
module" of the system enabling adequate mixing of nutrients and waste molecules from the
primary to secondary circuit while retaining erythrocytes and large proteins in the primary circuit
at hematocrits controlled by the flow rates of each circuit.
Evaluating the need for impermeants or colloids.
The addition substrates to reduce or prevent cell swelling are a popular topic in organ
preservation as edema is a natural correlate of reduced ATP. Numerous impermeants and
colloids have been considered with various degrees of success50. Bovine serum albumin (BSA)
was used in this study. A natural colloid with substantial importance it has nevertheless
contended with controversy in its use - some believe it to be toxic to murine cells, while others
have shown no difference at short perfusion times49'51 . We opt to exclude this from the perfusate
and initially supplement only with flash frozen and filtered plasma from freshly drawn blood6'1 0.
Should the addition of this fragment be either redundant or deemed as conferring additional
levels of unregulated complexity to perfusion, it will be removed altogether.
Improving the basic perfusate composition through metabolic analysis.
Findings due to perfusion-based metabolism analysis may be supplemented with
additional prior results by Yamaguchi, Chen and Lee et. al. 28,35,3. Evaluation of their outcomes
reveals mixed consistency in results. While no attempts at seeking conclusions of hepatic
hypermetabolism through ex vivo perfusion are sought in this work, the point of consistency and
accuracy in perfusate content and metabolic analysis is highly valued in being able to derive
meaningful results. The volatility in these measurements speaks to the difficulty of assessing
organ function based on rapidly-changing organ metabolism. Nevertheless, through the
development of systematic stable perfusion, identifying the combination of parameters that most
strongly reflect viability will be possible.
The use of MFA improves the ability to compare perfusion outcomes based on intrinsic
organ function and metabolic state rather than highly system-specific findings. Nevertheless, the
impact of mass action driving effects further supports the need to evaluate organ function with
certain standardized perfusion conditions. For example, subtle differences between in-lab
models result in very different outcomes and interpretations. In Yamaguchi and Lee et. al.'s
work, perfusate flow rates were between 2.7 and 3.4 ml/min/g liver compared to Banta et. al. at
5.5ml/min/g liver. Flow rates in perfusion were increased in Banta et. al. in order to ensure
adequate oxygen delivery to the livers; oxygen uptake was found to be increased compared to
Lee et. al. Further, Lee et. al. did not recirculate the perfusate implying a constant concentration
at the influx compared to other groups which closed the perfusion circuit, inducing cumulative
changes in metabolite concentrations over time. The latter groups observed tendencies to arrive
at steady state values in 60 minutes, while mostly linear trends were observed in Lee et. al.
Particular pathways impacted by large influxes can be appreciated in Table 2 and Figure 3. The
rate of influx does not appear to correlate with liver function in all cases however, due to other
likely mechanisms of metabolism control.
Hormonal impact of metabolism is an important consideration in enabling stable and
non-futile metabolism. It was observed that in fasted sham in vivo livers, insulin levels were low,
but 4-fold higher in fasted 20% burn rats 52, while MEM-based perfusate was not supplemented
with insulin. Insulin was determined to be a strong factor in the reduction of gluconeogenesis
and lipid metabolism, and subsequent increase consumption of amino acids in vivo.
In conclusion, these results suggest that ILP is amenable to depicting in vivo
phenomena provided perfusate composition is used that mimics the ratios of metabolites
present in vivo, and includes appropriate amounts of hormonal constituents such as insulin and
glucagon. We subsequently propose the use of a perfusate medium more closely resembling in
vivo conditions and better suited to the culture of rat hepatocytes, such as phenol-red Williams
Medium E9. To prevent significant leukocyte activation we propose the addition of the steroid
hydrocortisone, a common finding in cell culture medium. We also propose the addition of
penicillin and streptomycin to reduce bacterial contamination over long perfusion times".
METHODS
Isolated Liver Perfusion
Surgical preparation and in situ liver perfusion have been described elsewhere 35,39
Briefly, access to the hepatic vasculature was obtained after anesthesia induction and
laparotomy. The portal vein and then the SHVC were cannulated with a 2.0-mm O.D. basket-
tipped cannula (Harvard Apparatus). The hepatic artery and inferior vena cava were ligated. The
perfusion apparatus (Harvard Apparatus) comprised a peristaltic pump, a membrane
oxygenator (95% 02, 5% CO2), and heat exchanger (38*C). A flow rate of -5.5 ml/min/g of liver
was chosen to ensure adequate oxygen delivery. The liver was flushed with -100 ml of
perfusate, prior to closing the circuit. Perfusate samples (1 ml) were collected every 10 min for
an hour and the final weight of the liver and perfusate volume were recorded. Perfusate
comprised a standard solution of Minimum Essential Medium supplemented with amino acids,
lactate, pyruvate, and 3% bovine serum albumin (BSA) as previously described 35. Measured
fluxes were calculated from the linear segment of the slope obtained by plotting the metabolite
concentration in perfusate as a function of time.
Metabolite Analyses
All blood/perfusate samples were immediately evaluated for blood gases (Bayer
Diagnostics, Pittsburgh, PA). The remaining sample was spun down at 3000 x g and the plasma
frozen at -80*C. The samples were later analyzed for glucose, lactate, urea, albumin,
acetoacetate and p-hydroxybutyrate, using biochemical assays. Amino acid composition was
determined using an automated high-performance liquid chromatography system (Waters Co.,
Milford, MA).
Statistical evaluation of the differences between perfusion and in vivo outcomes
The measured fluxes, calculated influxes and MFA results of the experiments conducted
by Izamis et. al. and Banta et. al. were compared using a 2-tailed Student's t-test, and p<0.05
was the criterion used for statistical significance.
3-2. Transplantable organ preservation with NELP.
A normothermic extracorporeal liver perfusion (NELP) is established that is comparable
to static cold storage (SCS) in the preservation of viable organs for successful
transplantation. This system enables the investigation of the treatment of reversible
pathologies such as ischemia53 and steatosis5* which could not be achieved with SCS,
thereby significantly increasing the sources of hepatocytes and transplantable organs.
In this study, we describe a novel rat NELP system (Figure 1) based on an extensively
documented isolated perfused rat liver system that was originally developed for short-term
perfusions38,43,55,56. We have modified the latter by (a) the use of a cell culture-based perfusate
supplemented with plasma, (b) the use of autologous erythrocytes as oxygen carriers, and (c)
the incorporation of continuous dialysis. This improved system can maintain healthy rat livers
metabolically stable for at least 6 hours, significantly extending the normothermic perfusion time
from the typical 2-4 hours for perfused rat livers.56 Furthermore, we show that the perfused
livers could be routinely transplanted into syngeneic recipients with excellent long-term survival.
RESULTS
Integrity of Liver During Perfusion
Levels of AST and ALT measured in the primary circuit increased 3 to 4 fold during the
course of the perfusion (Figure 2). No ALT or AST could be found in the dialysate (data not
shown). Liver wet weight slightly decreased from 9.74±0.81 g to 9.51±0.82 g during perfusion
(p<0.05 by two-tailed paired t-test, n=1 1). Hematoxylin and eosin evaluation of livers after 6
hours of normothermic perfusion showed a healthy appearance with no signs of degradation or
vacuolization, except for a slight dilation of the sinusoids compared to livers in simple cold
storage in UW solution for 6 hours (Figure 3a). TEM images demonstrate that livers stored
under both conditions appear normal. Hepatocyte mitochondria appear elongated and not
swollen, dominant rough endoplasmic reticulum. Sinusoids have open lumens and fenestrated
endothelial wall. Cell nuclei appear round and healthy, clear cell borders and obvious bile
canaliculi (Figure 3).
Metabolic Function Parameters During Perfusion
Bile production, oxygen uptake, glucose uptake, and urea secretion were monitored
during the perfusions. Bile was secreted at a constant rate with an average total of 536±75 mg
bile/g liver produced after 6 hours of perfusion (Figure 4A). The oxygen uptake rate declined
rapidly during the first 60 min after initiation of the perfusion and reached a steady state value of
0.052±0.018 ml/min/g (2.32±0.08 pmol/min/g) liver for the remainder of the perfusion (Figure
4B). The glucose level in the perfusate decreased slightly from the initial value of 200 mg/dl to
reach 182±12 mg/dl after 6 hours (Figure 4C). Urea levels exhibited a biphasic response
(Figure 4D). In the early phase, urea levels were initially flat, and then increased almost linearly
to reach a plateau at 0.6 mg/dl/g liver at 3 hours. At that time point, the dialysate was changed,
causing the levels to suddenly decrease, followed by an increase at a rate similar to that
observed in the 1 to 3 hour period, reaching a maximum level of 0.68±0.04 mg/dI/g at 6 hours.
Survival after Transplantation
Livers were transplanted into recipient rats after 6 hours of normothermic perfusion
(n=1 1) or 6 hours of simple cold storage in UW solution at 00C (n=5). In the perfused liver
group one animal died during recipient surgery due to bleeding from the anastomosis of the
SHVC and subsequent air embolism. All other animals (n=10) recovered rapidly from surgery
and survived at least one month after transplantation. No signs of liver failure, such as jaundice,
were observed. In the simple cold storage group, all animals also recovered from surgery and
survived beyond one month.
Post-operative Liver Enzymes and Bilirubin
Transplant recipients were monitored for circulating liver enzyme and bilirubin levels to
assess liver graft function (Figure 5). Both AST and ALT levels were increased on post-
operative day 1 in both groups, with values of 699±85 u/I and 431±80 u/I respectively in the
NELP group, and 615±177 u/I and 372±138 u/I respectively for the SCS group. In the NELP
group both AST and ALT levels subsequently declined to reach 131±15 u/I and 72.7±6.6 u/I
respectively on day 5, and increased again to reach 812±257 u/I and 373±133 u/I for AST and
ALT, respectively, on day 7. In contrast, in the SCS group, the levels of AST and ALT peaked
on day 5, reaching 182±182 u/I and 915±210 u/1, respectively, and then decreased
subsequently on day 7. Comparing the NELP and SCS groups shows no statistically significant
difference between AST and ALT levels, except on day 5 (p<0.05 by two-tailed n=3 unpaired t-
test n=3). Total bilirubin levels, an indicator of liver function, were similar in both groups (N=3)
on day 1, and increased to reach the maximum levels of 0.37±0.09 mg/dl and 1.73±0.83 mg/dl
in the NELP and SCS groups, respectively, on day 7.
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Figure 1: Normothermic Extracorporeal Liver Perfusion system with: (1) Primary Circuit (Pump
#1, Oxygenator, Bubble Trap, Heat Exchanger, Manometer, Sampling Port leading directly to
portal vein catheterized access of the liver in Perfusion Chamber), (II) Secondary Circuit (Pump
#2, Dialyzer, Pump #3, Dialysate Reservoir).
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Figure 2: Liver integrity during normothermic perfusion. (A) Aspartate aminotransferase (AST)
and (B) alanine aminotransferase (ALT) levels in perfusate samples collected hourly from the
primary circuit. Values are normalized to the wet weight of the liver. Values at 360 min were
17.39±6.34 U/L per g for AST and 6.25±2.18 U/L per g for and ALT, n=6.
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Figure 3: Microscopic appearance of livers after (A) 6 h of normothermic perfusion and (B) 6 h
in simple cold storage in University of Wisconsin solution. Bar=1OO[tm.
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Figure 4: Transmission electron micrograph of livers after (A) 6 h of simple cold storage in
University of Wisconsin solution and (B, C) 6 h of normothermic perfusion. Under both
conditions, the liver appears normal. Mitochondria (Mt) appear elongated and not swollen,
with dominant rough endoplasmic reticulum (RER). Sinusoids appear have open lumens (Lu)
and fenestrated endothelial wall. Cell nuclei (Nu) appear round and healthy, with clear cell
borders and obvious bile canaliculi (BC). The perfused liver shows a section of an erythrocyte
(Eryt) and a thrombocyte in the lumen. Bar=2ptm.
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Figure 5: Hepatic metabolic activity during perfusion. (A) Total bile produced normalized to wet
liver weight. (B) Hepatic oxygen uptake rate normalized to wet liver weight. (C) Glucose
concentration during the perfusion. (D) Urea levels normalized to wet liver weight, n=6.
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Figure 6: Markers of hepatic integrity and function in the
Postoperative plasma aspartate aminotransferase (AST)
levels. (C) Total plasma bilirubin levels, n=3.
transplant recipient. (A, B)
and alanine aminotransferase (ALT)
DISCUSSION
We modified the traditional isolated perfused liver system so that it can be applied to
normothermic preservation of the rat liver. The most important changes that were made are: (a)
the use of a cell culture-based perfusate supplemented with plasma and hormones, (b) the use
of autologous erythrocytes as oxygen carriers, and (c) the incorporation of continuous dialysis.
Using this modified isolated liver perfusion system, rat livers could be normothermically
preserved for 6 hours and subsequently transplanted with 100% success. Livers preserved in
this manner were similar to livers preserved with conventional simple cold storage in UW
solution with respect to gross morphology, histological appearance, recovery from surgery and
long-term survival after orthotopic transplantation. Furthermore, liver metabolic function, as
judged by bile production, hepatic oxygen uptake, and urea synthesis, were stable throughout
the perfusion after an initial 60 min period of equilibration, making it relatively easy to assess the
functional activity of donor livers prior to transplantation.
We chose the rat as model species because of relatively low cost (compared to large
animals) and extensive body of published work with isolated rat perfusion systems. The blood
supply of the rat liver is -10% arterial and -90% venous 57. Although some studies indicate that
certain areas of the liver are accessed by arterial blood only58, the bulk of the literature suggests
that it is possible to perfuse via the portal vein only56'59 , as well as to carry out the
transplantation without reconstruction of the hepatic artery60. The transplantation procedure can
be performed by one person with a total operating time around 50 min. Finally, inbred rat strains
are widely available, which makes it possible to decouple immunological compatibility issues
from handling, storage, and perfusion-related factors that affect the outcome of the transplanted
livers. We have chosen to characterize our system using healthy liver grafts in order to establish
optimal perfusion parameters, determine baseline metabolic values and establish transplant
survival data.
A key component of this perfusion system is the use of rat red blood cells as oxygen
carriers. Unlike the traditional isolated perfused liver circuit, which typically utilizes a large
circulating volume ranging from 150-300 ml (16), the primary perfusion circuit used in our
system has a volume of 50 to 55 ml, making it possible to use blood from two to three 400 g rats
providing 15 ml of blood each to achieve the hematocrit close to 20 deemed necessary for
optimal liver function 46 for one perfusion experiment. Artificial oxygen carriers have successfully
been used by others6 1,6 2, and in principle have the advantage of being inert and could potentially
exhibit more reproducible properties. However, current products, which mainly fall in the classes
of polymerized hemoglobins and perfluorocarbons, are costly and have found limited use.
Polymerized hemoglobins lose oxygen carrying capacity as they become oxidized into
methemoglobin during perfusion because they lack the erythrocyte enzymatic machinery to
reduce methemoglobin to hemoglobin. Perfluorocarbons, which are highly hydrophobic, must be
incorporated as emulsions. They have been used with success as oxygen carrier for
hypothermic machine preservation 0 . Our poor preliminary experience using perfluorocarbon
based oxygen carriers in our setup, possibly based on instability of the used emulsion, lead us
to not pursue their further use.
In our initial experiments without dialysis, we observed gradual acidosis,
hypernatraemia, and depletion of metabolic substrates in the perfusate (unpublished
observations). Our efforts to transplant livers perfused in this manner were unsuccessful,
consistent with the poor survival reported previously63 with rat livers normothermically perfused
without dialysis. Long-term normothermic perfusion of the porcine liver has been
demonstrated", but transplantation of these livers has not been reported. The only study that
demonstrates successful stable post-transplant survival employed a dialysis circuit53 . Clearly,
given the small volume of the primary perfusion circuit, a means to remove waste products and
replenish nutrients was necessary; therefore, we incorporated a secondary dialysis circuit with a
10 times greater volume, which we found effective to stabilize the pH, electrolyte, and substrate
levels in the primary perfusion circuit. The molecular cut-off weight (MCOW) of 30 kD is large
enough to enable free exchange of electrolytes, nutrients and metabolites while retaining
albumin in the perfusate, thus providing the necessary oncotic pressure.
In conclusion, we have developed a simple and cost-effective NELP system that
successfully preserves rat livers for up to 6 hours. Normothermically preserved livers were
histologically similar to livers preserved by simple cold storage in UW solution for the same
duration, and could be orthotopically transplanted successfully. Although we do not claim to
have improved on simple cold storage as a preservation method for healthy liver grafts, the
system described herein is a cost-effective alternative to the porcine liver perfusion and
transplantation models that have been employed in the field so far. It could be easily set up in
most laboratories, which should speed up the development of NELP as a preservation method.
More specifically, we envision that this system could be used to further optimize perfusion
conditions to extend normothermic preservation times for normal livers, as well as to provide
new opportunities for the preservation and recovery of marginal liver grafts.
METHODS
Chemicals
Phenol red-free Williams Medium E was from Sigma Chemical, St. Louis, MO. Human
insulin (Humulin) was from Eli Lily (Indianapolis, IN). Penicillin/streptomycin and L-glutamine
stock solutions were from Gibco Invitrogen (Grand Island, NY). Hydrocortisone (solu cortef)
was from Pharmacia &Upjohn, Kalamazoo, Mi. Heparin was from APP (Schaumberg, IL).
Isolation of donor livers
Experiments were performed using male Lewis rats (Charles River Labs, Wilmington,
MA) weighing 250-300 g. The animals were maintained in accordance with National Research
Council guidelines and the experimental protocols were approved by the Subcommittee on
Research Animal Care, Committee on Research, Massachusetts General Hospital.
The liver transplantation procedure used was the cuff technique first described by
Kamada and Calne6 5-67 . All the surgery was carried out by the same microsurgeon (H.T.) with a
prior experience of more than 100 orthotopic liver transplants in the rat. Surgery was carried out
using a Zeiss Opmi 1 microscope (Prescott, Monument, CO) with 6X magnification.
Briefly, donor operations began with a transverse abdominal incision. The bowel and
the duodenum were retracted to the right using a moist gauze to expose the portal area of liver,
the common bile duct (CBD) and the inferior vena cava (IVC). The right phrenic vein emptying
into the supra-hepatic vena cava (SHVC) was ligated. The CBD was transected after distal
clamping and insertion of 22 G polyethylene stent (Surflo, Terumo, Somerset, NJ). The IVC
was divided from the right renal and adrenal veins. The portal vein (PV) was divided from the
splenic and gastro-duodenal veins. One ml of saline containing 200 U of heparin was injected
through the penile vein. Several liver ligaments were dissected. The IVC was cross-clamped
using a microvessel clip. The PV was clamped distally and a hemicircumferrential incision was
made. An 18 G polyethylene cannula (Terumo) was inserted into the PV and the liver was
flushed with 5 ml of cold (4'C) university of Wisconsin (UW) solution (Viaspan, Barr Labs,
Pamona, NY). The diaphragm was opened, the SHCV was transected and the liver was flushed
with an additional 5 ml of UW solution. The liver was removed and placed in a bowl of ice-cold
UW solution and cuffed as described previously 68. Some livers were left in simple cold storage
for 7 hours prior to transplantation. The others were used for normothermic extracorporeal liver
perfusion.
Liver perfusion system
The perfusion system consists of a primary liver perfusion circuit and a secondary
dialysis circuit (Figure 1A). The primary circuit consists of a jacketed liver perfusion chamber
(Radnoti Glassware Technologies, Monrovia, CA) shown in Figure 1B, a MasterflexTM
peristaltic pump (Cole Parmer, Vernon Hill, IL), a membrane oxygenator (Radnoti), heat
exchanger (Radnoti), bubble trap (Radnoti), a second peristaltic pump (Cole Parmer), and a
hollow fiber dialyzer with a 2200 cm2 membrane area and a 30 kD nominal molecular weight
cut-off (Spectrum Labs, Rancho Dominguez, CA). Temperature within the liver was maintained
at 37.50C with a homeothermically controlled water bath (Lauda, Brinkmann, Westbury, NY) and
was continuously monitored by two thermocouples (Omega, Stamford, CT), one located
between the lobes of the liver, and the other in the PV cannula just before entering the vein.
The oxygenator was gassed with a 95% 02/5% CO2 mixture. The secondary dialysis circuit
consists of a 500 ml reservoir and peristaltic pump.
Normothermic extracorporeal liver perfusion
Dialysis medium consisted of phenol red-free Williams Medium E to which was added 2
U/I insulin, 40,000 U/I penicillin, 40,000 pg/I streptomycin, 0.292 g/l 1-glutamine, 10 mg/I
hydrocortisone and 1000 U/I heparin. Perfusate medium was prepared by supplementing the
same medium used for dialysis with 25% (v/v) freshly isolated rat plasma, and then adding
freshly isolated rat erythrocytes to a hematocrit of 16-18%. To obtain rat plasma and red blood
cells, rats were anesthetised with isoflurane and 1 U heparin/g body weight was injected
through the penile vein. Puncture of the abdominal aorta using a 16 G intravenous catheter
(Surflow, Terumo, Somerset, NJ) was performed and the animal exsanguinated. Blood was
kept on ice and then centrifuged in 50 ml tubes at 3200 rpm for 15 min at 40C. The plasma was
removed and set aside. The buffy coat was discarded. Erythrocytes were twice washed with
saline containing 5% dextrose (Baxter, Deerfield, IL) and centrifuged for 5 min at 3200 rpm.
The total perfusate volume used for one liver perfusion was 55 to 60 ml. Dialysate volume was
500 ml.
The liver was immersed in perfusion medium placed in the jacketed perfusion chamber.
An 18 G polyethylene catheter (Terumo) was placed inside the PV cuff and gently secured
using a 6-0 silk suture. The CBD stent was connected to a PE 50 polyethylene catheter (Becton
Dickinson) emptying into a pre-weighed microfuge tube for bile collection. The liver was
perfused via the PV only and effluent flowed freely from the SHVC and IVC into the surrounding
medium. Flow rate was maintained at 1.8 ml/min/g liver wet weight. The volume of perfusate in
the primary circuit was visually monitored and kept constant by adjusting the flow rate of
dialysate in the secondary circuit, typically ±20% of the flow rate in the primary circuit. After 3
hours of perfusion, the reservoir of dialysate was replaced by a similar reservoir containing 500
ml of fresh dialysate.
Analysis of perfusate levels of metabolites and liver enzymes
Perfusate samples (1 ml) were collected from the inlet of the liver in the primary circuit
immediately prior to placing the liver in the perfusion system and hourly thereafter. Dialysate
samples (1 ml) were collected from the reservoir in the secondary circuit at the same times.
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), glucose, and urea levels
were measured using a Piccolo miniature blood chemistry analyzer (Abaxis, Union City, CA).
Oxygen and CO2 tensions were measured in perfusate samples (0.2 ml) taken from the
in- and outflow (PV and IVC) of the liver every 10 min for the first hour of perfusion and
subsequently every hour. Samples were analyzed immediately using a blood gas analyzer
(Rapidlab, Chiron Diagnostics, Norwood, MA). The total (free and bound to hemoglobin)
concentration of 02 (g/dl) in the samples was determined according to the formula
[02] = 0.0139 x [Hb] x FO2Hb + 0.00314 x p02
where [Hb] is the hemoglobin concentration in g/dl, FO2Hb is the fraction oxygenated
hemoglobin and p02 is the partial pressure of oxygen in mmHg. The hepatic oxygen uptake
rate (HOUR) was determined by subtracting the total 02 content in the outflow minus the inflow,
then multiplying by the flow rate, and normalizing to the wet weight of the liver:
HOUR = ([02] in - [02] out) x flow rate / weight of liver.
Bile was collected continuously in pre-weighed microfuge tubes that were exchanged
every hour. Wet weight of the liver was determined during the brief periods of cold storage
before and at the end of the perfusion.
Light Microscopy
Liver tissue slices were fixed in 10% formalin, embedded in paraffin, sectioned to a 4 pm
thickness, and stained with hematoxylin and eosin.
Transmission electron microscopy
Samples of liver tissue (approx.1mm 3) were fixed in a mixture of 2.5% glutaraldehyde and 2%
paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4), washed in 0.1M cacodylate
buffer and postfixed with a mixture of 1 % osmium tetroxide + 1.5% potassium ferrocyanide for 2
hours, washed in water and stained in 1% aqueous uranyl acetate for 1 hour followed by
dehydration in grades of alcohol (50%, 70%, 95%, 2 x 100%) and then infiltrated and embedded
in TAAB Epon (Marivac Canada Inc., St. Laurent, Canada). Ultrathin sections (about 60-80 nm)
were cut on a Reichert Ultracut-S microtome, picked up onto coppergrids, stained with 0.2%
lead citrate and examined in a Tecnai G2 Spirit BioTWIN transmission electron microscope.
Images were taken with a 2k AMT CCD camera.
Transplantation surgery
At the end of the perfusion the liver was flushed with 20 ml of cold (00C) UW solution
and placed on ice in a bowl containing UW solution. Typical cold storage time was around 60
min.
Briefly, the abdomen was opened with a midline incision and exposed with wound
retractors. The bowel and the duodenum were retracted to the right using a moist gauze to
expose the portal area of liver, the CBD and IVC. The right phrenic vein emptying into the
SHVC was ligated. A 20 G polyethylene stent (Terumo) was inserted into the CBD at its
bifurcation and secured with a 6-0 silk ligature, after which the CBD was transected. The
hepatic artery and the suprarenal veins were divided. All ligaments of the liver were divided
from the surrounding tissue. The PV was tied at its bifurcation and the IVC and PV were cross-
clamped with microvessel clips. The SHVC was clamped with a Satinsky pediatric diaphragm
clamp (Miltex, Lake Success, NY) and transected close to the liver. The PV and IVC were
divided and the liver was removed. After removal of the liver, gauze soaked in ice-cold UW
solution was placed in the liver space and the donor liver was placed upon it. The SHVC was
anastomosed using a 7-0 prolene running suture (Ethicon, Somerville, NY). The donor portal
cuff was inserted into the lumen of the PV and secured with 6-0 silk. The microvessel clip on
the PV as well as the Satinsky were removed. Reperfusion of the liver was established. The
anhepatic phase of the procedure did not exceed 17 minutes. The cuff of the IVC was inserted
into the lumen of the IVC and secured using 6-0 silk. The clip on the IVC was released. The
CBD was connected. The wound was closed using 3-0 gut suture (Ethicon, Somerville, NY)
and 8 ml/kg of warm (370C) lactated Ringer's solution with 5% dextrose and 2 ml/kg of
NaHCO3 7% w/v were injected into the penile vein. The animals were put in a clean cage and
allowed to recover from anesthesia under an infrared lamp for 30 min and were subsequently
returned to the housing facility in single cage housing.
Post-operative blood sampling
To determine the post-operative levels of AST, ALT and total bilirubin, 100-200 pl of
blood were collected on post-operative days 1, 3, 5 and 7 from tail vein puncture into a
heparinized syringe under isoflurane anesthesia. The samples were immediately analyzed using
a Piccolo miniature blood chemistry analyzer.
Statistics:
Data are expressed as means ± standard error of the mean. Comparisons were made
using the Student t test.
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Chapter 4: Perfusion Recovery of Ischemic Livers for Transplantation
In this chapter we describe the application of NELP as a methodology to recover non-
transplantable ischemically damaged organs to a viable state.
This work was first published as
Tolboom, H., Pouw, R., Izamis, M.-L., et. al. Recovery of Warm Ischemic Rat Liver Grafts by
Normothermic Extracorporeal Perfusion. Transplantation. (2009) 87, 170-77
The full publication is attached as Appendix 2. Permission to reuse this article has been granted
by Wolters Kluwer Health.
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We successfully recover organs damaged by warm ischemia to transplantable state
using NELP. By contrast, static cold storage (SCS) has a 100% mortality rate. This
illustrates the superior functional advantage of perfusion as a means of expanding the
current donor pool. Transplantation is currently the only established treatment for end-stage
liver disease, but it is limited by the shortage of available organs. Extending liver graft criteria to
include marginal livers, such as those obtained from donors after cardiac death (DCD), could
alleviate this problem 1. It is estimated that about 6,000 ischemic livers 1,2 could be reconditioned
for transplantation, effectively doubling the availability of grafts. However, conventional static
cold storage (SCS) of these marginal organs leads to unsatisfactory transplant outcome 1; they
exhibit a higher risk of primary non-function as well as delayed graft failure, especially due to
biliary complications such as stricture 3. It is thought that warm ischemic damage experienced
by DCD livers leads to increased sensitivity to subsequent cold ischemia and rewarming injury
associated with SCS.
Both hypothermic and normothermic machine perfusion have been suggested as
methods to improve the preservation of DCD livers. The advantages of hypothermic perfusion
over SCS have been previously demonstrated 4-8. Recently, functional recovery of ischemically
damaged rat livers was shown using a combination of SCS followed by short term hypothermic
machine perfusion'1 0. However, extended hypothermic machine perfusion can cause
endothelial damage 1, which may limit organ viability.
Normothermic extracorporeal liver perfusion (NELP) has been suggested as a method to
avoid the problems associated with SCS and hypothermic perfusion"2 -14 . Near-normothermic
machine perfusion has been successfully used in experimental kidney preservation15-7, and
recently normothermic perfusion was shown to be superior to SCS in the preservation of DCD
livers 13,14 ,18 . A survival benefit after transplantation of DCD livers preserved normothermically
has been demonstrated in one study using a porcine model.
The complexity and high cost of large animal models limits the number of thorough
studies that can be conducted, making systematic characterization and optimization of NELP
difficult. To provide an alternative model that is more amenable to research and development,
we developed a small-scale NELP system where rat livers can be successfully transplanted
after 6 hours of normothermic perfusion 9. Herein, we investigated the potential of NELP to
recover warm ischemic livers. We show that rat livers that underwent 60 minutes of ex-vivo
warm ischemia (340C) and then preserved by 5 hours of NELP could be successfully
transplanted into syngeneic recipients. By contrast, recipients of similar livers stored by SCS for
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5 hours, as well as those transplanted directly without having undergone preservation, did not
survive.
RESULTS
Integrity and Function of Liver during Perfusion
ALT and AST activities as indicators of hepatocellular damage are shown in Figure 1A &
B; both AST and ALT accumulated during the first 180 min of perfusion and then decreased.
These values were several fold higher than those previously reported for freshly isolated livers
not subjected to any warm ischemia 19. Neither ALT nor AST were detected in the dialysate
(data not shown).
Bile secretion and oxygen consumption describe the metabolic state of the liver. Bile
was produced at a constant rate throughout the perfusion (Figure 1C). This rate was 40% lower
than that previously reported for freshly isolated livers. The HOUR of warm ischemic livers
declined rapidly during the first 60 minutes of the perfusion and then remained stable (Figure
1 D). This behavior was very similar to that observed for freshly isolated livers. The HOUR's of
the perfused warm ischemic and freshly isolated livers were very similar in the plateau region
beyond 60 min.
The urea level in the perfusate showed a steady increase from 4.20 mg/dl at t=0 to 8.60
mg/dl at t=300 minutes, indicating a constant rate of urea production. This rate was consistently
higher than that observed in perfused healthy livers (Figure 1 E).
Figure 2 shows the histological appearance of warm ischemic livers after 5 hours of
NELP. Ischemic livers treated with NELP show minimal to no damage compared to freshly
isolated livers preserved either by SCS or NELP. In contrast, livers subjected to 1 hour of warm
ischemia and subsequently preserved by SCS show swelling of hepatocytes (indicated by the
arrows in the figure), widespread vacuolization and destruction of liver architecture (as indicated
by the asterisks).
Survival after Transplantation
Warm ischemic livers were transplanted into recipient rats after 5 hours of NELP (n=13)
or 5 hours of SCS in UW solution at 00C (n=6). In addition, freshly isolated livers not subjected
to any warm ischemia were transplanted after 6 hours of SCS (n=6) or NELP (n=l 1) and
ischemic livers were transplanted directly without having undergone preservation (n=9).
i1
Transplantation of NELP treated ischemic livers was uneventful in all but one case,
where bleeding at the anastomosis occurred. All animals recovered from anesthesia rapidly.
The animal that bled during surgery died on day 4 postoperatively. The other recipient animals
survived beyond one month and did not exhibit external signs of liver failure, such as jaundice
No surgical complications occurred during transplantation of ischemic livers preserved
by SCS and recipients recovered rapidly from anesthesia, but within 6 hours all developed
symptoms and died within 12 hours. Autopsy revealed patchy livers and serous fluid in the
abdomen.
All recipients of directly transplanted ischemic livers died in a similar way within 24 hours
post-operatively.
All controls that received freshly isolated livers preserved for 6 hours by SCS recovered
rapidly from surgery and survived beyond one month (Figure 3).
Post-operative liver enzymes and bilirubin
The levels of both AST and ALT (Figures 4A and B) were elevated on day 1 post-
operatively similar to the levels found in recipients of healthy cold stored livers. Overall, values
of recipients for healthy cold-stored livers and DCD livers showed similar and normal levels
implying successful transplantation. The AST levels were significantly lower for the perfused
warm ischemic livers as compared to the healthy cold-stored livers on post-operative day 5.
Both values were comparable to those observed in a hypothermic machine perfusion study 20
The total bilirubin level, an indicator of liver function, was similar in both groups post-
operatively and showed an increasing trend (Figure 4C). The increasing bilirubin value is within
expected ranges and is likely an artifact of non-rearterialization and ensuing histopathologically
observable bile duct proliferation 21. It is worth noting that the elevated bilirubin levels are
reported 21 to normalize after 6 weeks and survival is minimally affected. There was no
statistical difference of bilirubin levels between the groups on any day.
The recipient serum analysis is displayed in Figures 4D and E. Albumin levels were
similar for both SCS and WI-NELP groups (1.52 and 1.46 mg/dL respectively), though lower
than systemic levels we previously obtained in vivo (1.91±.23 g/dl) 22. The total protein was
higher in the SCS group (5.63 vs. 4.76 g/dl, both similar to the in vivo levels of 4.96±0.64 g/dl),
suggestive of immunoglobulin elevation. Glucose levels were similar and within the normal in
vivo range (241.64±.119.81 mg/dl), as were the electrolyte levels (results not shown). ALP,
indicative of general tissue damage, was beyond the normal rat values (208.54±.66.019 U/L) for
cold stored organs (472.75 U/L). NELP-treated ischemic livers were statistically lower than
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healthy DCD livers (273.36 U/L) and well within the normal range. These results are in
agreement with slightly increased ALT and AST levels in recipients of cold stored organs,
though the difference is statistically significant only for day 5. These results overall indicate that
the function of NELP-perfused DCD livers is slightly better than cold stored healthy organs.
This could be either due to avoiding the cold injury 1, or ischemic preconditioning effects of
warm ischemia 23
Short-term graft function
In order to evaluate the very-short-term graft function post-transplantation, we employed
a diluted whole-blood reperfusion model. This was preferred to repetitive blood sampling shortly
after transplantation, as the animals would not tolerate well additional manipulations.
Figure 5 displays ALT and AST as markers of cellular damage, bile secretion as a
viability indicator, as well as liver oxygen uptake rate as base-line indicator of metabolic activity.
ALT levels for WI+NELP group was lower than WI-only and WI+SCS groups at all time points,
and indifferent from normal livers after the first 45 minutes. Very similar trend were observed for
AST, although the difference between WI+NELP and freshly isolated livers was statistically
significant at all time points except t=45min. These results suggest that NELP improves early
graft function and viability.
It was observed that bile secretion in the reperfusion system was well correlated with the
survival results (Figure 5C). Post-transplant bile secretion has been previously shown to be
strongly correlated to graft survival 24-26 and to cellular ATP levels 27,28. The average bile
production during reperfusion of normal livers and NELP-treated WI livers was statistically not
different (p=0.21); secretion for both groups was higher than the other two WI groups (p<<0.01).
Further, WI + SCS group showed lower bile secretion than WI-only group. Overall these results
were as anticipated: it is known that substrate depletion causes reduction in bile synthesis, and
the degree of reduction is proportional to ischemic injury 29
As displayed in Figure 5D, reperfusion results in oxygen uptake rates that are different
between groups. The average oxygen uptake was highest for the freshly isolated livers,
statistically higher than that of WI+ NELP and WI +SCS groups, but not different from 1hr WI
alone. There was no difference between WI+NELP and WI+SCS groups. Interestingly the WI-
only livers displayed oxygen uptakes comparable to healthy livers. While oxygen uptake can be
considered a bottom-line figure for respiration and metabolism, these results suggest that there
is limited correlation between survival and early oxygen uptake rates.
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Figure 6 displays the TUNEL staining results at the end of reperfusion. Apoptosis was
absent in healthy and NELP-treated ischemic livers, and limited in WI-only livers. By comparison,
WI+SCS group demonstrated significant staining. These results confirm that NELP is an
effective method for preservation of ischemic livers. However, the absence of apoptosis in the
WI-only livers that result in primary non-function when transplanted, suggest that apoptosis is
not a determinant factor for graft survival.
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Figure 1: Function and Integrity of warm ischemic livers during normothermic perfusion. (A)
Asparate aminotransferase (AST) and (B) Alanine Aminotransferase (ALT) levels in perfusate
samples collected hourly from the primary circuit; (C) Total bile accumulation normalized to wet
liver weight; (D) Oxygen uptake rate normalized to wet liver weight. Data shown are averages of
6 ischemic livers ± Standard Error. Values for the warm ischemic livers are significantly lower
than the controls for bile and oxygen uptake, and significantly higher for urea (p<0.01 by
Analysis of Variance). Data for the control group (normothermic perfusion of non-ischemic
livers) are from Tolboom et al.19. * indicates statistical difference compared to healthy perfused
livers at p<0.1.
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Figure 2: Microscopic appearance of livers after preservation. A) Group 1: Warm ischemic livers
after 5 hours of Normothermic Extracorporeal Liver Perfusion (NELP). B) Group II: Warm
ischemic livers after 5 hours of Static Cold Storage (SCS) in University of Wisconsin (UW)
solution (Arrows indicate cell swelling and asterisks vacuolization and tissue destruction). C)
Group Ill: Freshly isolated livers after 6 hours of NELP. D) Group IV: Freshly isolated livers after
6 hours of SCS in UW solution. Bar = 200 pm.
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Figure 3: Survival curves of recipient rats after transplantation of perfused warm ischemic livers,
warm ischemic cold-stored livers, compared to healthy perfused livers, and healthy cold-stored
livers. Data for the Normal+ Normothermic Extracorporeal Liver Perfusion (NELP) group are
from Tolboom et al. 19.
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Figure 4: Values of A) Asparate aminotransferase (AST), (B) Alanine Aminotransferase (ALT) (C) Total Bilirubin (TBIL) measured on
days 1, 3, 5, 7, 14, 21 and 28 after transplantation of perfused warm ischemic livers compared to healthy cold-stored livers. (D) and
(E): comparison of the serum levels of Albumin (ALB), Total Protein (TP), Glucose (GLU) and Alkaline Phosphatase (ALP) within 1
week after transplant. * indicates statistical difference compared to cold stored livers at p<O.1.
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Figure 5: Reperfusion results: (A) Alanine Aminotransferase (ALT), (B) Asparate
aminotransferase (AST), (C) bile synthesis, and (D) oxygen uptake rate measured during
reperfusion. See text for statistical analysis.
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Figure 6: TUNEL of livers after preservation and reperfusion. A) Group 1: Freshly isolated liver
after reperfusion. B) Group II: Warm ischemic livers after reperfusion. C) Group IlIl: Warm
ischemic livers after 5 hours of Static Cold Storage (SCS) in University of Wisconsin (UW)
solution after reperfusion. D) Group IV: Warm ischemic livers after 5 hours of Normothermic
Extracorporeal Liver Perfusion (NELP) followed by reperfusion. Magnification (1 OX).
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DISCUSSION
We have demonstrated that livers subjected to 60 min of ex-vivo warm ischemia can be
resuscitated with NELP and transplanted with excellent graft function and long term survival of
the recipient, comparable to that of recipients of perfused fresh livers and fresh livers preserved
with cold storage. Animals that received ischemic livers that were either preserved with cold
storage or experienced no storage time at all, died within 24 hours of transplantation.
Diluted whole-blood reperfusion experiments were performed to assess early graft
function. It was observed that function of NELP-treated ischemic livers matched that of freshly
isolated livers, whereas the function of untreated ischemic grafts was significantly worse. The
transaminase levels and bile trends in the reperfusion system correlated very well with our
survival results. In addition, the results indicate that the reperfusion system can be used to
simulate liver transplantation for rapid optimization of NELP conditions.
Hypothermic machine perfusion provides the organ with constant supply oxygen and
nutrients while waste is removed. However, the basic approach to preservation still relies upon
slowing down metabolic rates, and herein does not differ from SCS. Under hypothermic
conditions, a delicate equilibrium exists between maintaining perfusate flow sufficient to ensure
adequate tissue oxygenation and damage of the sinusoidal endothelium due to barotrauma and
shear stress that may limit it usefulness 3032*.
Normothermic machine perfusion is fundamentally different from hypothermic perfusion
because its aim is to not only re-establish perfusion of the liver, but also closely mimic the in-
vivo conditions and maintain the liver in a metabolically active state. The organ's metabolic
activity can be continuously monitored throughout the preservation period, making it possible to
assess its viability and function, providing potential markers that could be used to predict
viability after transplantation. Furthermore, once oxidative metabolism has been sufficiently
restored and intracellular energy supplies have been replenished, induction of repair and even
regenerative processes might be possible. Other applications that have been suggested for
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normothermic machine perfusion include preconditioning, such as the induction of heat-shock
proteins, and immunomodulation, such as induction of resistance against recurrent hepatitis C
infection of the liver graft and possibly the reversal of hepatic steatosis 33,34
Although previous NELP efforts have predominantly used larger animal models, the rat
was our model of choice in order to keep our approach simple and inexpensive. Since the blood
supply of the rat liver is mostly venous 35'36, we have chosen to perfuse via the portal vein only,
as usually done in the traditional isolated perfused rat liver systems 35,37 , which further helped to
simplify the setup. For the same reason, the orthotopic liver transplant without reconstruction of
the hepatic artery was performed using the cuff technique first described by Kamada 38,39. By
using an inbred strain of rats, issues associated with immunoreactivity during perfusion and
after transplantation were avoided. A limitation of this approach is the lack of rearterialization,
which is known to introduce certain artifacts, including histopathologically observable biliary
proliferation 21. The recipient rats in our studies displayed the same complications (results not
shown), as well as the increased serum bilirubin which is known to return to normal levels after
6 weeks in this model 21; however, survival was not affected by this phenomenon. This artifact
makes it difficult to identify other biliary complications, such as biliary strictures, which is an
important long term issue with DCD transplantation.
In order to model DCD we subjected livers to ex-vivo warm ischemia in a
homeothermically controlled bath filled with warm saline as previously described 5. The benefit
of this method is precise control of the ischemic time and temperature due to the fact that the
explantation of the organ occurred before the period of ischemia. We have chosen 60 minutes
as clinically relevant time scale of prolonged ischemia. The temperature of 34 C was chosen to
simulate a degree of reduction of the core temperature after cardiac arrest. Although we have
also tested the effect of warm ischemia prior to liver explantation 40 we found that this approach
introduces more variability due to poor control of the temperature history of the liver and
variation of the duration of the donor surgery. Additionally we found that body-core temperature
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in the rat dropped much faster that what could be expected in a larger animal model or in
humans, reducing the impact of the ischemia. We have chosen to heparinize animals before
explantation for the same reason of consistency.
During normothermic perfusion of the ischemic livers, the initial peak in the release of
both AST and ALT suggests that hepatocellular damage occurred during the period of warm
ischemia but stopped upon perfusion of the liver. Post-operative values of the AST, ALT were
comparable, if not lower than those of recipients of fresh livers preserved with either NELP or
SCS for a similar period. The lower bile secretion of the ischemic livers suggests that the
damage sustained during warm ischemia may affect the biliary epithelium more than the hepatic
parenchyma. Interestingly, the urea production of the ischemic livers was higher than that of
freshly resected livers, which may reflect an increased nitrogen availability caused by
proteolysis secondary to cellular damage. The fact that the oxygen uptake rate was similar to
that of fresh livers indicates that the machinery responsible for oxidative metabolism was largely
intact and mitochondrial function maintained in warm ischemic livers.
One of the possible hypotheses to explain the beneficial effect of NELP in reconditioning
DCD organs is metabolic resuscitation through restoration of an oxygen supply and removal of
waste products. This is suggested by the correlation between bile secretion and survival
whereby the restoration of metabolic activity, perhaps ATP levels and/or other metabolites, may
play a role in the protective effects of NELP
A second hypothesis was that NELP reduced apoptosis, either through reduced Kupffer
cell activity (due to presence of hydrocortisone in the perfusate) which is known to be correlated
to improved graft survival4 or ROS reduction (through glutathione which is present in Williams
E) which was also found to correlate with graft viability42 . However, the TUNEL results of
reperfused livers displayed that WI-only and WI+NELP groups had both very limited apoptosis,
and yet the survival in recipients of WI-only livers were nil. This result indicates that suppression
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of Kupffer cells is an unlikely cause of survival in our system. However, it is possible that other
inflammatory mechanisms not present in our model are involved.
The goal of this study was to evaluate the possibility of resuscitating livers after warm
ischemia with normothermic perfusion in a modified isolated perfused rat liver system. We have
shown that livers subjected to one hour of ex vivo warm ischemia can be reclaimed using warm
perfusion technology. Post transplant survival of rats that received these perfused livers was far
superior to that of animals that received ischemic livers that did not undergo any preservation,
and those preserved with traditional SCS. Our system provides an effective to investigate the
various aspects of warm perfusion for preservation and resuscitation of the DCD liver grafts, as
well as a model to study liver metabolism 43. We envision that a similar, scaled up version of our
system could be used in a clinical setting enabling the use of DCD livers for transplantation.
In addition, this study establishes that the dilute whole-blood reperfusion system can be
used as a model simulating rat liver transplantation, and transaminase levels and bile synthesis
are all adequate markers of viability.
METHODS
Isolation of donor livers
Experiments were performed using male Lewis rats weighing 250-300g (Charles River
Labs, Wilmington, MA). The animals were maintained in accordance with National Research
Council guidelines and the experimental protocols were approved by the Subcommittee on
Research Animal Care, Massachusetts General Hospital. All animals were anesthetized with
isoflurane using a Tech 4 vaporizer (Surgivet, Waukesha, WI) under sterile conditions. The
donor liver surgery and is described in detail elsewhere44' 45.
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Warm ischemia induction
After isolation from the donor, the liver was weighed and then placed in a temperature
controlled chamber filled with saline and maintained at 34±0.1'C for one hour. During this period
the PV and IVC were cuffed as previously described19.
Normothermic liver perfusion
The perfusate and dialysate comprised phenol red-free Williams Medium E (Sigma
Chemical, St. Louis, MO) supplemented with: 2 u/I insulin (Humulin, Eli Lily, Indianapolis, IN),
100,000 u/I penicillin, 100 mg/I streptomycin sulfate (Gibco, Invitrogen, Grand Island, NY), 0.292
g/l I-glutamine (Gibco), 10 mg/I hydrocortisone (Solu-Cortef, Pharmacia & Upjohn, Kalamazoo,
MI), and 1000 u/I heparin (APP, Schaumberg, IL). Fresh frozen rat plasma (25% v/v), and
erythrocytes (18-20% v/v) were collected earlier19 and added to the perfusate only. The total
perfusate volume was 55-60 ml.
The perfusion system consisted of a primary liver perfusion circuit and a critical
secondary dialysis circuit 9. Briefly, the primary circuit included perfusate that recirculated via a
peristaltic pump through a jacketed perfusion chamber, a membrane oxygenator, a heat
exchanger and bubble trap. The oxygenator was gassed with a mixture of 74% N2/ 21% 02/ 5%
C02 and 100% 02 to maintain a constant pH. A fraction of the perfusate was diverted to the
secondary circuit through a hollow fiber dialyzer with a 2200 cm2 membrane area and a 30 kD
nominal molecular weight cut-off (Spectrum Labs, Rancho Dominguez, CA) at a rate of 3
ml/min/g wet liver weight. The secondary circuit dialyzed the perfusate by counter-current
exposure to 450ml of dialysate. The volumes of perfusate and dialysate were kept constant by
varying the flow of dialysate through the dialyzer in the secondary circuit. Temperature within
the system was maintained at 37.5*C.
After the warm ischemic period, the liver was flushed with 10ml of warm saline and
immersed in perfusate in the perfusion chamber. The liver was perfused at a constant flow rate
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via the portal vein and effluent flowed freely from the suprahepatic and inferior vena cava into
the surrounding medium. While the recipient hepatectomy was prepared, the liver was
disconnected from the circuit, rinsed in a bowl of saline at room temperature and weighed again
prior to transplantation. The operating parameters of the perfusion system were: Flow rate:
1.84±0.05 ml/min/g; Portal hydrostatic pressure: 12-16 cm H20 (8-12 mmHg); Hematocrit:
17.8%±0.8; Inlet p02: 128.4±8.1 mmHg; Outlet p02: 47.9±1.7 mmHg; Inlet pCO 2: 30.1±1.1
mmHg; Outlet pCO 2: 34.6±1.6 mmHg.
Analysis of perfusate levels of metabolites and liver enzymes
Perfusate samples (1 ml) were collected prior to placing the liver in the perfusion system
and hourly thereafter. For each sample, 100pl aliquots were immediately analyzed using a
Piccolo comprehensive metabolic panel (Abaxis, Union City, CA) for alanine aminotransferase
(ALT), aspartate aminotransferase (AST), total bilirubin, electrolytes and glucose. The
remainder was stored at -80*C for later analysis. Dialysate samples (1 ml) were collected at the
same times and stored at -80'C.
For analysis of the hepatic oxygen uptake rate (HOUR), 200 pl samples were taken from
the PV and IVC of the liver every 10 minutes for the first hour of the perfusion and every hour
subsequently. Samples were analyzed immediately using a blood gas analyzer (Rapidlab,
Chiron Diagnostics, Norwood, MA). The total concentration of 02 (ml/di) in the samples was
determined according to the formula:
[02] = 1.39 x [Hb] x FO2Hb + 0.00314 X PO2
where [Hb] is the hemoglobin concentration in g/dl, FO2Hb is the fraction oxygenated
hemoglobin and PO2 is the partial pressure of oxygen in mmHg. HOUR was determined as:
HOUR = (([02] in - [02] out)/ 1 00) x flow rate/weight of liver.
Bile was collected continuously in pre-weighed microfuge tubes that were exchanged
every hour.
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Recipient surgery
The cuff technique developed by Kamada and Caine 38,39,45 was implemented and is
described in detail elsewhere 19. All recipient surgery was carried out by the same microsurgeon
(H.T.). The anhepatic phase of the procedure was typically 13- 15 minutes and did not exceed
17 minutes. Animals were hydrated with 8ml/kg of warm (370C) lactated Ringer's solution with
5% dextrose and 2ml/kg of NaHC03 7%w/v (Abbott, North Chicago, IL) by penile vein injection.
The animals were put in single clean cages, allowed to recover from anesthesia under
an infrared lamp for half an hour, and subsequently returned to regular housing. The first 12
hours post-operatively animals were checked every 2 hours and subsequently every 8 hours for
one week.
Post-operative blood sampling
To determine the post-operative levels of AST, ALT and total bilirubin, 100-2 00pl of
blood were drawn from the tail vein under isoflurane anesthesia on post-operative days 1, 3, 5,
7, 14, 21, 28 and immediately analyzed using a Piccolo blood chemistry analyzer. For these
studies n was >4 for each group.
Simple cold storage
Warm ischemic livers (n=6) and freshly isolated livers (n=6) were flushed with 20ml of
ice-cold (0*C) UW solution and placed on melting ice in a bowl containing UW solution for the
duration of the SCS period; these livers were not perfused.
Diluted Whole Blood Reperfusion
For detailed evaluation of the graft response in the very early phase (0-2hrs) after
transplantation, we employed a diluted whole-blood reperfusion model. This method was
127
preferable as manipulation of animals for sampling immediately after transplantation could
further stress the animals, affect survival, and introduce artefactual findings. The reperfusion
circuit was identical to the normothermic perfusion system, but contained no secondary dialysis
circuit. The livers were reperfused for 120 minutes and inflow (portal vein) and outflow
(infrahepatic vena cava) sampling was performed every 15 minutes. The operating conditions
for the reperfusion system were: Flow rate: 1.74±0.15 ml/min/g; Hematocrit 13.8±8.2; Inlet p02:
263.5±111.9 mmHg; Outlet p02: 75.1±49.7 mmHg; Inlet pCO 2: 40.4± 14.9 mmHg; Outlet pC02:
43.4±15.9 mmHg.
Histology
Liver tissue slices were fixed in 10% formalin, embedded in paraffin, sectioned, and
stained with hematoxylin and eosin. Apoptosis was evaluated through TUNEL staining (Roche,
Indianapolis, IN).
Statistical Analysis
Data presented are means ± SE. All statistical analysis for differences performed with
ANOVA at significance level of a=0.1.
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Chapter 5: NELP Optimization
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5-1. MFA comparison of Fresh and Warm Ischemic Livers in NELP
MFA is performed on Fresh and WI livers in perfusion to evaluate the overall
performance of the organs in perfusion. The major differences between ischemic and
fresh liver metabolism is noted, time to recovery is suggested, and methods of improving
perfusion are discussed. As transplantation is currently the only treatment option for end-
stage liver disease and it enjoys a high success rate, there has been a significant increase in
the demand for organs as older and more clinically complex recipient candidates are
considered. An area of keen investigation is into the use of NELP as a means of resuscitating
controlled and uncontrolled donors after cardiac death (DCD), as they represent a virtually
unlimited source of organs'. Currently, unless very strict criteria regarding organ quality are
enforced, clinical outcomes using these marginal organs have generally been poor2. However,
porcine and murine models of DCD livers that have experienced an hour or more of warm
ischemia have shown that when stored with NELP, the organs fare significantly better than
organs exposed to static cold storage3,, and furthermore, NELP is necessary for their
5-7successful transplantation
Multiple parameters of organ damage8 ,9 and function 0 are currently measured during
perfusion to gauge organ viability and potential transplantability. The restoration of organ energy
charge and minimal lactate formation, for example, are suggestive of adequate mitochondrial
function, and avoidance of microcirculatory failure'. Other factors frequently considered are
trends in glucose metabolism, oxygen consumption, albumin or other complex protein
syntheses, as well as rates of excess amino acid breakdown and urea formation13 14. As
perfusate itself serves as a metabolic reservoir, it is reasonable and desirable to use whole-
organ metabolism as a basis for developing a standardized integrated index of viability.
In this study, we perform a temporal analysis of 28 metabolites measured during
perfusion in a rat model of NELP treatment of DCD livers6, and use the stoichiometric metabolic
flux analysis (MFA) model15, to provide a comprehensive overview of ex vivo machine-perfused
liver metabolism. This enables comparison of the metabolic state of ischemically damaged livers
to fresh livers after several hours of perfusion, as well as to an MFA model describing in vivo
liver metabolism 6.
The major findings of this work are:
* Recovery from ischemic damage occurs within 2 hours of perfusion signified by
the restoration to Fresh livers levels of oxygen uptake rate and a significant shift
in metabolic activity
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* Fresh livers differ from WI livers metabolically; even upon the "restoration" of WI
livers in their second phase of perfusion. WI livers appear to be overall less
metabolically active than. Fresh livers.
* The only distinct increase in WI liver activity is in the consumption and depletion
of arginine highly suggestive of attempts at vasodilation; WI specific therapeutic
protocols should focus on reversing microcirculatory damage and ischemia
reperfusion injury.
* Both perfusion groups consume less oxygen, metabolize fewer lipids and have
reduced TCA cycles compared to in vivo livers.
" Livers may have overall less of a requirement for aerobic respiration or, they may
be mildly ischemic.
* The use of erythrocytes is paradoxically a limitation to increasing the oxygen
delivery rate. The increased viscosity at higher hematocrits causes greater
problems of increased portal pressure and self-limits the rate of flow.
* Based on these results, a significant optimization strategy targeted particularly at
the isolation of hepatocytes from donor organs, where physiological performance
of the entire organ is not required, would be to reduce the temperature of
perfusion to 200C. This would reduce the metabolic activity and hence the need
for oxygen, potentially also obviating the need for erythrocytes. The result is a
highly simplified perfusion system designed for ischemic cell recovery.
RESULTS
In Chapters 3 and 4 we demonstrated that ex vivo normothermic perfusion of freshly
isolated rat livers results in transplantable organs, and further that the same perfusion system is
necessary for the restoration of ischemic rat livers to transplantable condition17 ,1 . In this work
we examine the temporal profiles of 28 metabolites measured hourly during perfusion. These
data provide information on the time frame of recovery of ischemically damaged organs, organ
stability during perfusion, and the impact of perfusion on organ metabolism through comparison
to in vivo values (see Appendix A for these reference values).
Moreover, since the trends in metabolite uptake or production in all groups were
generally linear (see Statistical Identification of Linear Response Phases During Perfusion in the
Methods section of the selected time segments) it was possible to raise the steady state
assumption for the fluxes hence enabling the use of MFA. MFA provided a comprehensive
overview of organ function during perfusion by enabling the evaluation of several intracellular
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fluxes from the measured extracellular fluxes. We also compared the MFA results to an in vivo
MFA study19 conducted previously to identify critical differences that could be corrected to
enhance the restorative capacity of the perfusion system. It should be noted that the in vivo
MFA study20 used for comparison here was performed with a different rat strain (Sprague
Dawley); although strain-to-strain variations are expected to be minimal in the basic metabolic
pathways considered in the model, these comparisons are best interpreted for their overall
significance rather than any specific differences in detail.
Oxygen Consumption
Samples of perfusate were taken hourly at the portal vein, to reflect oxygen delivery rate
(ODR), and at the infra-hepatic vena cava, to determine oxygen exit rate (OER). Oxygen uptake
rate (OUR) was determined as the difference between ODR and OER (Figure 1A). ODR and
OER were also compared to in vivo conditions (Figure 1 B). WI livers consumed significantly less
oxygen than Fresh livers during the first hour of perfusion, but by the second hour, consumption
had increased to 0.05-0.057ml 0 2/min/g liver and was comparable between groups. WI livers
showed a slow but steady decline in OUR from t=2-5hrs, the difference between WI and Fresh
livers again becoming statistically different at t=5hrs. Fresh livers also demonstrated a decline in
OUR from t=0-3hrs after which consumption began to very slowly increase again. Figure 1B
illustrates that the ODR in perfusion averages at 0.14 ml 02/min/g liver in both groups, and falls
within one standard deviation of the average in vivo ODR. The OER however, is significantly
higher than in vivo, which has negligible variation in value, demonstrating that despite reduced
oxygen supply, the liver does not consume all that is available to it in perfusion, regardless of
ischemic injury.
Glucose
Concentration profiles of glucose in both WI and Fresh livers were generally stable at a value
slightly above the original perfusate glucose content of 2g/L (Figure 2A). Subtle changes in
trends could be appreciated such as an increase in concentration within the first hour of
perfusion in both groups to values significantly above the starting value of Williams Medium E,
which is similar to the in vivo upper bound level. WI livers continued to increase the glucose
concentration, while Fresh livers reduced it during the second hour. During t=3-5hrs, both
groups had similar glucose concentrations that demonstrated a gradual steady increase from
2.18-2.24g/L for Fresh livers and to 2.29-2.37g/L for WI livers.
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Lactate
WI livers produced more lactate in the first hour than Fresh livers, exceeding the in vivo upper
bound value within the first hour (Figure 2B). The rate of production declined after the first hour
resulting in concentrations comparable to Fresh livers by the end of perfusion. Fresh livers
produced lactate linearly throughout, also exceeding the in vivo upper limits though this
occurred later, a little after 2 hours of perfusion. Note that WE does not contain any lactate.
Nitrogen Metabolism
Albumin concentration (Figure 3A) increased steadily in Fresh liver perfusions, reaching a
maximum of 0.68g/dL at t=4hrs, approximately 40% of the in vivo lower bound value. By
contrast, WI livers produced little to no albumin during this time span (0.0055 g/dL/hr, R2=0.6).
Urea concentration increased similarly and linearly in both groups (Figure 3B) at a rate of 4.1
mM/hr, R2=0.99 for Fresh livers and 4.4mM/hr, R2=0.98 for Wl livers. Urea concentration also
did not reach the in vivo lower bound concentration of approximately 2.8mM at the end of
perfusion. Ammonia concentration increased similarly in perfusate from zero to 40uM in both
groups (Figure 3C). The perfusate values of ammonia were significantly below the in vivo lower
bound of approximately 76uM. The amino acids methionine (Figure 3D), tyrosine, proline, lysine
and phenylalanine were all consumed at significantly lower rates in WI livers than in Fresh
livers. Glutamine uptake (Figure 3E) occurred at a stable rate that was similar for both WI and
Fresh livers. Rates of uptake between WI and Fresh livers were also similar for aspartate,
alanine, glycine, asparagine, cysteine and threonine (not shown). WI and Fresh livers differed
significantly in glutamate metabolism (Figure 3F). Glutamate concentration increased linearly in
Fresh livers but was relatively unchanged in WI livers and remained within the value present in
WE. Arginine (Figure 3G) by contrast was consumed at a significantly higher rate by WI livers,
to the extent that it became substrate depleted at t=4hrs. A reciprocal increase in ornithine was
observed (Figure 3H); a plateau was reached in the significant output by WI livers at t=4hrs, well
above the in vivo upper bound value. A linear increase in ornithine output by Fresh livers
resulted in a perfusate concentration within in vivo range at t=5hrs. Despite WE being deficient
in lactate, ornithine, ammonia, urea, albumin, and ornithine, the liver generally increased the
concentrations of each of these significantly during perfusion. However, in the case of histidine
(Figure 31) and serine (not shown), present in WE at values significantly below the in vivo lower
bound, neither were utilized or contributed to during perfusion. The branched chain amino acids
valine (Figure 3J), isoleucine and leucine were all produced linearly during perfusion.
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Figure 1. A) Oxygen uptake rate (OUR) for WI and Fresh livers. B) Oxygen delivery rate (ODR)
and exit rate (OER) in perfused livers compared to those in vivo. Red and blue lines represent
average ODR and OUR +/- 1std dev. *lndicates significantly different from Fresh (p<0.05)
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MFA of Fresh vs. Ischemic Perfused Livers
In order to identify whether there were distinct phases in liver metabolism during
perfusion, linear regressions were performed on the temporal concentration profiles of each of
the metabolites. Box-and-whisker plots of the resulting R2 values were evaluated for least
variation across different segments of time (Appendix B). Ischemic livers were found to exhibit
stable but distinctly different metabolic rates between 0-2hrs and 2-5hrs of perfusion; MFA was
conducted for both phases. Fresh livers were generally stable throughout perfusion; MFA was
performed on the segment with greatest linearity, determined as being t=1-5hrs. Table 1
delineates the results of MFA for all groups.
In Figure 4, the first two hours of ischemic liver perfusion are compared to fresh liver
metabolism using MFA. The map suggests ischemic livers were significantly more
glycogenolytic than fresh livers at NELP onset, breaking down glycogen for glycolysis and
glucose release. Glycolysis appeared to result in a 116% increase in the production of lactate
(Flux #8). Oxygen uptake rate (Fluxes 53-55) and the TCA cycle were comparable between
groups. Ischemic livers demonstrated a preferential uptake of the amino acid arginine (118%
increased in Flux #18) and a reciprocal, 304% increase, in the release of ornithine into the
extracellular space (Flux #20). Ischemic livers also showed a 46% increase in the formation of
asparagine from aspartate (Flux #47). Phenylalanine uptake was increased by 24% (p<0.1, Flux
#36) while tyrosine uptake was reduced by 63% (p<0.05, Flux #38) resulting in an overall
reduction of fumarate production (Flux #37). Methionine and serine metabolism were
significantly reduced (Flux #44); extracellular serine release was observed at this time also (Flux
#25). Glutamate production (Flux #40) was 58% of that found in fresh livers, a significant
reduction due likely to a decline in contribution from lysine and 2-oxo-glutarate (Flux #35), which
were reduced by 61% (p<0.1).
Between 2-5hrs of ischemic liver perfusion (Figure 5) more differences were apparent
between fresh and ischemic livers than at 0-2hrs. Ischemic livers appeared to be predominantly
gluconeogenic and demonstrated a 30% reduction in lactate output compared to fresh livers,
despite a further decline in oxygen uptake rate (Figure 1A). Contributions to the TCA cycle via
phenylalanine conversion to tyrosine were reduced, such that fumarate production via this
pathway (Flux #37) was only 50% of fresh liver flux values. Reduced acetyl-CoA and
oxaloacetate (Flux #9) resulted in a 61% reduction of citrate formation, while threonine
conversion to acetyl-CoA was increased 470%. Glutamate output was further reduced to within
4% of Fresh liver fluxes; contributions to its formation from both lysine (50% of fresh livers, Flux
#35) and proline (40% of fresh livers, Flux #42) impacted its production substantially. There was
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however, a 260% increase in glutamate formation via glutamine (Flux #41) which resulted in a
100% increase in glutamate formation of 2-oxo-glutarate (Flux #39). This increased flux
converged on the TCA cycle at a point of reduced incoming fluxes from citrate, such that the
downstream pathway of the cycle was restored to a value similar to that of fresh livers.
Asparagine to aspartate production was further increased to a rate 60% greater than fresh
livers, while tyrosine, methionine and serine metabolism remain reduced, though extracellular
serine was then actively consumed at a higher rate (Flux #25). Arginine uptake and ornithine
output were significantly reduced compared to fresh livers, but the increased metabolism of
asparagine, threonine and glutamine resulted in an overall increased urea cycle.
MFA of perfused vs. in vivo livers
In order to appreciate the impact of perfusion itself on liver metabolism and evaluate potential
limitations to the perfusate, a comparison of perfused and in vivo livers was performed using
MFA (Figures 6-8). Figure 9 summarizes the MFA findings demonstrating that perfused liver
activity of the major pathways of metabolism including oxygen uptake, electron transport, lipid
oxidation, the TCA cycle and the PPP was reduced compared to in vivo values. Lactate
production was increased in perfusion while amino acids and urea cycle were similar to in vivo
livers. The latter findings correlate well with the MFA maps that demonstrate either very little
amino acid variation from in vivo as in Figure 7, or a synchronous increased uptake in some and
decreased uptake in others (Figures 6 and 8). All perfused livers released branched chain
amino acids and had negligible histidine uptake compared to in vivo livers. Further, in the
absence of any lipids in the perfusate, and with the unusual formation of branched chain amino
acids, the model predicted formation of propionyl-CoA from succinyl-CoA (Flux #34). Perfused
livers were generally glycolytic compared to fasted gluconeogenic in vivo livers, though
extracellular glucose content varied little in concentration during perfusion.
Fresh livers compared to in vivo livers (Figure 6) represent the response of a healthy liver in
perfusion. Amino acid metabolism was substantially altered. Extracellular glutamate production
and 2-oxo-glutarate levels were significantly increased by the catabolism of proline, aspartate,
lysine and glutamine (Fluxes #31, #32, #33, and #35). Phenylalanine and tyrosine metabolism
were significantly increased contributing to fumarate production, while increased serine and
methionine consumption contributed to the pyruvate pool. Conversely, asparagine, histidine,
serine and alanine uptake were significantly reduced. The urea cycle remained within in vivo
range.
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During the first two hours of ischemic liver perfusion glutamate output was significantly
increased but in contrast to fresh livers, there were no major amino acid changes except an
increase in phenylalanine and a decrease in methionine, serine and alanine (Figure 7). Between
the 2nd and 5th hours of perfusion, amino acid metabolism picked up to include lysine, glutamine,
phenylalanine, tyrosine and aspartate catabolism. Glutamate was oxidized rather than released
into the extracellular pool, increasing the 2-oxo-glutarate flux such that downstream TCA activity
was comparable to the first two hours of perfusion and the urea cycle was increased. WI livers
also reverted to gluconeogenesis (Figure 8) and possible glycogen formation, though at
significantly reduced rates compared to fasted in vivo livers. Lactate formation was reduced
67% from the first two hours of perfusion.
The impact of perfusate content can be appreciated from the concentration of metabolites in
Williams Medium E, and the portal influxes (Appendix A and Table 2). The content, and
subsequent influx, of Williams Medium E exceeded in vivo values for all amino acids except
serine and histidine, and their uptake in perfusion was negligible. The converse, exceedingly
high influxes (Table 2) as seen in the cases of cysteine, aspartate and glutamine, which were
20x, 1Ox and 5x higher than the upper bound in vivo influx respectively, resulted in 5-1Ox higher
uptake rates than in vivo. Influxes 1-4x higher than the upper bound in vivo value had variable,
less substrate-driven responses by the livers in each of the groups. Arginine was taken up, and
ornithine reciprocally released, at a high rate in WI livers and finally demonstrated a plateau
when perfusate concentration reached 26ptM, suggestive of substrate depletion at t=4hrs. Only
tyrosine in fresh livers demonstrated a similar final concentration, though its concentration
profile was linear for the entire duration of the perfusion. All other amino acids exhibited linear
concentration profiles and had yet to be depleted at t=5hrs. The systematic production of
branched chain amino acids appeared to be a perfusion artifact. By contrast, methionine
metabolism depended on the state of the liver, being upregulated in Fresh liver perfusions but
down-regulated in WI perfusions. The metabolism of certain amino acids remained within in
vivo ranges across all groups, for example, glycine (Fluxes #28-30) and even aspartate (Fluxes
#17, #45, #47) despite the increased aspartate uptake (Flux #46).
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Table 1. Metabolic Flux Analysis.
# REACTION
1 Glucose 6-phosphate ++ Glucose
2 Fructose 6-phosphate - Glucose 6-phosphate
3 Fructose 1,6-Bisphosphate +-+ Fructose6-phosphate
4 2 Glyceraldehyde 3-P <-+ Fructose 1,6-Bisphosphate
5 Phosphoenolpyruvate + NADH <-+Glyceraldehyde 3-P
Oxaloacetate <-+ C02 +Phosphoenolpyruvate
(Gluconeogenic)
6 Phosphoenolpyruvate + ADP -+ Pyruvate (Glycolytic)
Pyruvate + C02 +-* Oxaloacetate (Gluconeogenic)
Pyruvate + CoA + NAD+ -> Acetyl-CoA + C02 + NADH
7 (Glycolytic)
8 Lactate *-+ Pyruvate + NADH
9 Acetyl-CoA + Oxaloacetate -+Citrate
10 Citrate <-+ 2-oxo-Glutarate + NADH + C02
PATHWAY
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Gluconeogenesis
Lactate
metabolism &
TCA cycle
Lactate
metabolism &
TCA cycle
Lactate
metabolism &
TCA cycle
FRESH
T=1-5hr
(n=ll)
-31±15*
24+85
-5±21*
-5±21*
-24±26*
-24±26*
-37±23*
-57±21*
31+14*
31+14*
IN VIVO FLUX DATA
(umol/h/g liver)
ISCHEMIC ISCHEMIC
T=0-2hr
(n=7)
88+201
-26±71*
-43±51*
-43±51*
-94+99*
T=2-5hr
(n=7)
44±17*
22±25
6+8*t
6±8*T
4+14*t
-94±99* 4+14*T
-110±101* -2 4 +12 *'
20±26* 12+9*
20+26* 12t9* 71+47
IN VIVO
(n=6)
93±37
79±82
31±22
31±22
37±29
37±29
24±19
6±3
71±47
11 2-oxo-Glutarate -> Succinyl-CoA + NADH + C02
12 Succinyl-CoA *-* FADH2 +Fumarate
13 Fumarate *-. Malate
14 Malate <-+ Oxaloacetate + NADH
15 Arginine -> Ornithine + Urea
16 Ornithine + C02 + NH4 -+Citrulline
17 Citrulline + Aspartate -*Arginine + Fumarate
18 Arginine uptake
19 Ammonia Output
20 Ornithine Output
21 Citrulline Output
22 Alanine --+ Pyruvate + NH4 + NADH
23 Alanine Output
24 Serine -- Pyruvate + NH4
Lactate
metabolism &
TCA cycle
Lactate
metabolism &
TCA cycle
Lactate
metabolism &
TCA cycle
Lactate
metabolism &
TCA cycle
Urea cycle
Urea cycle
Urea cycle
Aminoacid
metabolism
Urea cycle
Urea cycle
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
-1.2±1.1* 0.5±0.2*t 2.7±1.7
35±14*
32±14*
69±19*
69±19*
35±12
31±10
29± 10
4.3±1.6
0.7±0.2*
2.3±1.2*
2±1.9*
8.6±2.4
-7.1±1.4*
8.6±6.3
30±26*
26±26*
56±27*
56±27*
35±4
25±8
25±8
9.316.7
0.8±0.9*
9.3±6*
-0.1±9
4.9±8.3
-3.9±7.6*
6.7± 13.5
34±9*
32±9*
56±17*
56±17*
57+4*t
56±4*
20± 13
2.6 0.6*t
0.5±0.1*
0.7±1.1 *
2±1.2*
7.2±1.8
-7.2±1.8*
6.6±1.5
80±46
82±46
107±53
107±53
28±23
32±20
25±20
3.6±5.1
-6.2±1.7
-3.4±0.9
7±5.2
12±6.8
-12.7±6.2
6.4±11.5
25 Serine Uptake metabolism 0.2±0.3*
Aminoacid
26 Cysteine -+ Pyruvate+ NH4 + NADH metabolism 2.9±3.2 3±4.8 2.1±0.5 -0.1 ±3.8
Aminoacid
27 Cysteine Output metabolism -0.1±2.7 -1.4±1.9 -1.2±0.5* 0.2±0
Aminoacid
28 Threonine -> NADH + Glycine +Acetyl-CoA metabolism 0.4±0.7 0.6±8.2 2.1±1.2 1.2±4
Aminoacid
29 Glycine <-> C02 + NH4 +NADH metabolism 8.2±4.2 7.5±10.2 6.9±1.4 5.2±8
Aminoacid
30 Glycine Uptake metabolism 4.8±0.9 5±0.1 4.8±0.8 5.4±1.2
Valine + 2-oxo-Glutarate -+ Glutamate + propionyl-CoA Aminoacid
31 + 3 NADH +FADH2 + 2 C02 metabolism -2.2±0.9* -2.9±1* -0.91.4*f 0.8±0.4
Isoleucine + 2-oxo-Glutarate -> Glutamate + propionyl- Aminoacid
32 CoA + Acetyl-CoA + 2 NADH + FADH2 +C02 metabolism -1.7±0.6* -1.4±0.3* -1.7±0.7* -0.2±0.7
Leucine + 2-oxo-Glutarate -> Glutamate + NADH + Aminoacid
33 FADH2 Acetoacetate + Acetyl-CoA metabolism -2.6±2.1 -4±3.5 -2.4±1 -0.2±3.5
Aminoacid
34 Propionyl-CoA + C02 ->Succinyl-CoA metabolism -2.6±1.1* -3.7±1* -1.7±1.6*t 1.4±0.8
Lysine + 2 2-oxo-Glutarate -+ 2 Glutamate + 4 NADH + Aminoacid
35 FADH2 + 2CO2 + Acetoacetatyl-CoA metabolism 7.2±4.2* 2.9±6 3.7±1.6* 1.5±0.4
Aminoacid
36 Phenylalanine + 02 -+ Tyrosine metabolism 2. 1±0.6* 2.6±0.4* 0 .9 ±0 .2 *t 0.5±0.4
Tyrosine + 2 02 -+NH4 + C02 + Fumarate + Aminoacid
37 Acetoacetate + NADH metabolism 7.5±2.2* 5±4.8 3.6+0.2 0.8±3.9
Aminoacid
38 Tyrosine Output metabolism -3.9±0.4* -1.5±2 -2.7±0.1* -1± 1.1
Aminoacid
39 Glutamate *-+ 2-oxo-Glutarate + NADH +NH4 metabolism 12.1±9.4 7.2±24.9 24.2+6.8* 12.8±7.6
Aminoacid
40 Glutamate Output metabolism 5.4±3.5* 2.3±0.1* 0.2±0.9' 0.8±1.3
Aminoacid
41 Glutamine -+ Glutamate + NH4 metabolism 5.7±3.3* 9.3±25.9 20.4±5.6* 2±2.5
42 Proline +0.5 02-> Glutamate + 0.5 NADH
43 Histidine -+ NH4 +Glutamate
Methionine + Serine -* Cysteine + NADH + Propionyl-
44 CoA + C02
45 Aspartate<-*Oxaloacetate + NH4 +NADH
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
metabolism
Aminoacid
46 Aspartate Uptake metabolism
47 Asparagine --+ Aspartate + NH4
48 Palmitate--+ 8 Acetyl-CoA +7 FADH2 + 7 NADH
49 2 Acetyl-CoA +-+ Acetoacetyl-CoA
50 Acetoacetyl-CoA -+ Acetoacetate
51 Acetoacetate Output
52 Acetoacetate + NADH -+b-Hydroxybutyrate
53 NADH + 0.5 02 -- NAD
54 FADH2 + 0.5 02 --+ FAD
55 02 Uptake
Aminoacid
metabolism
Lipid, glycerol,
fatty acid
metabolism
Lipid, glycerol,
fatty acid
metabolism
Lipid, glycerol,
fatty acid
metabolism
Lipid, glycerol,
fatty acid
metabolism
Lipid, glycerol,
fatty acid
metabolism
Oxygen uptake
and electron
transport
Oxygen uptake
and electron
transport
Oxygen uptake
and electron
transport
2.6±0.4* 2±1.9
-0.2±0.4* -0.2±0.3*
1.3±0.2* 0.6±0.1*
-24±8.7 -20.3±10.9
2.5±0.7*
0.8±0.4*
4.2±2.3*
-0.8±4.9*
6.5±3.5*
11.4±1.8*
0±0*
164±52*
62±26*
132±38*
2.1±1.9
1.2+0
4.1±4*
3.9± 14.1
6.7± 13.2
7.7±11.9
0±0*
109±87*
49±44*
92±63* 95±24* 249± 132
1.6+0.9
0.1±0.2*
0 .9 ±0 .2 '
-15.9±12.9
2.6±0.1 *
1.4±0.3
3.2±1.3*
5.5±2.1
9.2±1.3
10.4±0.9*
0±0*
119±32*
53±16*
0.7±2.9
8±5.3
0.8±0.1
-23±16.7
0.5±0.4
2±1.1
13.2±6.7
17.6±16.4
19.2±16.4
-1.3±0.6
21±16
317± 178
176±87
56 Glucose 6-phosphate-- 2 NADPH + CO2 +Ribulose 5-P
57 Ribulose 5-P <-> Ribose 5-P
58 Ribulose 5-P <-> Xylulose 5-P
Ribose 5-P + Xylulose 5-P <-* Fructose6-P + Erythrose 4-
59 P
Erythrose 4-P + Xylulose 5-P <-* Glyceraldehyde 3-P +
60 Fructose 6-P
61 C02 Output
62 Glycogen +-> Glucose-6-P
Note
Bolded items are significantly different (p<0.05) from FRESH.
* Items significantly different (p<0.05) from IN VIVO.
t Items significantly different from ISCHEMIC T=0-2hrs
PPP
PPP
PPP
PPP
PPP
Oxygen uptake
and electron
transport
Glucose
metabolism
43±100
14±33
29±67
14±33
14±33
120±97*
-13±26*
25±61
8±20
17±40
8±20
8±20
81±39*
139±208*
25±29
8±10
16±19
8±10
8±10
60+23
-34±14*i
73±97
24±32
49±65
24±32
24±32
216±30
87±43
Table 2. Measured Influx Values
PARAMETER PV+HA Perfusate
Albumin (g/min/g liver) 0.02-0.05 0.00
Lactate (mmol/min/g liver) 0.03-0.1 0.00
Glucose (mg/min/g liver) 1.13-2.5 3.68
Alanine (umol/min/g liver) 0.36-0.92 1.86
Ammonia 0.11-0.2 0.00
Arginine 0-0.5 0.53
Asparagine 0.04-0.12 0.28
Aspartate 0.02-0.04 0.41
Cysteine 0.01-0.03 0.61
Glutamate 0.07-0.15 0.56
Glutamine 0.28-0.68 3.64
Glycine 0.26-0.6 1.23
Histidine 0.1-0.35 0.18
Isoleucine 0.07-0.23 0.70
Leucine 0.21-0.66 1.05
Lysine 0.18-0.54 1.10
Methionine 0.04-0.1 0.18
Ornithine 0.11-0.28 0.00
Phenylalanine 0.05-0.13 0.28
Proline 0.16-0.36 0.48
Serine 0.17-0.48 0.18
Threonine 0.19-0.47 0.62
Tyrosine 0.05-0.17 0.51
Valine 0.12-0.43 0.79
Note
In vivo influx is the combined portal vein (PV) and hepatic artery (HA) contribution to that flux (ave - 1 std
dev, ave + 1 std dev). Perfusate influx is calculated according to the initial perfusate concentrations and a
flow rate of 1.8ml/min/g liver.
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Figure 4. Flux directions reflect Phase I (t=0-2hrs) of WI vs. Fresh livers. Red arrows = significantly increased. Blue = significantly
reduced. Green = reversed. Bold lines = p<0.05, Thin lines = p<0.1, Dotted lines = glycolysis.
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Figure 5. Flux directions reflect Phase II (t=3-5hrs) of WI vs. Fresh livers. Red arrows = significantly increased. Blue = significantly
reduced. Green = reversed. Bold lines = p<0.05, Thin lines = p<0.1, Dotted lines = glycolysis
Figure 6. Flux directions reflect Fresh vs. in vivo. Red arrows = significantly increased. Blue = significantly reduced. Green =
reversed. Bold lines = p<0.05, Thin lines = p<0.1, Dotted lines = glycolysis
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Figure 7. Flux directions reflect phase I (t=0-2hrs) of WI vs. in vivo. Red arrows = significantly increased. Blue = significantly
reduced. Green = reversed. Bold lines = p<0.05, Thin lines = p<0.1, Dotted lines = glycolysis
Figure 8. Flux directions reflect phase II (t=3-5hrs) of WI vs. in vivo. Red arrows = significantly increased. Blue = significantly
reduced. Green = reversed. Bold lines = p<0.05, Thin lines = p<0.1, Dotted lines = glycolysis
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Figure 9: Summary of major pathways in perfused livers normalized to in vivo values.
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DISCUSSION
Perfusion systems are capable of significantly impacting the availability of transplantable
organs by optimally supporting donor organs during storage, and recovering reversibly
damaged tissues through perfusate-based treatment protocols21 22. To facilitate the translation of
this technology to clinical use, comprehensive and dynamic analyses of organ function during
perfusion are needed that identify parameters critical to organ stability and recovery. As a first
step in this direction, we performed a comprehensive metabolic analysis to capture the
biosynthetic capacity of the liver and evaluate the impact of perfusate nutrient supply and toxin
dilution. We conducted our study on hourly perfusate samples from Fresh and WI livers that
were successfully transplanted after 5-6hrs of NELP. Through the measurement of 28
metabolites and the calculation of an additional 34 fluxes using MFA, we were able to evaluate
the stability of our perfusion system, identify perfusate short-comings, and establish significant
differences between Fresh and WI livers useful in the future design of treatment protocols.
WI livers demonstrated two distinct phases of metabolic stability, separated at t=2hrs,
during a 5hr normothermic perfusion. The first phase appeared to include both a trajectory of
ischemic organ metabolism by well-fed livers23 and recovery. Livers depicted substantial
dependence on glycogen breakdown for both glucose synthesis and glycolysis, marked lactate
production and arginine uptake reflecting dependence on preexisting nutrient stores, anaerobic
respiration and the likely recruitment of nitric oxide metabolism to sustain viability24 25. Woods
and Krebs23 further observed a reduction in the production of both glucose and lactate when
glycogen stores were depleted within 135 minutes of perfusion. During this same time frame
however, oxygen uptake rate by WI livers increased and matched the values of Fresh livers
demonstrating increased access to, and metabolism of, viable cells. WI livers subsequently
moved into their second stable phase of perfusion. It is possible that the restoration of OUR of
WI livers to Fresh liver values within 2 hours marks a "recovery" time during perfusion. Phase II
of WI livers more closely resembled a high insulin state with reduced gluconeogenesis and
glycogen storage, and an increased uptake of select amino acids, particularly glutamine, to fuel
the TCA and urea cycles.
The differences that existed between WI and Fresh livers in extracellular metabolite
accumulation or consumption, such as methionine uptake, or albumin and glutamate production,
were sustained throughout perfusion and did not show evidence of coinciding over time. Though
not critical to recipient survival, these differences summarily reflect the fact that ischemic livers
are functioning suboptimally and are not fully recovered at the time of transplantation. While it is
evidently not necessary to fully restore all organ function for transplantability, enhancing organ
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performance to a predefined level of viability will be necessary in the clinically relevant
circumstances of unknown ischemic duration. These metabolic analyses support the need to
facilitate the restoration of the endothelin/nitric oxide balance through the arginine pathway,
though other markers of ischemic injury should also be included for future viability analyses26.
Evidence of the possible impact of vasodilation may partly explain the increased oxygen uptake
rate during t=0-2hrs2 ,27' 28 though other effects of perfusion can be further optimized to enhance
recovery including: facilitation of debris washout by exposing otherwise live tissue using higher
but non-detrimental flow rates and thrombolytics; the resuscitation of cellular activity through
more rapid ATP restoration, and reduction of the inflammatory ischemia-reperfusion cascade to
minimize cell loss26'29
Fresh livers served to illustrate how a healthy organ functioned in ex vivo perfusion and
highlighted baseline factors to be enhanced in future perfusions. Fresh livers in perfusion
demonstrated stable changes in metabolite concentrations throughout perfusion and no
evidence of substrate limitation within 5 hours. Greatest stability was gained within the first hour,
likely reflecting a period of adjustment to the ex vivo environment. MFA depicted the expected
response to a fed/high insulin state with glucose uptake, glycogen storage and glycolysis.
Alanine and lactate uptake, the usual precursors for gluconeogenesis were down-regulated and
produced, respectively. The TCA cycle was reduced, as were ketone body production and fatty
acid oxidation, altogether requiring a minimum of oxygen as might be expected in a high energy,
low-lipid, state. Amino acid metabolism differed substantially from in vivo trends, some of which
reflects perfusion-specific artifacts. For example, Fisher and Kerly,31 who performed analyses of
amino acid metabolism in healthy, albeit fasted, perfused rat livers, observed a steady increase
in perfusate content of branched chain amino acids valine, isoleucine and leucine, as seen in
both the Fresh and WI livers. Further, these authors found both histidine and glutamate to be
unchanged in perfusion. Both trends held true in WI livers, while Fresh livers demonstrated a
net production of glutamate. This may be related to a normal transamination of excessive
perfusate amino acids in conjunction with an otherwise reduced TCA cycle.
One major consideration in the improvement of the perfusion system would be the
removal of erythrocytes from the perfusate. Red blood cells increase the overall complexity of
the perfusion setup significantly, affect the quantitative metabolic analyses, and may also incur
damage in the form of variable hematocrit on hepatic function, hemolysis and the tendency to
embolize . OUR was overall significantly reduced in perfused livers compared to in vivo livers
but OERs were higher than in vivo values suggesting livers were not oxygen-limited. OUR in
fresh livers demonstrated a steady decline from t=Ohrs to t=3hrs after which uptake plateaued. It
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is well-documented that livers perfused with erythrocyte-containing perfusion media consume
less oxygen over time32 -5 , which can be further modulated by perfusate temperature 6 The final
steady state oxygen uptake of these livers is typically equivalent to OUR in livers perfused
without erythrocytes, provided a delivery rate can be achieved at low-shear flow rates32. This
decline in OUR has been correlated with a reduction in erythrocyte viability,37 though it may also
be associated with a change in the metabolic rate of the liver as it adjusts to its new,
metabolically less-demanding, environment. Further, erythrocytes are also metabolically active.
Though initial lactate content of erythrocytes was minimized by freshly harvesting blood hours
before perfusion and washing 3 times with 0.9% sodium dextrose 33,38 they were nevertheless
actively glycosylating and subsequently continuing to produce lactate during perfusion. The
extent to which they impacted perfusate glucose and lactate levels was not accounted for in
these experiments though Fisher and Kerly31 performed controls whereby normothermic
perfusions were carried out without livers giving an average uptake of glucose of approximately
60mg/hr in the presence of a hemoglobin concentration of 26mg/100ml blood. As our perfusion
contained an average hemoglobin concentration of 5-7mg/100ml blood, the total expected
uptake of glucose was approximately 12mg/hr, impacting the perfusate glucose concentration of
2000mg/L negligibly. Similar reasoning applied to the formation of lactate, however this had a
greater impact on the total concentration at perfusion end. Again 60mg of lactate were produced
in an hour in the study of Fisher and Kerly. This is equivalent to 0.13mmoles produced per hour
or 0.65mmoles in 5 hours, for a total change in perfusate concentration of 1.3mM or roughly one
third of the lactate observed at the end of our perfusions. This reasoning supports the removal
of erythrocytes from the perfusate for more accurate metabolic analyses. As erythrocyte-free
media have been successfully implemented with high oxygen uptake rates at a range of
temperatures from 22*C-37*C, 3 2,39 organ perfusion may benefit substantially from this
simplification.
In conclusion, this study describes an integrated metabolic analysis of the performance
of transplantable Fresh and Ischemic livers in normothermic machine perfusion. Stable function
is observed throughout perfusion and recovery of WI livers may occur with the restoration of
oxygen uptake rate within the first 2 hours. These data provide the basis for rational NELP
optimization, such as the removal of erythrocytes; and design of treatment protocols, such as
the inclusion of substrates specific to the amelioration of ischemia reperfusion injury with
emphasis on reversing microcirculatory collapse. Further, the data and analysis presented here
may enable future meta-analyses such as data mining for an index of organ viability and Flux
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Balance Analysis4 , necessary steps to build automated feedback control systems for real-
time organ support.
MATERIALS AND METHODS
Animals.
Male Lewis rats weighing 200-300g were obtained from Charles River Laboratories
(Wilmington, MA) and maintained in accordance with National Research Council guidelines. The
Subcommittee on Research Animal Care, Committee on Research, Massachusetts General
Hospital approved the experimental protocols. All animals were allowed to acclimatize for at
least 2 days prior to any experimentation. Rats were divided into two groups: 1) Fresh livers
(n=1 1) and 2) warm ischemic (WI) livers (n=7).
Ex Vivo Perfusion Model
Isolation of Donor Livers.
Full details of the procedure are describe elsewhere.4 Briefly, a transverse abdominal
incision was made and the intestines retracted to expose the portal vein (PV), the common bile
duct (CBD), and the inferior vena cava (IVC). The CBD was cannulated (22 G polyethylene
stent, Surflo, Terumo, Somerset, NJ) and the IVC freed from the right renal and adrenal veins.
The portal vein (PV) was freed from the splenic and gastroduodenal veins. The right phrenic
vein emptying into the supra-hepatic vena cava (SHVC) was ligated. Heparin (200 U) was
injected through the penile vein. The IVC and PV were clamped. For Fresh livers, an 18 G
polyethylene cannula (Terumo) was inserted into the PV, and the liver was flushed with 5mL of
cold (4*C) University of Wisconsin (UW) solution (Viaspan, Barr Laboratories, Pamona, NY).
The diaphragm was opened, the SHCV was transected, and the liver was flushed with an
additional 5mL of UW solution. The liver was removed, weighed, and placed in a bowl of ice-
cold UW solution to be cuffed. For WI livers, flushing of the organ via the PV was omitted. After
isolation from the donor, these livers were then weighed and placed in a temperature-controlled
chamber filled with saline and maintained at 34±0.1*C for 1 hr. During this period the portal vein
(PV) and inferior vena cava (IVC) were cuffed.
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Normothermic Liver Perfusion and Metabolite Sampling.
The perfusate and dialysate comprised phenol red-free Williams Medium E (Sigma
Chemical, St. Louis, MO) supplemented with 2 u/L insulin (28.85units/mg Humulin, Eli Lily,
Indianapolis, IN), 100,000 u/L penicillin, 100mg/L streptomycin sulfate (Gibco, Invitrogen,Grand
Island,NY), 0.292 g/L L-glutamine (Gibco), 10mg/L hydrocortisone (Solu-Cortef, Pharmacia &
Upjohn, Kalamazoo, MI), and 1000 u/L heparin (APP, Schaumberg, IL). Fresh rat plasma (25%
v/v) and erythrocytes (18-20% v/v) were collected earlier17 and added to the perfusate. The
total perfusate volume was 55 to 60 mL, while that of the dialysate was 450-475ml. The primary
circuit comprised perfusate that recirculated by means of a peristaltic pump through a jacketed
perfusion chamber, a membrane oxygenator, a heat exchanger, and a bubble trap. The
oxygenator was gassed with a mixture of 74%N 2/21%O 2/5%CO 2 and 100%02 to maintain a
constant pH. A fraction of the perfusate was diverted to the secondary circuit through a hollow
fiber dialyzer with a 2200 cm2 membrane area and a 30 kDa nominal molecular cutoff weight
(SpectrumLabs, Rancho Dominguez, CA) at a rate of 3mL/min/g wet liver weight. The
secondary circuit dialyzed the perfusate by counter-current exposure to dialysate. The volumes
of perfusate and dialysate were kept constant by controlling the flow of dialysate through the
dialyzer in the secondary circuit. Temperature within the system was maintained at 37.50C.
Upon completion of cuffing of Fresh livers (-5min) and after the period of warm ischemia for WI
livers, they were immersed in perfusate in the perfusion chamber. Livers were perfused at a
constant flow rate through the portal vein17 while maintaining portal pressure between 10 and
12cmH 20. The effluent flowed freely from the SHVC and IVC into the surrounding medium.
Perfusate and dialysate samples (1mL) were collected hourly from the liver effluent and
reservoir respectively. Perfusate samples were first spun down at 3000g before storing the
supernatant at -800C. Oxygen delivery and exit rate were determined from samples taken
immediately prior to entry to the portal vein and from the IVC. When the recipient hepatectomy
was prepared, the liver was disconnected from the circuit, rinsed in a bowl of saline at room
temperature, and weighed again before transplantation.
Metabolite Analysis
Biochemical Assays.
Blood gases were determined immediately using a blood gas analyzer (Rapidlab, Chiron
Diagnostics, Norwood, MA). Oxygen concentration delivered and removed from the liver was
calculated using the following equation:
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[02] = (1.39 x [Hb]x FO2Hb)+0.00314 x p0 2  (1)
which expresses the concentration of oxygen (ml/dL of blood) as the sum of oxygen bound to
hemoglobin and free in plasma. [Hb] (g/dL) is the concentration of hemoglobin, FO2Hb is the
fraction of oxyhemoglobin present, 1.39 (mlO 2/g Hb) is the binding capacity of oxygen to
hemoglobin and 0.00314 (ml0 2/dL/mmHg) is the solubility coefficient of oxygen in plasma,
which is dependent on the partial oxygen tension in the blood, PO2 (mmHg). The rate at which
oxygen is delivered to the liver (ODR) and exits the liver (OER) is subsequently dependent on
the flow rate, V (ml/min), and the difference between the two normalized to the weight of the
liver W(g) provides the hepatic oxygen uptake rate (HOUR):
HOUR = OER - ODR
(2)
HOUR ] uet x V - [02 ]inlet x V
WLiver
Similarly, total carbon dioxide release rate (CRR) at each time point was calculated
based on the total carbon dioxide measures in the samples via Piccolo Blood Chemistry
Analyzer (Abaxis) as:
CRR = ([tCO2 ]utet -[tCO 2 ]iniet ) X i
wLiver
Urea was assayed by reaction with diacetyl monoxime using a commercial assay kit
(BUN, Sigma-Aldrich, St. Louis, MO). Ketone bodies were measured enzymatically, by following
the appearance of NADH in the conversion to acetoacetate and the disappearance of NADH in
the conversion to p-hydroxybutyrate in the presence of p-hydroxybutyrate dehydrogenase42.
Nineteen of the common amino acids (except tryptophan) and ammonia were fluorescently
labeled using the AccQ-Tag system (Waters Co., Milford, MA), separated by high-performance
liquid chromatography (HPLC; Model 2690, Waters Co.) and quantified by a fluorescence
detector (Model 474, Waters Co.), as previously described43 . Lactate was measured using the
enzymatic conversion to pyruvate and hydrogen peroxide with lactate oxidase from a
commercially available kit (Trinity Biotech, Berkeley Heights, NJ). Albumin concentration was
determined by an enzyme-linked immunosorbent assay using a polyclonal antibody to rat
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albumin44 . A standard curve was derived using chromatographically purified rat albumin (Cappel
Laboratories, Aurora, OH) dissolved in medium. Note that the dialyzer molecular cutoff weight
was determined so that albumin could not pass through, and subsequently did not appear in the
secondary dialysate circuit. Concentrations were calculated based on the primary circuit volume
of approximately 60ml supplemented with fresh frozen plasma and erythrocytes. Glucose
measurements were quantified with an enzymatic assay kit through conversion to 6-phospho-
gluconate (Glucose assay kit, Sigma).
Statistical Identification of Linear Response Phases During Perfusion.
Linear regressions were performed on the temporal concentration profiles of each of the
metabolites at different time-periods of the perfusion (e.g. 0-5 hrs, 0-2 hrs etc). This was done in
order to identify whether there were distinct phases in liver metabolism during perfusion. The
concentration profiles and R2 values obtained from linear regression for each metabolite were
checked to confirm that each metabolite changed in an approximately linear fashion, necessary
to calculate fluxes accurately. Box-and-whisker plots of the resulting R2 values for each time
period and experimental group were evaluated for least variation across different segments of
time (Appendix B). Ischemic livers were found to exhibit stable but distinctly different metabolic
rates between 0-2hrs and 2-5hrs of perfusion. Fresh livers were found to be generally stable
throughout perfusion, with the greatest linearity between 1-5hrs.
Calculation of Fluxes.
Fluxes were calculated as the gradient of concentration of each metabolite (i.e. slope of
the linear regression curve)45 over the selected segments of perfusion, normalized to the weight
of the liver and averaged for each group.
Oxygen and Carbon Dioxide fluxes were determined every hour for each liver and were
then averaged for each group over the selected segments of time.
Date Preprocessing and Outlier Analysis.
An initial outlier analysis was performed for each measurement by plotting box-and-
whisker diagrams in MATLAB and eliminating obvious errors (e.g. negative values). This was
followed by a more stringent analysis where for each group any measurement value
above/below mean±2x inter-quartile range for that group were considered outliers. This process
is a necessity to eliminate artefactual values that increase variability.
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Metabolic Flux Analysis.
MFA was performed based on a stoichiometric model for the metabolic reaction network
developed and tested in more detail previously 46'47 and is referred to in Chapters 2 and 3.
In this work, the model consistency and validity of the steady state assumption was confirmed
by the method of Wang and Stephanopoulos 48. Briefly, this approach tests if the errors from the
regression for a chi-square distribution, which indicates a normal, expectable measurement
error distribution. If the regression errors do not follow a chi-square distribution at p<0.05, then
the measured fluxes can be eliminated iteratively to identify any issues. This approach was
used to identify two artefactual oxygen uptake measurements, which when eliminated resolved
the issues observed.
Statistical Analysis.
All statistical comparisons were performed using 2-tailed Student's t-test (p<0.05).
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5-2. Evaluation of Perfusate Temperature on Transplant Success
We demonstrate that sanguineous perfusion at room temperature results in
transplantable organs and that all metrics of organ function are similar if not improved
compared to NELP. Further we significantly simplify the requirements of the perfusion
system by removing the need for any temperature regulation. Metabolic analysis of livers
perfused at 370C demonstrates that the presence of erythrocytes may require compromising on
parameters known to cause damage. The presence of erythrocytes enable the use of
physiological oxygen tensions, reducing the risk of oxidative damage at hyperbaric oxygen
pressures, but subsequently require a higher hematocrit in order to deliver oxygen at the
desirable rates. Increasing the hematocrit however, also increases the viscosity and the portal
pressure, which necessitates a reduction in flow rates. The reduction in oxygen uptake rate by
perfused livers could not easily be dissociated from the likelihood of ischemia because of
significantly elevated lactate levels present in perfusate. The source of lactate may well have
been the hepatocytes, but it could also simply have derived from the erythrocytes. In order to
completely allay the seemingly perilous quest to provide the liver with ample oxygen while
minimizing damage, the solution was to attempt sanguineous perfusion at room temperature
thereby reducing both the metabolic demand of the liver and its oxygen requirements, while
potentially even eliminating the need for erythrocytes.
A major limitation to the use of perfusion systems in the clinic is their complexity which
makes them both generally immobile and resource intensive whether they operate at
hypothermic conditions (~40C), which utilizes the static cold storage modality of reducing the
organ's metabolic needs 49-55, or normothermic conditions (370C) which aims at maintaining the
donor organ under near-physiological circumstances for oxidative metabolism to take place as
usual 6,7,35,56-1. Subnormothermic Machine Perfusion (SNMP, 200C) potentially stands to confer
a substantial practical and functional advantage over these methods, rendering it steps closer to
clinical applicability.
In 1980 62 the first successful transplantation of healthy livers after perfusion at 10*C was
reported. Subsequent analyses of liver function tests, metabolism, histology and transplantation
of healthy livers perfused at 1 OOC-20*C demonstrated superior liver function compared to those
stored on ice or perfused at temperatures above or below that range in the absence of oxygen
carriers 63,64. In addition, beneficial effects of hypothermia in ischemia/reperfusion injury were
observed in the range of 40C to 26C 65. Yet, no study had investigated the use of
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subnormothermic perfusion-resuscitation of DCD organs using recipient survival as the
endpoint.
In this work, we show excellent one-month survival of transplanted rat livers that
underwent 60 minutes of ex-vivo warm ischemia (34*C) and preservation with 5 hours of SNMP.
This success is similar to ischemic livers resuscitated with NMP 6,7. By contrast, control
recipients of ischemic livers stored by CS for 5 hours, as well as those who received an
ischemic liver without preservation, did not survive. To assess early graft function, a separate
set of experiments was conducted using an isolated reperfusion model. These tests also
demonstrated superior performance of livers preserved with SNMP and NMP compared to
those not machine-perfused. The lack of a need for perfusion temperature control, in addition to
greatly decreased organ oxygen demand, promises to dramatically simplify machine perfusion
of donor organs increasing the likelihood of incorporation into clinical practice.
RESULTS
Integrity and Function of Liver during Perfusion
ALT and AST activities as indicators of hepatocellular damage are displayed in Figure
1A & B and are several fold lower in freshly isolated livers compared to warm ischemic livers
(p=0.0031 and 0.0247 respectively). There was no statistical difference in either ALT or AST for
room-temperature vs. normothermically perfused ischemic livers (p=0.1552 and 0.6864,
respectively). Change with time in ALT or AST during perfusion was statistically not significant
(p=0.1793 and 0.1142, respectively), indicating stability of the organ during perfusion.
Bile secretion, describing liver function, was produced at a constant rate throughout all
perfusions (Figure 1C). lschemically damaged livers produced bile at a rate -37% lower than
Fresh + NMP livers (p=0.0229). Bile levels were not significantly different from WI + NMP livers
(p=0.6071).
The metabolic state of the liver was assessed through its oxygen uptake rate. The
HOUR of warm ischemic livers perfused at room-temperature was significantly lower compared
to normothermically perfused fresh or ischemic liver rates (-35%, p=0.0130 and 0.0219
respectively). Statistically there was no change in HOUR throughout perfusion (p=O.l 142).
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Survival after Transplantation
Transplantation of all SNMP treated ischemic livers was uneventful. All animals
recovered from anesthesia rapidly. Like other recipients of MP and fresh livers, SNMP recipients
survived beyond one month and did not exhibit external signs of liver failure, such as jaundice.
No surgical complications occurred during transplantation of ischemic livers preserved
by CS and recipients recovered rapidly from anesthesia, but within 6 hours all developed
symptoms and died within 12 hours. Autopsy revealed patchy livers and serous fluid in the
abdomen. All recipients of directly transplanted ischemic livers died in a similar way within 24
hours post-operatively.
All controls that received freshly isolated livers preserved for 6 hours by CS recovered
rapidly from surgery and survived beyond one month (Figure 2).
Post-operative liver enzymes and bilirubin
Serological analysis was performed on recipients of the successful preservation
modalities. Both ALT and AST (Figures 3A and B) were elevated on day 1 post-operatively for
all groups similar to the levels found in recipients of healthy cold stored livers. Fresh, UW cold-
stored livers displayed a spike in both enzyme levels on day 5; a much less pronounced spike
was also evident in NMP-resuscitated ischemic livers on day 7, whereas the SNMP livers
displayed consistent levels throughout the observation period. Enzyme levels for SNMP
recipients were statistically lower compared to both recipients of cold-stored fresh livers (ALT:
p= 0.0393, AST: p=0.0042) and normothermically perfused ischemic livers (ALT: p= 0.0023,
AST: p= 0.0670).
The post-operative total bilirubin level was similar for SNMP-treated ischemic livers,
cold-stored fresh livers (p= 0.0547) and NMP-treated ischemic livers (p= 0.2466) (Figure 3C).
The bilirubin value increased with time for all groups (p<<0.01 in all cases).
Short-term graft performance post transplantation
In order to evaluate graft function immediately post-perfusion we employed a reperfusion
system using diluted whole-blood.
Figure 4 shows ALT and AST secretion for WI+SNMP group was lower than WI-only and
WI+CS groups at all time points (all p<0.05), and comparable to Fresh+NMP and WI+NMP
groups (all p>0.05). These results indicate SNMP is significantly better than CS in the short
term, and is equivalent to NMP in terms of reducing hepatocellular damage. The time-course
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changes in ALT and AST release rates during reperfusion were not statistically significant (p=
0.3927 and p= 0.5477 respectively).
The average bile production during reperfusion of WI+SNMP livers was statistically lower
than fresh livers (p=0.0006) but not different than any of the other groups (all p>0.05) (Figure
4C); however, the WI+SNMP group displayed a trend of increasing bile production, whereas in
all other groups bile production remained constant. SNMP livers lag behind NMP livers in bile
production rates.
As displayed in Figure 4D, the oxygen uptake rate of SNMP-treated Wl livers was similar
to that of NMP-treated Wl livers (p=0.3101), but lower compared to fresh livers (p=0.0140). The
changes in oxygen uptake rate over time during reperfusion were statistically not significant (p=
0.1458).
Figure 5 displays the H&E staining results at the end of reperfusion. NMP and SNMP-
preserved WI livers appear healthy and very similar to fresh livers in H&E images, whereas Wl
and WI +SCS livers show necrosis, with loss of macro and micro architectural integrity observed
in the latter. Apoptosis was negligible in all reperfused livers.
168
120 A 100
100 - 80
80
- 60
5 60 -- 3
o 40
F- 40
20 20
0 0
0 120 240 360 0 120 240 360
0 600 0.08
-O-Fresh+NMP y D
2 400 - -WI+NMP 
0.06
- -WI+SNMP
c
0 120 240 360 0 120 240 360
Perfusion time [min] Perfusion time [min]
Figure 1: Function and integrity of warm ischemic livers during SNMP. (A) ALT and (B) AST
levels in perfusate samples collected hourly from the primary circuit; (C) Total bile accumulation
normalized to wet liver weight; (D) Oxygen uptake rate normalized to wet liver weight. Data
shown are means ±SEM. Values for the SNMP livers are significantly higher than the fresh +
NMP controls for ALT and AST, and significantly lower for bile and oxygen uptake (p<O.05).
Only difference between NMP and SNMP was in the oxygen uptake rates.
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Figure 2: Survival curves of recipient rats after transplantation of perfused warm ischemic
livers, warm ischemic cold-stored livers, compared to healthy perfused livers, and healthy cold-
stored livers.
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Figure 4: Reperfusion results: (A) ALT, (B) AST, (C) bile synthesis, and (D) oxygen uptake rate
measured during reperfusion. Data shown are means ± SEM. ALT and AST values for the
SNMP livers are statistically not different from fresh livers and normothermically perfused
ischemic livers (p>0.05).
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Figure 5. Microscopic appearance of livers after preservation and reperfusion. Top: 1OX, Bottom: 20X. Bar = 200 pm.
DISCUSSION
We found that, in concurrence with our previous NMP studies6 , ischemic grafts
preserved with SNMP outperformed the ones preserved with CS. This was demonstrated by the
100% one-month survival of the recipients of SNM P-preserved grafts, compared to the 0%
survival of those in the CS group. Postoperatively, the profiles of transaminases and billirubin of
the SNMP groups were similar or improved compared to those of previously observed NMP
preserved ischemic livers, and healthy CS preserved controls. Similar trends were observed
during the reperfusion experiments: Both the metabolic function and histological appearance of
SNMP groups was similar to that of NMP livers and CS preserved healthy controls.
In general the livers preserved/resuscitated with subnormothermic perfusion displayed
lower ALT and AST release during both perfusion and reperfusion. The recipient serum-enzyme
levels were also lower. However, it was noted that the bile production of SNMP livers during
reperfusion was slightly (but not statistically) lower compared to NM P-resuscitated livers, and
postoperative serum total bilirubin levels were slightly (but not statistically) elevated in recipients
of SNM P-treated grafts suggestive of exacerbated biliary damage associated with SNMP.
However the rat model is not ideal for analysis of this issue, since the most commonly used
non-arterialized OLT method is often associated with postoperative damage to the biliary
system 66. Though the recent work of Brockmann et. al. 67has demonstrated a more suitable
porcine DCD-liver model of NMP resuscitation, the long-term effects of machine perfusion on
the biliary epithelium remain to be elucidated.
The use of machine perfusion in liver resuscitation after ischemic damage has gained
significant traction over the years. The use of hypothermic machine perfusion demonstrates that
despite the likelihood of cold-induced damage 6, perfusion results in superior organs compared
to static cold storage 69,70. Further, the establishment of NMP systems implies transplantable
outcomes with the prevention of cold storage damage 7' 9 during which a number of real-time
organ treatments can occur 71,72. The benefit of SNMP has now been demonstrated here and
elsewhere 64,73,74 as a winning simplification strategy, removing the need for temperature
regulation. Here we demonstrate that SNMP was equal to or better than NMP in most of the
tests performed.
Fujita et. al. 63 reported the change in oxygen uptake rate of livers perfused at different
temperatures, using Krebs Henseleit medium. Their model suggests that the oxygen uptake rate
at 200C is 32.4% of the oxygen consumed at 37*C NMP. The actual measured oxygen uptake
rate of the grafts during SNMP was about 35% of NMP, only slightly higher than Fujita et. al.'s
prediction. This is important however as it is yet another suggestion that livers at physiological
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temperatures were oxygen deprived; had they been consuming enough oxygen Fujita et. al.'s
results could have coincided. These findings suggest that exsanguinous perfusion or use of
artificial oxygen carriers will prove sufficient in delivering the requisite oxygen to a liver perfused
at room temperature, thus eliminating the need for erythrocytes. The removal of erythrocytes
would further obviate the necessity of continuous dialysis of the perfusate 4. Coupled with the
absence of the need for temperature regulation, this could enable the use of a much less
complicated perfusion system such as the portable and disposable perfusion system proposed
by Doorschodt et. al. 7 for hypothermic kidney perfusion.
In summary, this work demonstrates for the first time in literature, that a rat model of
subnormothermic extracorporeal machine perfusion can successfully resuscitate 1 hr ischemic
livers for transplantation, comparable to that of normothermic perfusion. Clinically, SNMP can
provide a practical model of machine perfusion while retaining the resuscitative benefits of NMP
with the ease of operation of HMP.
METHODS
Groups
Six groups that received transplants were compared: i. 1hr WI followed by
transplantation (n=9); 1hr WI followed by ii. 5hr SNMP (n=5), iii. NMP (n=8), iv. CS in UW
solution at 0*C (n=6); fresh livers transplanted after v. 6hr CS (n=6) or vi. NMP (n=1 1). Data
from groups iii, iv, v, and vi were derived from a prior publication using identical perfusion and
surgical methods 6. For all groups that received 1hr WI, additional experiments were done
employing a reperfusion method using diluted whole-blood 76 to provide acute post-
transplantation results; the results were compared to the reperfusion of a fresh liver.
Isolation of donor livers
Experiments were performed using male Lewis rats weighing 250-300g (Charles River
Labs, Wilmington, MA). The animals were maintained in accordance with National Research
Council guidelines and the experimental protocols were approved by the Subcommittee on
Research Animal Care, Massachusetts General Hospital. All animals were anesthetized with
isoflurane using a Tech 4 vaporizer (Surgivet, Waukesha, WI) and heparinized under sterile
conditions. The donor liver isolation procedure is a modification of Delrivibre's technique 77 and
is described in detail elsewhere 4. Liver excision occurred by ligation of the HA, clamping of the
IVC and PV, followed by transection of the SHVC, PV, HA and IVC. The liver was not flushed.
175
Warm ischemia induction
After isolation from the donor, the liver was weighed and then placed in a temperature
controlled chamber filled with saline and maintained at 34±0.10C for one hour. Ex vivo ischemia
ensured a constant temperature 78 and enabled a severe model of warm ischemia 79. During this
period the PV and IVC were cuffed as previously described 4.
Subnormothermic and normothermic liver perfusion
The perfusate and dialysate comprised phenol red-free Williams Medium E (Sigma
Chemical, St. Louis, MO) supplemented with: 2 u/I insulin (Humulin, Eli Lily, Indianapolis, IN),
100,000 u/I penicillin, 100 mg/I streptomycin sulfate (Gibco, Invitrogen, Grand Island, NY), 0.292
g/I 1-glutamine (Gibco), 10 mg/I hydrocortisone (Solu-Cortef, Pharmacia & Upjohn, Kalamazoo,
MI), and 1000 u/I heparin (APP, Schaumberg, IL). Fresh frozen rat plasma (25% v/v), and
erythrocytes (18-20% v/v) were collected earlier 4 and added to the perfusate only. The total
perfusate volume was 55-60 ml.
The perfusion system consisted of a primary liver perfusion circuit and a secondary
dialysis circuit as described previously 4. This design enabled a small blood supply to provide a
high hematocrit in the primary circuit and retained the benefit of a large reservoir for nutrients
and waste dilution via the secondary circuit. The primary circuit included perfusate that
recirculated via a peristaltic pump through a jacketed perfusion chamber, a membrane
oxygenator, a heat exchanger and bubble trap. The oxygenator was gassed with a mixture of
74% N2/ 21% 02/ 5% CO2 and 100% 02 to maintain a constant pH. Inflow was maintained at
approximately 2 mi/min/g liver, and 10-14 cmH 20 portal pressure. A fraction of the perfusate
was diverted to the secondary circuit via continuous peristaltic flow through a hollow fiber
dialyzer with a 2200 cm2 membrane area and a 30 kD nominal molecular weight cut-off
(Spectrum Labs, Rancho Dominguez, CA) at an average rate of 3 ml/min/g wet liver weight. The
secondary circuit dialyzed the perfusate by counter-current exposure to 450ml of dialysate. The
volumes of perfusate and dialysate were kept constant by varying the flow of dialysate through
the dialyzer in the secondary circuit. Room temperature was recorded as 200C throughout
SNMP perfusions, or maintained at 370C via the water-jacketed apparatus for NMP.
Fresh livers were immersed in ice-cold UW, cuffed in less than 10 minutes and then
either stored on ice or flushed with saline prior to being placed in the perfusion system. After the
warm ischemic period, livers were flushed with 10ml of warm saline and connected to the
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perfusion system. Livers were perfused at a constant flow rate via the portal vein and effluent
flowed freely from the suprahepatic and inferior vena cava into the surrounding medium. At the
end of perfusion, flow was terminated; the liver was disconnected from the circuit, rinsed in a
bowl of saline at room temperature and weighed again prior to transplantation.
Analysis of perfusate levels of metabolites and liver enzymes
Perfusate samples (1 ml) were collected prior to placing the liver in the perfusion system
and hourly thereafter. For each sample, 100pl aliquots were immediately analyzed using a
Piccolo comprehensive metabolic panel (Abaxis, Union City, CA) for alanine aminotransferase
(ALT), aspartate aminotransferase (AST), total bilirubin, electrolytes and glucose. The
remainder was stored at -80*C for later analysis. Dialysate samples (1 ml) were collected at the
same times and stored at -80'C.
For analysis of the hepatic oxygen uptake rate (HOUR), 200 pl samples were taken from
the PV and IVC of the liver every 10 minutes for the first hour of the perfusion and every hour
subsequently. Samples were analyzed immediately using a blood gas analyzer (Rapidlab,
Chiron Diagnostics, Norwood, MA). The total concentration of 02 (ml/dI) in the samples was
determined according to the formula:
[02] = 1.39 x [Hb] x FO2Hb + 0.00314 x P02 [1]
where [Hb] is the hemoglobin concentration in g/dl, FO2Hb is the fraction oxygenated
hemoglobin and PO2 is the partial pressure of oxygen in mmHg. HOUR was determined as:
HOUR = (([02] in - [021 out)/ 1 00) x flow rate/weight of liver. [2]
Bile was collected continuously in pre-weighed microcentrifuge tubes that were
exchanged every hour.
Recipient surgery
A modification of the cuff technique designed by Kamada and Caine 77,80,81 was
implemented and is described in detail elsewhere 4 . All recipient surgery was carried out by the
same microsurgeon (H.T.). The anhepatic phase of the procedure was typically 13-15 minutes
and did not exceed 17 minutes. Animals were hydrated with 8ml/kg of warm (370C) lactated
Ringer's solution with 5% dextrose and 2ml/kg of NaHCO 3 7%w/v (Abbott, North Chicago, IL) by
penile vein injection.
The animals were put singly in clean cages, allowed to recover from anesthesia under
an infrared lamp for half an hour, and subsequently returned to regular housing. During the first
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12 hours post-operatively animals were checked every 2 hours and subsequently every 8 hours
for one week, and daily afterwards.
Post-operative blood sampling
To determine the post-operative levels of AST, ALT and total bilirubin, 100-200pl of
blood were drawn from the tail vein under isoflurane anesthesia on post-operative days 1, 3, 5,
7, 14, 21, 28 and immediately analyzed using a Piccolo blood chemistry analyzer. For these
studies n was >3 for each group.
Simple cold storage
Warm ischemic livers (n=6) and freshly isolated livers (n=6) were flushed with 20ml of
ice-cold (0-40C) UW solution and placed on melting ice in a bowl containing UW solution for the
duration of the CS period; these livers were not perfused.
Diluted Whole Blood Reperfusion
For detailed evaluation of the graft response in the very early phase (0-2hrs) after
transplantation, we employed an extracorporeal diluted whole-blood reperfusion model. This
method was preferable as manipulation of animals for sampling immediately after
transplantation could further stress the animals, affect survival, and introduce artifactual
findings. The primary circuit was identical to the room temperature perfusion system with the
exception that the temperature was set at 370C and the secondary circuit comprising the
dialyzer was disconnected from the perfusion apparatus. The livers were reperfused for 120
minutes and inflow (portal vein) and outflow (infrahepatic vena cava) sampling was performed
every 15 minutes. Details of this system can be found elsewhere4 .
Histology
Liver tissue slices were fixed in 10% formalin, embedded in paraffin, sectioned, and
stained with hematoxylin and eosin. Apoptosis was evaluated through TUNEL staining (Roche,
Indianapolis, IN).
Statistical Analysis
Data presented are means ± SEM. Statistical analysis for comparison of groups in
survival was done by the log-rank test. The rest of the analysis was performed using 2-way
ANOVA in MATLAB (v7.7.0) at a=0.05, with Tukey-Kramer correction for multiple comparisons.
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For all measured variables (ALT, AST, bile, 02) group comparisons were performed on overall
time responses, rather than individual time points such that the differences between groups
could be identified.
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5-3. Evaluation of NELP Duration on Hepatoycte Yield
We use hepatocyte isolation as an endpoint to quantify the extent of perfusion
success. In a simple series of experiments we show that maximum cell yield is obtained
at short perfusion durations of 2 hours when using NELP. Based on our MFA analyses of
ischemic liver recovery that demonstrated a turnaround in liver metabolism at t=2 hours, we
hypothesized that this corresponded with the time to organ recovery. In order to evaluate this
claim, we conducted a series of perfusion experiments in which we varied the duration of
perfusion from 5 hours to 3, 2, and 1 hours and measured the number of hepatocytes procured
per gram of liver weight.
RESULTS
Upon completion of 5, 3, 2 or 1 hours of liver perfusion using NELP, at each time point,
perfusion was stopped and the livers were subjected to a normal two-step collagenase-based
isolation technique. Figure 1 illustrates that though there are no significant differences between
the groups, the trends are higher in cell yield earlier in perfusion.
100
80 *1hr W1 + 5hr NELP80 hrW1+3hrNELP
1lhr W1 +2hr NELP
60 - lhrWl +IhrNELP
40
20
0
Cell yield after percoll Viability
Figure 1. Cell yield and viability after NELP, n=5.
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DISCUSSION
The enhancement of warm ischemic livers within the first 2 hours, and the correlation
this has with increased oxygen uptake rate ties in well with the concept of debris washout,
enhanced cell access and energy recovery. It is unclear however, why livers do not
subsequently go on to exhibit Fresh-like liver metabolic rates in MFA, or indeed, why fewer cells
are recovered as soon as an hour later (t=3 hrs). It is possible that the two phases of ischemia
reperfusion injury (IRI) are at play here, where the first is microcirculatory collapse and the
second is neutrophil mediated damage. The first is known to occur within minutes of
reperfusion, while the second begins a few hours later27,30,82-84. The consequences are cell
death due to "necroapoptosis" - a term used to define the seemingly combined signals of
induced and programmed cell death in this unusual form of tissue damage. Therefore, capturing
cells before leukocyte mediated oxidative damage would ensure maximal cell yield. Usefully,
these findings imply that cell recovery can occur within 1-2 hours if perfusing at 37*C. Less
optimistic however, is the suggestion that livers transplanted after resuscitation with NELP may
still be in the throes of combating IRI. While these livers have been shown to result in long-term
viability in excess of 1 month after transplantation, they have also been transplanted into healthy
syngeneic recipients who have intact immune systems capable of handling this stress. Further
careful analysis of recipients of perfusion-recovered ischemic livers may provide insight as to
both the severity of the injury as well as the immunomodulatory factors responsible for
ameliorating the damage.
METHODS
Hepatocyte Isolation
A two-step collagenase perfusion technique described by Seglen 5, and modified
by Dunn et al.86 was used to isolate hepatocytes. Briefly, using aseptic technique, after gaining
portal vein access with an 18G catheter, warm oxygenated KRB+EDTA was flowed through the
livers at approximately 17ml/min. For Fresh livers, the IVC was immediately dissected and the
liver subsequently removed from the animal into a petri dish until perfusion was completed.
Perfused and WI livers were already in petri dishes with cuffed PVs. A collagenase (type IV,
Sigma, C5138-1G) solution with KRB and CaC12 was introduced to perfusion as the KRB
solution was depleted and allowed to flow until successful digestion was observed. The livers
were then moved to a sterile hood on ice where approximately 10mL of sterile, cold KRB were
added. The liver capsule was gently broken to release the cells which were then passed through
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a 250um filter followed by a 60um filter. The suspension was divided into 50 mL conical tubes
and centrifuged at low speed (15g-21g, 40C, no brake, 5 minutes). The supernatant was
aspirated and the pellet resuspended with 10ml KRB. An initial cell count and viability was
performed. A volume of 24mL of cold Percoll solution (9 parts Percoll : 1 part 1.5M NaCl, pH 5-
5.5) was used for every 25mL of cell suspension. Cells were added at a concentration of 5
million cells/mL and inverted several times before being centrifuged (49-58 g, 4*C, no brake, 10
minutes). The buffy coat and supernatant were discarded and resuspended to 1 OmL in DMEM +
10% FBS + 100,000 u/L penicillin + 1 00mg/L streptomycin sulfate, after which a final count was
performed using Trypan Blue exclusion.
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Appendix A. In vivo and Perfusate (WE) Reference Concentrations
METABOLITE Portal Vein1  WilliamsMedium E2
Acetoacetic acid (pM) 110±73 0
Alanine (pM) 397±13 1010
Albumin (g/dL) 1.9±0.21 0
Ammonia (pM) 109±33 0
Arginine (pM) 141±93 287
Asparagine (pM) 49±5.4 151
Aspartate (pM) 21±7.6 225
b-Hydroxybutyric acid (pM) 110±96 0
Cysteine (pM) 15±1.5 330
Glucose (g/dL) 123±62 0
Glutamate (pM) 68±7.7 302
Glutamine (pM) 293±46 2000
Glycine (pM) 273±27 666
Histidine (pM) 137±26 97
Isoleucine (pM) 86±16 381
Lactate (mM) 1.0±0.18 0
Leucine (pM) 261±33 572
Lysine (pM) 220±38 598
Methionine (pM) 44±7.0 101
Ornithine (pM) 120±3.5 0
Phenylalanine (pM) 59±3.9 151
Proline (pM) 163±12 261
Serine (pM) 199±13 95
Threonine (pM) 204±41 336
Tyrosine (pM) 68±7.4 278
Urea nitrogen (mM) 4.6±1.8 0
Valine (pM) 165±31 427
Izamis ML, et. al. In vivo metabolic flux analysis of the liver:
Effect of burn injury in rats. 2010.
2 Sigma-Aldrich cat. #W1878
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Appendix B. Box-and-whisker plots of linear regressions performed on the temporal
concentration profiles of 28 metabolites measured for WI and Fresh livers.
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Legend: m Minimum. * First quartile. A Median. * Third quartile. x Maximum.
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Chapter 6: Perfusion-Enhanced Cell Yields from Fresh and
Ischemic Grafts
193
We design a room temperature-operated ex vivo organ perfusion system
with an off-the-shelf perfusate medium for the easy and rapid recovery of
hepatocytes. The major findings of this study are:
* We demonstrate using this method that donor pretreatment with heparin
is unnecessary for high cell yields and viabilities.
* We obtain seventeen times as many hepatocytes from livers exposed to
an hour of WI (34*C) compared to untreated WI livers.
* We increase fresh liver hepatocyte yields by 32%.
* We demonstrate a linear correlation between post-purified (Percoll
treated) cell yield and tissue ATP content, normalized to total protein. This
enables direct measures of organ viability and organ recovery during
perfusion resuscitation.
" A strong correlation between perfusion flow rate and cell yield is
established supporting the use of flow rates as low as possible without
causing hypoperfusion or oxygen deprivation.
" Morphologically and functionally, perfusion-isolated hepatocytes
performed comparably or better than fresh hepatocytes in cell suspension
and plate culture.
There is a tremendous need for high-quality hepatocytes in the fields of cell-
based therapeutics, toxicology, drug metabolism, tissue engineering and basic research.
Optimizing cell yield and viability from both transplantable as well as discarded donors
would have a dramatic impact on meeting this demand. lschemically damaged organs
present a promising, virtually limitless supply of hepatocytes, based on evidence that ex
vivo perfusion of these organs recovers functionality to a significant degree' 2 . Additional
findings show the resuscitative benefits of ex vivo sanguineous perfusions can also be
achieved at room temperature3 where a reduced metabolic rate numerically obviates the
need for erythrocytes thereby enabling a significantly simplified perfusion design. A
dynamic study of organ metabolism during normothermic perfusion further speculated
4that the recovery of ischemic livers occurs within 2-3 hours of perfusion inception .
Based on these data we developed an ex vivo organ perfusion system
comprising only a pump that takes an off-the-shelf perfusate from a reservoir at room
temperature through an oxygenator and bubble trap to the liver, before being recycled.
The simplicity of the design lends itself readily to translation into clinical practice where it
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stands to recover an order of magnitude more hepatocytes from ischemic livers than
currently obtained5 6 at viabilities greater than 90% in less than 3 hours of un-manned
perfusion. Further, it has the ability to enhance hepatocyte performance in healthy livers
procured for donation, promoting the ubiquitous use of perfusion techniques in donor
organ storage.
RESULTS
Our goal was to investigate a clinically translatable perfusion technology for the
enhanced recovery of transplantable-grade cells from all donor organs, particularly
donors after uncontrolled cardiac death. Using a highly simplified ex vivo perfusion
system we recovered rat hepatocytes from non-pharmacologically pre-treated rat donors
who experienced 10 minutes or 60 minutes of warm ischemia prior to perfusion. The
results were compared to freshly isolated hepatocytes and hepatocytes procured from
livers exposed to 60 minutes of warm ischemia without treatment.
Livers that experienced 10 minutes of ischemia (cooled from 370C to
approximately 200C for cuffing purposes prior to ex vivo perfusion) and livers that
experienced 60 minutes of WI (340C) were subsequently perfused at 200C (room
temperature, RT) for 3 hours prior to hepatocyte isolation. Figure 2a illustrates that there
was no significant difference in the number of hepatocytes obtained from WI livers
treated with 3hr RT perfusion (34±11 million cells/g liver tissue, n=9) and Fresh livers
(34±9 million cells/g liver tissue, n=15). By contrast, untreated WI livers yielded
significantly fewer hepatocytes (1.7±0.6 million cells/g liver tissue, n=8). Further, fresh
livers that experienced 10 minutes of ischemia prior to 3hr RT perfusion resulted in
significantly more hepatocytes than untreated Fresh livers (45±10 million cells/g liver
tissue, n=12). All hepatocyte isolations were treated with Percoll to obtain a viability
>90% (Figure 2c).
Hepatocyte function was tested under two conditions: 6hr cell suspension culture
and 2 week double layer collagen gel sandwich plate culture. Cell viability and
mitochondrial activity were measured in suspension using trypan blue exclusion and
MTT reduction to formazan (Figure 3A and C respectively). While freshly isolated
hepatocytes started with relatively high viability during the first hour of suspension, their
viability was the lowest at t=6hrs. Similarly, while mitochondrial activity of fresh livers
was generally higher than that of perfusion-treated groups, they also showed the
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greatest decline at t=6hrs, whereas there were no differences between initial and final
values in the perfused liver groups. Cell damage in suspension was measured with ALT
and AST. Figures 3B and D demonstrate that both perfusion groups start with
significantly higher ALT and AST values compared to Fresh cells; ALT remains relatively
constant in WI+3hrRT cells, gradually degrades in 3hrRT cells and inclines in Fresh
cells. AST continues to increase during the first 2 hours before reaching a plateau in
WI+3hrRT cells, is stable in 3hrRT cells and inclines steadily for Fresh livers.
Cytochrome P450 activity was measured by dealkylation of benzyloxy resorufin
(CYP4502B2), pentoxy resorufin (CYP4502B 1), ethoxy resorufin (CYP4501AI) and
methoxy resorufin (CYP4501A2) after 3,3'-.methylene-bis(4-hydroxycoumarin) activation
(Figure 3E). CYP450 activity was comparable amongst all groups except for 3hrRT cells
which exceeded Fresh EROD and MROD activity significantly. Metabolic activity was
evaluated at t=6hrs and it was observed that all groups produced equal amounts of
glucose (2g/L at baseline), and urea (0mM at baseline), while WI+3hrRT cells produced
significantly less albumin than either Fresh or 3hrRT cells.
In plate culture, perfused liver cells showed excellent confluency at day 14 when
observed using phase contrast imaging (Figure 4C); better than Fresh hepatocytes
(Figure 4A) and structurally better-preserved compared to WI cells (Figure 4B). Viability
and mitochondrial activity were comparable amongst all groups and displayed a mild but
insignificant decline over the two-week culture period. CYP450 activity did not differ
significantly across groups. Certain trends could be observed, such as Fresh cells
generally peaking in activity within 7 days, while perfused livers appeared to either
remain constant throughout culture or gradually pick up in activity, peaking at Day 14.
Daily metabolism of albumin shows that Fresh and 3hrRT cells behaved comparably but
WI+3hrRT cells did not produce as much. 3hrRT cells produced significantly more urea
than either WI+3hrRT or Fresh cells, which were comparable. All groups metabolized
glucose equally.
Performance. of livers in perfusion was evaluated via several metrics. Figure 5
illustrates the metabolic characteristics of ex vivo livers perfused at room temperature.
The rates of glucose consumption, and lactate7 and urea production were comparable in
both groups, and neither demonstrated a net production of albumin (Figures 5A, E, G
and C respectively). The liver's ability to control pH8 was demonstrated from the very
beginning of perfusion by 3hrRT livers, while WI+3hrRT livers recovered this function
within the first hour (Figure 5B). Both livers extracted almost all available oxygen in
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perfusate (Figure 5D). Overall, 3hrRT livers tended to consumed slightly more oxygen
(0.016±0.003mlO2/min/gliver) than WI+3hrRT livers (0.012±0.003mlO2/min/gliver),
though the difference was insignificant at each measured time point (Figure 5F). Bile
production was delayed in WI+3hrRT, frequently initiating at t=2hrs compared to the
instantaneous production by 3hrRT livers. Subsequently the cumulative amount of bile
from WI+3hrRT livers was less at t=3hrs than that produced by 3hrRT livers (Figure 5H).
Liver weights in WI+3hrRT livers averaged 7.3±0.6g before ischemia, 7.9+0.91g after
1hr of warm ischemia, and 7.6±0.7g after perfusion. Liver weights in 3hrRT weighed
7.2±0.5g before perfusion and 7.9±0.6g after perfusion. None of these increases in
weight were significant.
To evaluate the impact of ATP normalized to total protein on cell yield, its content
was measured in liver tissue biopsied from organs immediately after harvest, 1hr of WI,
1hr WI+3hrRT and 3hrRT. Figure 1B illustrates that there is a significantly high
correlation between ATP content and purified cell yield per gram of liver tissue
(Pearson's correlation 0.96). As the ATP measurements were made on biopsied tissue
sections, a comparison to initial cell yields was also made (Figure 6) but this shows a
weaker correlation. Percoll subsequently removed 48% of the total yield in Fresh livers,
47% in 3hrRT livers, 51% in WI+3hrRT livers and 96% in WI livers.
Further differences between WI+3hrRT and 3hrRT livers were highlighted by
perfusion hemodynamics. A scatter-plot of final flow rate vs. cell yield and pressure was
created for both perfusion groups (Figures 7B and C). Both plots show that generally
higher yields are obtained at lower flow rates; this relation is distinctly linear in 3hrRT
livers (Pearson's correlation -0.94). Pressure across the livers was held generally
constant and demonstrated no correlation to cell yield in these experiments. The ratio of
pressure drop across the liver and flow rate, initially measured every 5 minutes for the
first half hour, and then every half hour thereafter, provided a value of hepatic resistance
(Figure 7A). 3hrRT (n=13) livers were generally reduced in resistance compared to
WI+3hrRT (n=14) livers though there was no consistent statistical difference between
the groups. Flow rates for 3hr RT livers started at 8.5±1.6ml/min, with initial pressures at
4.5±2.4cmH20. WI+3hrRT livers experienced a similar initial flow rate of 8.6±2.4ml/min
with initial pressures at 6.25±4.8cmH 20. By the end of perfusion, 3hrRT livers saw flow
rates of 13±0.8ml/min and pressures of 1.9±0.8 cmH 20 while WI+3hrRT livers
experienced flow rates of 12.6±1.2ml/min and pressures of 3.3±1.8 cmH 20. This
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demonstrates that despite slightly lower flow rates in WI+3hrRT, pressure across these
livers remained higher.
Histological evaluation using TEM allowed visualization of the presence of
edema in WI livers (Figure 8), with generally reduced cytoplasm-to-nuclear space, a
suggestion of rounded or swollen mitochondria and the presence of vacuoles. These
were also present in WI+3hrRT livers though to a lesser extent and gross edema was
significantly reduced by comparison. However, sinusoids appeared generally dilated and
congested while hepatocyte sinusoidal cell boundaries were indistinct. 3hrRT cells did
not show significant vacuolation or edema but also suggested evidence of sinusoidal
congestion and indistinct sinusoidal hepatocyte borders. At 0.5microns (Figure 9),
nuclear and mitochondrial membranes appeared intact, and their contents comparable
to Fresh livers. Mitochondria appeared more swollen in the WI and perfused livers
compared to Fresh livers. Rough endoplasmic reticulum and glycogen rosettes
appeared comparable in Fresh and Wl livers, less-distinct and discontinuous in perfused
livers.
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Figure 1: Simplified liver perfusion system
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Figure 2: A) Cell yield post-Percoll purification normalized to wet liver weight. B) ATP
content of biopsied tissue normalized to the total protein content. C) Viability of cells
post-Percoll purification. Data shown are means ± std dev. Values for WI and 3hrRT
livers are significantly different from other groups (p<0.05); there is no statistical
difference between Fresh and WI+3hrRT groups
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Figure 3: Cell function in suspension for WI+3hrRT and 3hrRT groups compared to
Fresh hepatocytes. A) Percent viability of cells using Trypan Blue exclusion. Fresh
hepatocytes are significantly reduced in viability at t=6hrs (p<0.05). B) ALT; perfused
groups have significantly higher starting values (p<0.05). C) Mitochondrial activity
measured by absorbance of formazan produced from MTT at 570nm. D) AST; significant
differences exist between all groups (p<0.05). E) CYP450 activity measured using
resorufin production by dealkylation of benzyloxy resorufin (CYP4502B2), pentoxy
resorufin (CYP4502B1), ethoxy resorufin (CYP4501A1) and methoxy resorufin
(CYP4501A2) after 3,3'-methylene-bis(4-hydroxycoumarin) activation. Activity is
significantly higher in 3hrRT cells for CYP4501A1 and CYP4501A2 (p<0.05). F)
Metabolic assays of glucose, albumin and urea. Albumin is significantly reduced in
WI+3hrRT cells at t=6hrs (p<0.05). All data shown are means ± std dev.
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Figure 4: Cell function in double layer collagen gel sandwich plate culture. A-C) Phase
contrast images for Fresh, WI and WI+3hrRT livers respectively. D) Mitochondrial activity
measured by absorbance of formazan produced from MTT at 570nm. E) Viability of cells
using Hoechst 33452/Ethidium homodimer-1 double stain. F-1) CYP450 isoenzyme
activity for days 5, 7, 10 and 14 of culture. J-L) Metabolic assays for Albumin, urea,
glucose. Urea production is significantly increased in 3hrRT livers (p<0.05).
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Figure 8: Transmission electron microscopy (10ptm) revealing gross edema in WI livers,
vacuolation, diminished cytoplasm-to-nucleus ratio and congested sinusoids. Perfused
livers have sinusoidal congestion, and variegated cell borders.
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Figure 9: Transmission electron microscopy (500nm) shows WI and perfused livers
have swollen mitochondria and potentially disrupted endoplasmic reticulum.
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DISCUSSION
Our goal was to develop a highly simplified ex vivo organ perfusion system to
recover and temporarily store all donor livers for the purposes of hepatocyte isolations or
transplantations. By choosing to operate at room temperature3 our system comprised
only a pump, a reservoir of perfusate, an oxygenator and a bubble trap. We
subsequently achieved cell yields from a model of uncontrolled warm ischemia in rat
livers that were comparable to fresh hepatocyte isolations. Both WI+3hrRT and Fresh
livers yielded approximately 34 million cells/g liver with viabilities in excess of 90% post-
Percoll purification, compared to non-perfused WI livers, which yielded only 2 million
cells/g liver' 6, or 6% of the total possible outcome. Further, the perfusion of healthy fresh
livers (3hrRT) for the same duration resulted in 32% more hepatocytes than Fresh livers
not treated by perfusion. Cell procurement
The quality of the hepatocytes was determined through a select series of
standard techniques9 to demonstrate competency in the likely uses of cell-based
therapies, pharmaceutical tests and research. The ability to attain a viability above
90%10 was preferred for optimal function in culture settings, though higher than the 60%
cutoff required for cell transplantation". The number of cells lost during the Percoll step
reflected, to some extent, the degree of pre-existing damage and possibly the extent to
which it had been reversed in perfusion; healthy liver cell yields were reduced to 52-
53%, ischemia-resuscitated yields were reduced to 49%, while the ischemic group
retained only 4% of its initial yield.
Cell suspension was used to reveal the impact of cell source on function6 9 , but
also as a rapid means of assessing batch performance 0 . Viability in suspension was
assessed by hourly measurements of the production of formazan from MTT, and trypan
blue exclusion. Perfused cells retained their viability better than Fresh cells over the
course of 6 hours despite having higher initial values for ALT and AST. These signs of
cell damage may have originated in perfusion or the process may have left the cells
more susceptible to damage in the subsequent cell isolation phase. Nevertheless,
perfused hepatocytes ceased further ALT and AST production once in suspension while
Fresh hepatocytes gradually increased their levels. Perfused cells generally appeared to
function as well as, if not better, than Fresh cells. Albumin was the exception; its
production was highest in 3hrRT cells, but lowest in WI+3hrRT cells. Urea was produced
equally in all groups; a clinical marker for ammonia removal, while biotransformation
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capacity was evaluated through CYP450 enzyme activity with significantly enhanced
performance by 3hrRT cells13 .
Plate culture, useful for long-term evaluation of cell function, demonstrated
similar trends as in cell suspension. Here, WI+3hrRT hepatocytes initially produced very
low amounts of albumin; however production was recovered by Day 2 and was
comparable to the other groups for the remaining 12 days. Plate culture also served to
verify that cells were kept free of microbiological contamination during perfusion. Overall,
these results demonstrate a simple basis upon which to procure, and further enhance, a
significant source of high-quality, high-functioning hepatocytes from currently available
resources.
The striking correlation between post-Percoll cell yield and ATP content
normalized to total protein suggests that direct or indirect measurements of ATP during
perfusion will enable the observation of the trajectory to optimal cell yield. This will also
allow dynamic testing of organs from uncontrolled cardiac death providing an objective
metric of hepatocyte viability. The correlation of ATP with cell yield was stronger after
cell purification suggesting that cells with low ATP content are unlikely to have fully intact
energy-dependent processes. These include simple membrane functions controlling cell
density, thereby being eliminated with Percoll. However, as can be seen by the
significant recovery of WI cells, perfusion enables restoration of ATP and ATP-
dependent functions and should be further optimized to this end.
The cell yield in WI+3hrRT livers was almost exactly the same values in Fresh
livers and may be purely coincidental, or it may relate to a similar phenomenon that
3hrRT livers are seemingly able to overcome. Our observations in this study support the
likely combined effects, though to varying degrees, of microcirculatory collapse, mild
ischemia reperfusion injury (IRI) and ischemic preconditioning on the final cell yield.
For Fresh livers, access to the portal vein represents two major insults that may
cause an immediate vasoconstrictive response to shock: 1) A sudden drop in blood
pressure and 2) Asanguineous reperfusion. The consequences of shock under these
circumstances may persist for the duration of washout, without the time to recover
before the advent of collagenase". It is possible that localized areas of hypoperfused
cells result in suboptimal cellular ATP levels. WI induction for 60 minutes in the rat model
significantly depleted ATP levels, caused generalized edema, ultrastructural changes,
and capillary narrowing, as expected15 18 . The extent of damage from subsequent IRI is
known to result in essentially non-transplantable grafts from untreated WI livers'.
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Evidence of extensive vasoconstriction in our livers upon initiation of ex vivo perfusion
was observed by the elevated portal pressures at low flow rates. This coincides with the
acute "no-reflow" phase of IRI which occurs within minutes of flow initiation due to
endothelial dysfunction creating an endothelin/NO imbalance, exacerbated by resident
leukocytes 9 -22 . For the first 20 minutes, perfusate was not recirculated allowing
accumulated toxins and debris to be washed out. This washout phase contributed
significantly to the decline in portal pressure though hepatic resistance was never
reduced to 3hrRT values suggesting continued microcirculatory compromise throughout
perfusion. The presence of hydrocortisone in the perfusate may also have conferred
positive anti-inflammatory effects on resident leukocytes. Leukocyte activity in "late"
phase IRI was further curtailed by cutting perfusion short at t=3hrs. Cumulatively, it may
be concluded that rat livers exposed to 60 minutes of WI are generally recovered by
perfusion due to the benefits of a large reservoir of nutrients devoid of inciting toxins.
However, only partial amelioration of microcirculatory collapse occurred, potentially
resulting in a liver not unlike a Fresh liver at the time of KRB+EDTA flushing. The use of
endothelin receptor agonists, thrombolytics and muscle relaxants may enable further
optimization of cell yields23-25 . The "pH paradox" is another IRI phenomenon that can be
optimized in perfusion by lowering pH to abrogate cell death, a trend already in progress
by anaerobic glycolysis and hydrolysis of ATP 26 ,27. 3hrRT livers potentially benefited
from ischemic preconditioning (IP), having been exposed to the suspected optimal 10
minute ischemic duration2 1,28 ,29. Their increased ATP levels, enhanced cell yield, lower
hepatic resistance, and somewhat improved metabolic performance is strongly
associated with the protective mechanisms of 1P30-33.
Removing erythrocytes from perfusate was favored for a number of reasons34
including the significant reduction in complexity of system setup and analysis. It was
justified by the reduced metabolic rates of livers perfused at room temperature. In our
previous reports, livers perfused at 370C consumed on average 0.05mlO2/min/gliver,
necessitating a minimum hemoglobin concentration of 7g/dL as a partial oxygen tension
of 600mmHg could only supply 0.03mlO2/min/gliver at physiological flow rates of
approximately 1.8ml/min/g liver. However, measures of oxygen uptake rate were
correlated to temperature by Fujita et. al. 35 who showed that at room temperature,
oxygen uptake rate of fresh livers in our system would approximate
0.01 7mlO 2/min/gliver, below the amount of oxygen deliverable by solution at
physiological flow rates. In practice, oxygen delivery rate averaged 0.021±0.002
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m10 2/min/gliver while uptake averaged 0.016±0.003 m102/min/gliver. These uptake rates
are slightly lower than we predicted. They are also lower than results obtained in a study
by Hcper and Kessler36 who also demonstrated feasibility of asanguineous liver
perfusion at room temperature. Further, the livers perfused at room temperature in a
sanguineous system also actually slightly exceeded our observations3. Combined with
the finding that our oxygen exit rates were very low, it is likely that our livers were
oxygen deprived during perfusion. This is particularly important in light of the correlation
between cell yield and low flow rates (maximum cell yield occurred at 1.6ml/min/g liver),
and hence even lower oxygen delivery rates. Interestingly, H6per and Kessler 36
reported ischemic times of 7 minutes or less before initiation of perfusion, and they
recommended perfusate flow rates of 2.2ml/min/g liver which are twice our suggested
flow rates, but they reported ATP levels that were below fresh liver controls. It is unclear
whether ischemic preconditioning was not achieved in these livers or whether the higher
flow rates resulted in fewer viable cells with high ATP content. It is reasonable to
suggest though that a strategy for optimal perfusion of fresh livers should likely include
an ischemic preconditioning period of 10-15 minutes, and an artifical oxygen carrier in
perfusate to sustain perfusion simplicity while meeting the oxygen requirements of the
liver with very low flow rates.
In conclusion, these results demonstrate that a simple ex vivo perfusion system
operating at room temperature provides a hands-free technology which, when applied to
all donor organs for recovery and assessment, can significantly optimize cell yield and
function.
MATERIALS AND METHODS
Experimental Groups
Experiments were conducted on female Lewis rats (160g-180g) which were kept
in accordance with National Research Council guidelines. The Subcommittee on
Research Animal Care, Committee on Research, Massachusetts General Hospital
approved the experimental protocols. Animals were randomly divided into four groups: 1)
Livers that were exposed to an hour of WI at 34*C (WI), 2) Livers that were perfused for
3 hours at room temperature after 1hr WI (WI+3hrRT), 3) Fresh livers (Fresh), and 4)
Fresh livers perfused for 3 hours at room temperature (3hrRT).
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Hepatectomy
Livers were excised according to the technique of Delrivibre et. al.37. Briefly, a
transverse abdominal incision was made and the intestines retracted to expose the
portal vein (PV), the common bile duct (CBD), and the inferior vena cava (IVC). The
CBD was cannulated (12cm, 22 G polyethylene stent, Surflo, Terumo, Somerset, NJ)
and the IVC freed from the right renal and adrenal veins. The portal vein (PV) was freed
from the splenic and gastroduodenal veins. The right phrenic vein emptying into the
supra-hepatic vena cava (SHVC) was ligated. The hepatic artery was then ligated and
the IVC clamped. Finally, the PV was clamped and the clock started for ischemic
duration. The diaphragm was opened, the SHVC was transected, and the liver was
removed, and weighed. Fresh livers were then immediately prepared for biopsy. 3hrRT
livers were placed in a bowl of room temperature saline to be cuffed at the PV and IVC
prior to perfusion with an average ischemic time of 10 minutes. WI livers were placed in
a temperature-controlled chamber filled with saline and maintained at 34±0.1*C for 1 hr
during which time they were cuffed.
Perfusion Circuit
The perfusate comprised 750ml phenol red-free Williams Medium E (Sigma
Chemical, St. Louis, MO) supplemented with 2 u/L insulin (28.85units/mg Humulin, Eli
Lily, Indianapolis, IN), 100,000 u/L penicillin, 100mg/L streptomycin sulfate (Gibco,
Invitrogen,Grand Island,NY), 0.292 g/L L-glutamine (Gibco), 10mg/L hydrocortisone
(Solu-Cortef, Pharmacia & Upjohn, Kalamazoo, MI), and 1000 u/L heparin (APP,
Schaumberg, IL). The circuit comprised a peristaltic pump which brought perfusate from
a reservoir to a membrane oxygenator, through a bubble trap and to an 18G catheter for
portal flow into the liver. The liver was positioned on a fine flexible mesh surface,
permeable to perfusate, in a perfusion chamber. Effluent flowed freely from the PV and
SHVC into the chamber where it was then returned to the perfusate reservoir (Figure 1).
The oxygenator was gassed with a mixture of 95%02/5%C02. Upon completion of
cuffing of Fresh livers and after the period of warm ischemia for WI livers, organs were
immersed in a drained perfusion chamber into which perfusate dripped at 4ml/min;
perfusion chamber outflow was redirected to a catch basin where effluent from the liver
was collected for the first 20 minutes before the circuit was closed. Using a simple
manometer, portal pressure was recorded every 5 minutes during this flushing, as were
flow rates which were gradually increased over time in accordance with the drop in
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pressures observed. It was desirable to achieve in vivo flow rates of -1.8ml/min/g liver38
but preference was given to sustaining an absolute pressure below 4-6cmH20. At
t=30mins and every half hour after, additional sampling commenced with 1.2ml perfusate
aliquots collected and stored at -80'C for later analysis. Inflow and outflow blood gas
analysis was also performed at this time for p02 and pH measurements, corrected to
200C (Rapidlab, Chiron Diagnostics, Norwood, MA). Bile was collected in a tube outside
the perfusion chamber and both it and the livers were weighed at the end of perfusion.
Hepatocyte Isolation
A two-step collagenase perfusion technique described by Seglen (1976), and
modifiedby Dunn et al. (1991) was used to isolate hepatocytes. Briefly, using aseptic
technique, after gaining portal vein access with an 18G catheter, warm oxygenated
KRB+EDTA was flowed through the livers at approximately 17ml/min. For Fresh livers,
the IVC was immediately dissected and the liver subsequently removed from the animal
into a petri dish till perfusion was completed. Perfused and WI livers were already in petri
dishes with cuffed PVs. A collagenase (type IV, Sigma, C5138-1G) solution with KRB
and CaCl 2 was introduced to perfusion as the KRB solution was depleted and allowed to
flow until successful digestion was observed. The livers were then moved to a sterile
hood on ice where approximately 10mL of sterile, cold KRB were added. The liver
capsule was gently broken to release the cells which were then passed through a 250um
filter followed by a 60um filter. The suspension was divided into 50 mL conical tubes and
centrifuged at low speed (300- 350 RPM, 4*C, no brake, 5 minutes). The supernatant
was aspirated and the pellet resuspended with 10ml KRB. An initial cell count and
viability was performed. A volume of 24mL of cold Percoll solution (9 parts Percoll : 1
part 1.5M NaCl, pH 5-5.5) was used for every 25mL of cell suspension. Cells were
added at a concentration of 5 million cells/mL and inverted before being centrifuged (50
g, 4*C, no brake, 5-10 minutes). The buffy coat and supernatant were discarded and
resuspended to 10mL in DMEM + FBS + 100,000 u/L penicillin + 100mg/L streptomycin
sulfate, after which a final count was performed.
Cell Suspension
Cells were diluted to 1 million/mI in Williams Medium E and aliquoted into 1.6mL
microcentrifuge tubes, 4 separate vials were used for each assay except for Trypan Blue
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exclusion where time permitted only 2. The tubes were subsequently rotated at slow
speeds in a 37*C incubator, except light-blocked vials for CYP450 activity which were
allowed to settle between readings so as to reduce pipetting errors.
ALT and AST.
4 vials each were prepared for ALT and AST. At every hourly time point starting
at t=Ohrs, 15ul from each vial was placed into a 96 well plate on ice. At t=6 hours, Triton-
X 100 was diluted to 1% concentration with a volume of the remaining cells. The cells
were lysed by rapid pipetting, and then diluted 1:4 with PBS; 15ul from each vial was
finally added to the 96 well plate as the positive control. 150ul of reagent at room
temperature was then rapidly pipetted into the wells and a kinetic endpoint assay
provided enzyme activity per minute (TR71121 and 7200-006, Thermo Electron,
Pittsburgh, PA). The results were subsequently normalized to the completely lysed cells.
CYP450 activity.
4 vials for each of the CYP450 enzymes to be tested were prepared; these
included benzyloxy resorufin (CYP4502B2), pentoxy resorufin (CYP4502B1), ethoxy
resorufin (CYP45O1A1) and methoxy resorufin (CYP4501A2). 20IL of 6mM stock
solution 3,3'-methylene-bis(4-hydroxycoumarin) was added to each vial (Sigma M1390)
and allowed to incubate for 20 minutes. 10ptL of 1mM solutions of each of the
isoenzymes was then added to the vials. The vials were inverted several times and a
50pL sample was taken at t=0 minutes and stored on ice, away from light. Samples were
taken again at 10, 20, 30 and 40mins. A standard was prepared by serial dilution of
10OOnM resorufin. Samples and standards were read with a.fluorescence plate reader
(Ex530, Em590) and recorded as rates of resorufin production per million cells.
Glucose, Albumin and Urea
4 vials were incubated for the entire 6hr duration, spun down and the supernatant
was stored at -80*C. Standard assay reagents were used for glucose (Stanbio 1075-
825) and urea (Stanbio proc. No. 0580), and an elisa was used to detect albumin.
Viability
2 vials were counted hourly using Trypan Blue exclusion to test for viability.
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Mitochondrial activity
The MTT assay was performed hourly by pipetting approximately 50,000 cells
(50ptL) from 4 vials into 4 wells on a 96-well plate and diluting with 50pLL of Williams
Medium E for 4x100piL of cell suspension. 1 vial of MTT was thawed (Biotium, Inc.,
30006) and 1OptL added to each well. Samples were mixed gently while incubating at
370C, protected from light. The plates were then spun at 800rpm, the supernatant
removed, and 200tL of DMSO added to dissolve the Formazan. Absorbance was read
at OD57o-OD630.
Plate Culture
Cells were plated in standard 6-well plates using a double layer collagen gel
sandwich plate culture39 with C+H as the culture medium; phenol red-free medium was
used in the CYP450 assays. Enough plates were prepared for 3 wells to be devoted to
each assay on days 5, 7,10 and 14.
Viability
Hoechst 33452 and Ethidium homodimer-1 double stain was used to detect all
nuclei, and dead nuclei, obtaining a measure of viability. Briefly, 1 0ptL of a 1 mM solution
of Ethd-1 and 5pL of Hoechst 33452 were added to 5ml of PBS, while protecting from
light exposure. Medium from the cells was washed with PBS and 1ml of the dye added
to each well. The cells were incubated at 37C for 10-15 minutes before processing using
a Zeiss axiovert 200 microscope. Thirty five snapshots were taken at distinct locations
within each well for each dye, overlaid on corresponding phase contrast images. Cell
nuclei were subsequently counted using CellProfiler (Broad Institute, Cambridge, MA).
Mitochondrial activity
100Lp of MTT were added to each well and incubated for 1hr at 370C. The
medium was subsequently aspirated from the wells and 1mL of 6mg/mL collagenase
was added and incubated at 370C for 15 minutes and pipetted rigorously to dissolve all
collagen. 1mL of DMSO was then added and the contents rigorously pipetted up and
down to dissolve the Formazan present. 250iL samples were subsequently placed in
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triplicate on a 96 well plate (3 wells x 3 samples) and absorbance was read at OD570-
OD630.
CYP450 activity
48 hours before the assay, 1 mL of a 2ptM solution of 3-methylcholanthrene
inducer was added to each well. This medium was left on the cells for the subsequent 48
hours. 5tM and 80pM solutions of substrate solution and dicumarol respectively were
prepared to a volume of 5ml (1 ml/well) by diluting in EBSS. After 48 hours, the medium
was aspirated and 1 ml of warm EBSS was added to each plate. After 15 minutes, the
EBSS was aspirated and 1ml of the substrate+dicumarol solution was added to each
well. 50ptL of medium was subsequently removed at t=5,15 25, and 35 minutes and
placed in a 96-well plate protected from light. Fluorescence intensity was subsequently
measured (Ex530, Em590).
Glucose, Albumin, Urea.
Media from plates prepared for assay analysis on Day 14 were collected daily
and stored for metabolic analysis using the same techniques as above.
Tissue Biopsies
Tissue sections were rapidly frozen in liquid nitrogen upon resection of Fresh
livers, after perfusion was complete for WI+3hrRT and 3hrRT livers, and after 1 hr of
warm ischemia for WI livers. Remaining lobes were then perfused with 15mL of
Karnovsky's solution for histological preparation.
ATP
ATP content was measured in tissue segments homogenized with a mortar and
pestle under liquid nitrogen and resuspended in 500tL of nucleotide releasing buffer
(Biovision, #K354-1 00). Each sample was spun down at 16rpms for 2 minutes. 10IL of
sample was subsequently placed in a cuvet and the assay continued as prescribed in
the kit. Data were plotted against a standard and normalized to the total protein present
in the sample supernatant using a standard Bradford assay.
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Transmission Electron Microscopy
Constructs were fixed overnight in modified Karnovsky fixative (2.5%
Glutaraldehyde, 2.5% formaldehyde, 0.1M cacodylate buffer, pH 7.2), washed with 0.1M
buffer, post fixed in 1% osmium tetroxide in 0.1M cacodylate buffer, and dehydrated in a
graded series of ethanol. The samples were infiltrated and embedded in a mixture of
Spurrs resin and Quetol according to Ellis40 . 60-80nm cross sections and en face
sections were cut on an Ultracut E microtome (Reichert, Depew, NY) using a diamond
knife. Thin sections were stained with 5% uranyl acetate and Reynolds lead citrate. The
sections were viewed with a JEOL JEM 1010 transmission electron microscope (JEOL,
Tokyo, Japan) and images were digitally captured on an AMT XR-41 B CCD camera
system (Advanced Microscopy Techniques Inc., Danvers, MA) 41.
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ABSTRACT
Current techniques for the preservation of donor livers typically rely on cold temperatures (- 0-4'C) to
slow down metabolic processes. Recently, normothermic extracorporeal liver perfusion (NELP) has re-
gained interest as a potentially promising approach for long-term liver preservation. Unlike cold-storage
techniques, NELP attempts to maintain the liver in a near physiological environment, thus enabling nor-
mal metabolic and tissue repair processes to take place, which may help in the recovery of ischemically
damaged and fatty donor livers, both of which represent significant untapped sources of donor livers.
However, NELP is technically more complex than cold-storage techniques, and the lack of standardized
small animal models limits its development. Here we describe a rat NELP system that is simple and cost-
effective to run. We show that rat livers that underwent NELP for 6 h could be routinely transplanted into
syngeneic recipient rats with excellent 1-month survival. During perfusion, the release of cytosolic enzymes,
bile and urea production, and oxygen uptake rate could be readily monitored, thus providing a compre-
hensive picture of hepatic function before transplantation. This system will help in the optimization of
NELP in several ways, such as for the improvement of perfusion conditions and the development of quan-
titative metabolic criteria for hepatic viability.
INTRODUCTION
L IVER TRANSPLANTATION is currently the only establishedtreatment for end-stage liver disease. Demand continu-
ously exceeds the supply of donor livers, and a large number
of patients die while on the waiting list for a donor liver
(www.unos.org). Various approaches are being investigated
to alleviate the donor shortage, which can be categorized as
surgically based or tissue-engineering based. The former in-
cludes extending liver graft criteria to include marginal and
rejected donor livers and split liver transplants from living
donors. The latter includes extracorporeal liver support us-
ing whole xenogeneic or rejected human donor livers," 2 bio-
artificial livers, and hepatocyte transplantation techniques.
Normothermic extracorporeal liver perfusion (NELP) has
been suggested as an alternative to cold storage of donor
organs, in particular when applied to the preservation of mar-
ginal donor livers.3'4 Near-normothermic machine perfusion
has been successfully used in experimental kidney preser-
vation,5- 7 and normothermic perfusion has recently been
shown to be superior to simple cold storage (SCS) in the
preservation of livers donated after cardiac death.4 '8 '9
Unlike cold storage and cold machine perfusion techniques,
which rely on the reduction of metabolic rates as a result of
decrease in temperature, NELP attempts to maintain the
organ in an environment that is as close to physiological as
possible. NELP therefore has a number of potential benefits
over cold storage, including the ability to restore oxidative
metabolism in ischemically damaged organs, the removal of
end products of metabolism, and the possibility of pretrans-
plantation diagnostic testing of the graft and the induction of
repair processes. Possible other uses include immunomodu-
lation and (pre)conditioning of the donor organ.9
Although NELP is a promising technique for long-term pre-
servation of donor livers, there are many obstacles that need
to be overcome before it is a clinically feasible approach. The
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main issue is that NELP is more complicated than hypother-
mic preservation methods and some other experimental pres-
ervation techniques such as hypothermic perfusion and oxygen
persufflation.10 Because its complexity, some investigators
envision using NELP after a period of cold storage, but this
approach has yielded mixed results.' 1 "2 Hypothermic oxy-
genated machine perfusion has been successfully used in this
manner, although a clear advantage over static cold storage
could only be shown upon ex vivo reperfusion.' 3 "4 The lack
of standardized small animal models has impeded evaluation
of the potential benefits of NELP.
In this study, we describe a novel rat NELP system based
on an extensively documented, isolated, perfused rat liver
system that was originally developed for short-term perfu-
sion.15-1 8 We modified the latter by using a cell culture-based
perfusate supplemented with plasma, autologous erythrocytes
as oxygen carriers, and the incorporation of continuous di-
alysis. We demonstrate, using normal healthy rat livers, that
this improved system can maintain livers in a metabolically
stable condition for at least 6 h, significantly extending the
normothermic perfusion time from the typical 2 to 4 hours for
perfused rat livers.15 Furthermore, we show that the perfused
livers can be routinely transplanted into syngeneic recipients
with excellent long-term survival. This system will be useful
in optimizing NELP and comparing NELP with other liver
preservation techniques, such as SCS and cold machine per-
fusion.
MATERIALS AND METHODS
Chemicals
Phenol red-free Williams Medium E was from Sigma
Chemical (St. Louis, MO). Human insulin (Humulin) was
from Eli Lily (Indianapolis, IN). Penicillin/streptomycin and
L-glutamine stock solutions were from Gibco Invitrogen
(Grand Island, NY). Hydrocortisone (solu cortef) was from
Pharmacia & Upjohn (Kalamazoo, MI). Heparin was from
APP (Schaumberg, IL).
Isolation of donor livers
Experiments were performed using male Lewis rats (Char-
les River Laboratories, Wilmington, MA) weighing 250 to
300 g. The animals were maintained in accordance with Na-
tional Research Council guidelines, and the Subcommittee on
Research Animal Care, Committee on Research, Massachu-
setts General Hospital approved the experimental protocols.
The liver transplantation procedure used was the cuff
technique first described by Kamada and Kalne. 19-21 The
same microsurgeon (HT), with prior experience of more
than 100 orthotopic liver transplants in the rat, performed all
surgeries. Surgeries were performed using a Zeiss Opmi 1 mi-
croscope (Prescott, Monument, CO) with 6x magnification.
Briefly, donor operations began with a transverse abdom-
inal incision. The bowel and the duodenum were retracted
to the right using moist gauze to expose the portal area of
liver, the common bile duct (CBD), and the inferior vena cava
(IVC). The right phrenic vein emptying into the supra-hepatic
vena cava (SHVC) was ligated. The CBD was transected
after distal clamping and insertion of a 22 G polyethylene
stent (Surflo, Terumo, Somerset, NJ). The IVC was divided
from the right renal and adrenal veins. The portal vein (PV)
was divided from the splenic and gastroduodenal veins.
One mL of saline containing 200 U of heparin was injected
through the penile vein. Several liver ligaments were dis-
sected. The IVC was cross-clamped using a microvessel
clip. The PV was clamped distally and a hemicircumferen-
tial incision was made. An 18 G polyethylene cannula
(Terumo) was inserted into the PV, and the liver was flushed
with 5 mL of cold (4'C) University of Wisconsin (UW)
solution (Viaspan, Barr Laboratories, Pamona, NY). The
diaphragm was opened, the SHCV was transected, and the
liver was flushed with an additional 5 mL of UW solution.
The liver was removed and placed in a bowl of ice-cold UW
solution and cuffed as described previously.' 9 Some livers
were left in SCS for 7 h before transplantation. The others
were used for normothermic extracorporeal liver perfusion.
Liver perfusion system
The perfusion system consists of a primary liver perfu-
sion circuit and a secondary dialysis circuit (Fig. 1A). The
primary circuit consists of a jacketed liver perfusion cham-
ber (Radnoti Glassware Technologies, Monrovia, CA) (Fig.
1B), a Masterflex peristaltic pump (Cole Parmer, Vernon
Hill, IL), a membrane oxygenator (Radnoti), a heat exchan-
ger (Radnoti), a bubble trap (Radnoti), a second peristaltic
pump (Cole Parmer), and a hollow fiber dialyzer with a
2200-cm 2 membrane area and a 30-kDa nominal molecular
weight cut-off (Spectrum Laboratories, Rancho Dominguez,
CA). Temperature within the liver was maintained at 37.5'C
with a homeothermically controlled water bath (Lauda,
Brinkmann, Westbury, NY) and was continuously monitored
using 2 thermocouples (Omega, Stamford, CT): 1 located
between the lobes of the liver and the other in the PV
cannula just before entering the vein. The oxygenator
was gassed with a 95% oxygen (0 2)/5%carbon dioxide
(C0 2) mixture. The secondary dialysis circuit consisted of
a 500-mL reservoir and peristaltic pump.
Normothermic extracorporeal liver perfusion
Dialysis medium consisted of phenol red-free Williams
Medium E to which was added 2 U/L insulin, 40,000 U/L
penicillin, 40,000 ptg/L streptomycin, 0.292 g/L L-glutamine,
10 mg/L hydrocortisone, and 1000 U/L heparin. Perfusate me-
dium was prepared by supplementing the same medium used
for dialysis with 25% (v/v) freshly isolated rat plasma and
then adding freshly isolated rat erythrocytes to a hematocrit
of 16% to 18%. To obtain rat plasma and red blood cells, rats
were anesthetized with isoflurane, and 1 U heparin/g of body
225
2144
NORMOTHERMIC RAT LIVER PRESERVATION
FIG. 1. Schematic of the normothermic liver perfusion system. (A) Perfusion circuit. (B) Detail of liver perfusion chamber. Color
images available online at www.liebertpub.com/ten.
weight was injected through the penile vein. Puncture of the
abdominal aorta using a 16 G intravenous catheter (Surflow,
Terumo) was performed, and the animal exsanguinated. Blood
was kept on ice and then centrifuged in 50-mL tubes at 3200
revolutions per min (rpm) for 15 min at 4'C. The plasma was
removed and set aside. The buffy coat was discarded. Eryth-
rocytes were twice washed with saline containing 5% dextrose
(Baxter, Deerfield, IL) and centrifuged for 5 min at 3200 rpm.
The total perfusate volume used for 1 liver perfusion was 55
to 60 mL. Dialysate volume was 500 mL.
The liver was immersed in perfusion medium placed in
the jacketed perfusion chamber. An 18 G polyethylene cath-
eter (Terumo) was placed inside the PV cuff and gently secu-
red using a 6-0 silk suture. The CBD stent was connected to
a PE 50 polyethylene catheter (Becton Dickinson, Franklin
Lakes, NJ) emptying into a preweighed microfuge tube for
bile collection. The liver was perfused via the PV only, and
effluent flowed freely from the SHVC and IVC into the
surrounding medium. Flow rate was maintained at 1.8 mL/
min per g of liver wet weight. The volume of perfusate in the
primary circuit was visually monitored and kept constant by
adjusting the flow rate of dialysate in the secondary circuit,
typically ± 20% of the flow rate in the primary circuit. After
3 h of perfusion, the reservoir of dialysate was replaced by a
similar reservoir containing 500 mL of fresh dialysate.
Analysis of perfusate levels of metabolites
and liver enzymes
Perfusate samples (1 mL) were collected from the inlet of
the liver in the primary circuit immediately before placing
the liver in the perfusion system and hourly thereafter. Dia-
lysate samples (1 mL) were collected from the reservoir in
the secondary circuit at the same times. Alanine aminotrans-
ferase (ALT), aspartate aminotransferase (AST), glucose,
and urea levels were measured using a Piccolo miniature
blood chemistry analyzer (Abaxis, Union City, CA).
Oxygen and CO 2 tensions were measured in perfusate
samples (0.2 mL) taken from the in- and outflow (PV and
IVC) of the liver every 10 min for the first hour of perfusion
and subsequently every hour. Samples were analyzed im-
mediately using a blood gas analyzer (Rapidlab, Chiron
Diagnostics, Norwood, MA). The total (free and bound to
hemoglobin) concentration of 02 (g/dL) in the samples was
determined according to the formula
[02] = 0.0139 x [Hb] x F0 2Hb + 0.00314 x P 0 2
where [Hb] is the hemoglobin concentration in g/dL, FO2Hb
is the fraction of oxygenated hemoglobin, and PO2 is the
partial pressure of oxygen in mmHg. The hepatic oxygen
uptake rate (HOUR) was determined by subtracting the total
02 content in the outflow minus the inflow, then multiply-
ing by the flow rate and normalizing to the wet weight of the
liver:
HOUR = ([O2]n - [O2]out) x flow rate/weight of liver.
Bile was collected continuously in preweighed micro-
fuge tubes that were exchanged every hour. Wet weight of
the liver was determined during the brief periods of cold
storage before and after perfusion.
Light microscopy
Liver tissue slices were fixed in 10% formalin, embedded
in paraffin, sectioned to a 4-iim thickness, and stained with
hematoxylin and eosin.
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Transmission electron microscopy
Samples of liver tissue (- 1 mm 3) were fixed in a mix-
ture of 2.5% glutaraldehyde and 2% paraformaldehyde in
0.1 M sodium cacodylate buffer (pH 7.4), washed in 0.1 M
cacodylate buffer and postfixed with a mixture of 1% os-
mium tetroxide and 1.5% potassium ferrocyanide for 2h,
washed in water and stained in 1% aqueous uranyl acetate
for 1 h followed by dehydration in grades of alcohol (50%,
70%, 95%, 2x100%), and then infiltrated and embedded
in TAAB Epon (Marivac Canada Inc., St. Laurent, Canada).
Ultrathin sections (- 60-80 nm) were cut on a Reichert
Ultracut-S microtome, picked up onto copper grids, stained
with 0.2% lead citrate, and examined using a TEM (Tecnai)
G2 Spirit BioTWIN transmission electron microscope (FEI,
Hillsboro, OR). Images were taken with a 2k AMT CCD
camera (AMT, Danvers, MA).
Transplantation surgery
At the end of the perfusion, the liver was flushed with
20 mL of cold (00C) UW solution and placed on ice in a bowl
containing UW solution. Typical cold storage time was ap-
proximately 60 min.
Briefly, the abdomen was opened with a midline incision
and exposed with wound retractors. The bowel and the
duodenum were retracted to the right using moist gauze to
expose the portal area of liver, the CBD, and the IVC. The
right phrenic vein emptying into the SHVC was ligated.
A 20 G polyethylene stent (Terumo) was inserted into the
CBD at its bifurcation and secured with a 6-0 silk ligature,
after which the CBD was transected. The hepatic artery and
the suprarenal veins were divided. All ligaments of the liver
were divided from the surrounding tissue. The PV was tied
at its bifurcation, and the IVC and PV were cross-clamped
with microvessel clips. The SHVC was clamped with a Sat-
insky pediatric diaphragm clamp (Miltex, Lake Success, NY)
and transected close to the liver. The PV and IVC were
divided, and the liver was removed. After removal of the
liver, gauze soaked in ice-cold UW solution was placed in
the liver space, and the donor liver was placed upon it. The
SHVC was anastomosed using a 7-0 Prolene running su-
ture (Ethicon, Somerville, NY). The donor portal cuff was
inserted into the lumen of the PV and secured with 6-0 silk.
The microvessel clip on the PV and the Satinsky clamp
were removed. Reperfusion of the liver was established. The
anhepatic phase of the procedure did not exceed 17 min.
The cuff of the IVC was inserted into the lumen of the IVC
and secured using 6-0 silk. The clip on the IVC was
released. The CBD was connected. The wound was closed
using 3-0 gut suture (Ethicon, Somerville, NY), and 8 mL/
kg of warm (37'C) lactated Ringer's solution with 5% dex-
trose and 2 mL/kg of sodium bicarbonate 7% w/v were in-
jected into the penile vein. The animals were put in a clean
cage and allowed to recover from anesthesia under an
infrared lamp for 30 min, after which they were returned to
the housing facility in single-cage housing.
Postoperative blood sampling
To determine the postoperative levels of AST, ALT, and
total bilirubin, 100 to 200 pL of blood was collected on post-
operative days 1, 3, 5, and 7 using tail vein puncture into a
heparinized syringe under isoflurane anesthesia. The sam-
ples were immediately analyzed using a Piccolo miniature
blood chemistry analyzer.
Statistics
Data are expressed as means ± standard errors of the
mean. Comparisons were made using the Student t-test.
RESULTS
Average operating parameter values for 6 perfusions are
shown in Table 1, along with relevant values measured
in vivo. The flow of perfusate through the portal vein of 1.80
i 0.12 mL/min per g was close to reported in vivo values,
especially considering total (portal + arterial) blood flow.
The main differences were the lower hematocrit, which was
approximately 30% of the in vivo hematocrit, and the inflow
p02 of the perfusate, which was much higher than portal
blood and even arterial blood. The portal pressure was only
slightly higher than values typically found in vivo. CO 2
partial pressures were all within the reported physiological
values.
Integrity of liver during perfusion
Levels of AST and ALT measured in the primary circuit
increased 3- to 4-fold during the course of the perfusion
(Fig. 2). No ALT or AST could be found in the dialysate
(data not shown). Liver wet weight decreased slightly, from
9.74 ± 0.81 g to 9.51 ± 0.82 g, during perfusion (p <.05
according to two-tailed paired t-test, n = 11). Liver harves-
ted 6 h after normothermic perfusion showed a healthy ap-
pearance with no signs of degradation or vacuolization
except for a slightly greater dilation of the sinusoids than
with livers in SCS in UW solution for 6 h (Fig. 3A). Trans-
mission electron microscope images demonstrated that livers
stored under both conditions appeared normal. Hepatocyte
mitochondria appeared elongated and not swollen, with a
dominant rough endoplasmic reticulum. Sinusoids had open
lumens and fenestrated endothelial walls. Cell nuclei ap-
peared round and healthy, and cells exhibited clear borders
and obvious bile canaliculi (Fig. 4).
Metabolic function parameters during perfusion
Bile production, oxygen uptake, glucose uptake, and urea
secretion were monitored during the perfusions. Bile was
secreted at a constant rate, with an average total of 536 ±
75 mg bile/g liver produced after 6 h of perfusion (Fig. 5A).
The oxygen uptake rate declined rapidly during the first
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TABLE 1. OPERATING PARAMETERS DURING NORMOTHERMIC PERFUSION
Normothermic Published Reference for
Perfusion (n = 6) In Vivo Values In Vivo Value
Flow rate 1.80 i 0.12 ml/min/g Portal: 1.2 to 1.5 mL/min per g 22, 29
Arterial: 0.2 to 0.3 mL/min per g
Hydrostatic pressure 12 to 15 cm H20 Portal: 8 to 10 cm H20 15, 30
Hematocrit 17.63 i 0.58% 43% www.criver.com/techdocs/
84jan_tb/t84tab0l.html
Inlet P0 2 147.1 i62.03 mmHg Portal: 38 to 55 mmHg 31, 32
Arterial: 85 to 90 mmHg
Outlet P0 2 41.17 i 11.44 mmHg 37 to 42 mmHg 32
Inlet pCO2  31.58 i 4.71 mmHg Portal: 35 to 46 mmHg 30, 32
Arterial: 26 to 34 mmHg
Outlet pCO2  36.64 i 5.20 mmHg 33 to 50 mmHg 32
H20, water; PO2, partial pressure of oxygen; pCO2, partial pressure of carbon dioxide.
60 min after initiation of the perfusion and reached a steady
state value of 0.052 ± 0.018 mImin per g (2.32 ± 0.08 ptmol/
min per g) of liver for the remainder of the perfusion (Fig.
5B). The glucose level in the perfusate decreased slightly
from the initial value of 200 mg/dL to 182 ± 12 mg/dL after
6 h (Fig. 5C). Urea levels exhibited a biphasic response (Fig.
5D). In the early phase, urea levels were initially flat and then
increased almost linearly to reach a plateau at 0.6 mg/dL per
g of liver at 3 h. At that point, the dialysate was changed,
causing the levels to decrease suddenly, followed by an in-
crease at a rate similar to that observed in the 1- to 3-h period,
reaching a maximum level of 0.68 ± 0.04 mg/dL per g at 6 h.
Survival after transplantation
Livers were transplanted into recipient rats after 6 h of nor-
mothermic perfusion (n = 11) or 6 h of SCS in UW solution
at 0C (n = 5). In the perfused liver group, 1 animal died dur-
ing recipient surgery due to bleeding from the anastomosis of
the SHVC and subsequent air embolism. All other animals
(n = 10) recovered rapidly from surgery and survived at least
1 month after transplantation. No signs of liver failure, such as
jaundice, were observed. In the SCS group, all animals also
recovered from surgery and survived beyond 1 month.
Postoperative liver enzymes and bilirubin
Transplant recipients were monitored for circulating liver
enzyme and bilirubin levels to assess liver graft function
(Fig. 6). The levels of AST and ALT increased from base-
line on postoperative day 1 in both groups, with values of
699± 85 p/L and 431 ± 80 pt/L, respectively, in the NELP
group, and 615 ± 177 p/L and 372 ± 138 p/L, respectively,
for the SCS group. In the NELP group, ASL and ALT levels
subsequently declined, to 131 ± 15 p/L and 72.7 ± 6.6 p/L,
respectively, on day 5, and increased again, to 812 ± 257 p/L
and 373 ± 133 p/L for AST and ALT, respectively, on day 7.
In contrast, in the SCS group, the levels of AST and ALT
peaked on day 5, reaching 182 ± 182 p/L and 915 i 210 p/L,
respectively, and then decreased on day 7. There was no
statistically significant difference between AST and ALT
levels in the NELP and SCS groups, except on day 5
FIG. 2. Liver integrity during normothermic perfusion. (A) Aspartate aminotransferase (AST) and (B) alanine aminotransferase (ALT)
levels in perfusate samples collected hourly from the primary circuit. Values are normalized to the wet weight of the liver. Values at 360 min
were 17.39 + 6.34 U/L per g for AST and 6.25 + 2.18 U/L per g for and ALT, n =6.
228
2147
TOLBOOM ET AL.
EU
FIG. 3. Microscopic appearance of livers after (A) 6 h of normothermic perfusion and (B) 6 h in simple cold storage in University of
Wisconsin solution. Bar= 100 pm. Color images available online at www.liebertpub.com/ten.
(p < .05 according to 2-tailed (n= 3) unpaired t-test (n = 3)).
Total bilirubin levels, an indicator of liver function, were sim-
ilar in both groups (n =3) on day 1 and increased to maxi-
mum levels of 0.37 i 0.09 mg/dL and 1.73 + 0.83 mg/dL in
the NELP and SCS groups, respectively, on day 7.
DISCUSSION
We have modified the traditional isolated perfused liver
system so that it can be applied to normothermic preserva-
tion of the rat liver. The most important changes that were
made were the use of a cell culture-based perfusate supple-
mented with plasma and hormones, the use of autologous
erythrocytes as oxygen carriers, and the incorporation of
continuous dialysis. The lifespan of rat liver in traditional
isolated perfused liver systems was typically less than 4h,
and it was suggested that it be considered a "dying organ";
the system was primarily to be used as short-term analytical
model.' 5 Using this modified isolated liver perfusion sys-
tem, rat livers could be normothermically preserved for 6 h
and subsequently transplanted with 100% success. Livers
Cold Normothermic
Storaae B Perfusion
Normothermic
C Perfusion
FIG. 4. Transmission electron micrograph of livers after (A) 6 h of simple cold storage in University of Wisconsin solution and (B, C)
6 h of normothermic perfusion. Under both conditions, the liver appears normal. Mitochondria (Mt) appear elongated and not swollen,
with dominant rough endoplasmic reticulum (RER). Sinusoids appear have open lumens (Lu) and fenestrated endothelial wall. Cell
nuclei (Nu) appear round and healthy, with clear cell borders and obvious bile canaliculi (BC). The perfused liver shows a section of an
erythrocyte (Eryt) and a thrombocyte in the lumen. Bar= 2 pm.
229
'
2148
NORMOTHERMIC RAT LIVER PRESERVATION
S
.
X0
600
500
400
300
200
100
0
250
200
150
100 1
0 60 120 180 240
Perfusion Time (min)
0 60 120 180 240 300 31
Perfusion Time (min)
08R
.] 0.7-
0.6 -
0.5-
c 0.4-
w 0.3 -
o 0.2 -
aU 0.1 -
0
300 360 1 60 120 180 240 300 3
Perfusion Time (min)
FIG. 5. Hepatic metabolic activity during perfusion. (A) Total bile produced normalized to wet liver weight. (B) Hepatic oxygen
uptake rate normalized to wet liver weight. (C) Glucose levels during the perfusion. (D) Urea levels normalized to wet liver weight.
n =6.
- NELP
0 2 4 6
Post op thne (days)
2000
a 0 1 2 3 4 5
Postoptim(days)
0 2 4 6
Postoothmidavsl
FIG. 6. Markers of hepatic integrity and function in the transplant recipient. (A, B) Postoperative plasma aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) levels. (C) Total plasma bilirubin levels. n= 3.
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preserved in this manner were similar to livers preserved
with conventional SCS in UW solution with respect to gross
morphology, histological appearance, recovery from surgery,
and long-term survival after orthotopic transplantation. Fur-
thermore, liver metabolic function, as judged according to
bile production, hepatic oxygen uptake, and urea synthesis,
were stable throughout the perfusion after an initial 60-min
period of equilibration, making it easy to assess the func-
tional activity of donor livers before transplantation.
We chose the rat as the model species because of low cost
(compared with large animals) and extensive body of pub-
lished work with isolated rat perfusion systems. The blood
supply of the rat liver is approximately 10% arterial and 90%
venous. Although some studies indicate that certain areas
of the liver are accessed by arterial blood only,2 3 the bulk of
the literature suggests that it is possible to perfuse via the
portal vein only,' 5 as well as to perform the transplantation
without reconstruction of the hepatic artery.2 1 One person
can perform the transplantation procedure, with a total op-
erating time of approximately 50 min. Finally, inbred rat
strains are widely available, which makes it possible to de-
couple immunological compatibility factors from handling,
storage, and perfusion-related factors that affect the outcome
of the transplanted livers. We chose to characterize our sys-
tem using healthy liver grafts to establish optimal perfusion
parameters, determine baseline metabolic values, and estab-
lish transplant survival data.
Isolated liver perfusion has been extensively studied for
more than 90 years, although most studies have been con-
ducted in the rat using asanguineous buffers as perfusate.16
More recently, solutions containing a more-complete panel
of physiological substrates were used to assess various as-
pects of hepatic function. 17,18 Cell culture-based perfusates
have been used in reperfusion studies of the rat liver,
hypothermic liver preservation,2 and near-normothermic
kidney preservation.7 Here, we have chosen a basal perfusate
medium consisting of Williams Medium E, which is rou-
tinely used for culturing hepatocytes. This medium contains
essential and nonessential amino acids, vitamins, glucose,
and the antioxidant glutathione. Insulin was added to mimic
a "fed state," in which the liver uses the available glucose
in the medium. Hydrocortisone was added for its anti-
inflammatory characteristics. The basal medium was supple-
mented with plasma, and washed rat erythrocytes were used
as oxygen carriers. This approach ensured that no white
blood cells or platelets were present in the perfusion solu-
tion, because these cells can become activated and cause
undesirable reactions, such as clotting, the release inflam-
matory mediators, and endothelial activation, in an extra-
corporeal perfusion setting. Plasma was added primarily to
provide albumin and a high enough protein content to main-
tain oncotic pressure.
A key component of this perfusion system is the use of
rat red blood cells as oxygen carriers. Unlike the traditional
isolated perfused liver circuit, which typically uses a large
circulating volume ranging from 150 to 300 mL,16 the pri-
mary perfusion circuit used in our system has a volume
of 50 to 55 mL, making it possible to use blood from two
400-g rats providing 15 mL of blood each to achieve the
hematocrit close to 20 deemed necessary for optimal liver
function15 for one perfusion experiment. Others have suc-
cessfully used artificial oxygen carriers,5, 26 which in prin-
ciple have the advantage of being inert and could potentially
exhibit more reproducible properties. However, current pro-
ducts, which mainly fall in the classes of polymerized
hemoglobins and perfluorocarbons, are costly and have been
found to have limited use. Polymerized hemoglobins lose
oxygen carrying capacity as they become oxidized into me-
themoglobin during perfusion, because they lack the eryth-
rocyte enzymatic machinery to reduce methemoglobin to
hemoglobin. Perfluorocarbons, which are highly hydropho-
bic, must be incorporated as emulsions. They have been
used with success as oxygen carriers for hypothermic ma-
chine preservation.2 Our poor preliminary experience using
perfluorocarbon-based oxygen carriers in our setup, possi-
bly based on instability of the used emulsion, led us not to
pursue their further use.
In our initial experiments without dialysis, we observed
gradual acidosis, hypernatremia, and depletion of metabolic
substrates in the perfusate (unpublished data). Our efforts to
transplant livers perfused in this manner were unsuccessful,
consistent with the poor survival reported previously 28 with
rat livers normothermically perfused without dialysis. Long-
term normothermic perfusion of the porcine liver has been
demonstrated,4 but transplantation of these livers has not been
reported. The only study that has demonstrated successful,
stable post-transplant survival employed a dialysis circuit.8
Given the small volume of the primary perfusion circuit, a
means to remove waste products and replenish nutrients was
necessary; therefore, we incorporated a secondary dialysis
circuit with a volume that was 10 times as great, which we
found effective to stabilize the pH, electrolyte, and substrate
levels in the primary perfusion circuit. The molecular cut-off
weight of 30 kDa is large enough to enable free exchange of
electrolytes, nutrients, and metabolites while retaining albumin
in the perfusate, thus providing the necessary oncotic pressure.
In conclusion, we have developed a simple and cost-
effective NELP system that successfully preserves rat livers
for up to 6 h. Normothermically preserved livers were histo-
logically similar to livers preserved using SCS in UW solution
for the same duration and could be orthotopically transplanted
successfully. Although we do not claim to have improved on
SCS as a preservation method for healthy liver grafts, the sys-
tem described herein is a cost-effective alternative to the por-
cine liver perfusion and transplantation models that have been
employed in the field so far. It could be easily set up in most
laboratories, which should speed up the development of NELP
as a preservation method. More specifically, we envision that
this system could be used to further optimize perfusion con-
ditions to extend normothermic preservation times for normal
livers, as well as to provide new opportunities for the pres-
ervation and recovery of marginal liver grafts.
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Recovery of Warm Ischemic Rat Liver Grafts by
Normothermic Extracorporeal Perfusion
Herman Tolboom,1,2 Roos E. Pouw, 1,2 Maria-Louisa Izamis,1,2 Jack M. Milwid,1 ,2 Nripen Sharma,1,2
Alejandro Soto-Gutierrez,1,2 Yaakov Nahmias,1,2 Korkut Uygun,1,2 Franpois Berthiaume,1 ,2
and Martin L. Yarmush1 ,2 ,3
Liver transplantation is currently the only established treatment of end-stage liver disease, but it is limited by a severe
shortage of viable donor livers. Donors after cardiac death (DCD) are an untapped source that could significantly
increase the pool of available livers. Preservation of these DCD livers by conventional static cold storage (SCS) is
associated with an unacceptable risk of primary nonfunction and delayed graft failure. Normothermic extracorporeal
liver perfusion (NELP) has been suggested as an improvement over SCS. Livers recovered from male Lewis rats were
subjected to 1 hr of warm ischemia and preserved with 5 hr of SCS or NELP, and transplanted into syngeneic recipients.
As additional controls, non-ischemic livers preserved with 6 hr of SCS or NELP and unpreserved ischemic livers were
transplanted. After NELP, ischemically damaged livers could be orthotopically transplanted into syngeneic recipients
with 92% survival (n= 13) after 4 weeks, which was comparable with control animals that received healthy livers
preserved by SCS (n=9) or NELP (n= 11) for 6 hr. On the other hand, animals from ischemia/SCS control group all
died within 12 hr postoperatively (n=6). Similarly, animals that received ischemic livers without preservation all died
within 24 hr after transplantation (n=6). These results suggest that NELP has the potential to reclaim warm ischemic
livers that would not be transplantable otherwise. The rat model in this study is a useful platform to further optimize
NELP as a method of recovery and preservation of DCD livers.
Keywords: Transplantation, Reperfusion injury, Machine perfusion, Preservation, Preconditioning.
(Transplantation 2009;87: 170-177)
T ransplantation is currently the only established treatmentof end-stage liver disease, but it is limited by the shortage
of available organs. Extending liver graft criteria to include
marginal livers, such as those obtained from donors after car-
diac death (DCD), could alleviate this problem (1). It is esti-
mated that approximately 6000 ischemic livers (1, 2) could be
reconditioned for transplantation, effectively doubling the
availability of grafts. However, conventional static cold stor-
age (SCS) of these marginal organs leads to unsatisfactory
transplant outcome (1); they exhibit a higher risk of primary
nonfunction and delayed graft failure, especially because of
biliary complications such as stricture (3). It is believed that
warm ischemic damage experienced by DCD livers leads to
increased sensitivity to subsequent cold ischemia and re-
warming injury associated with SCS.
Both hypothermic and normothermic machine perfusion
have been suggested as methods to improve the preservation of
DCD livers. The advantages of hypothermic perfusion over SCS
have been previously demonstrated (4-8). Recently, func-
tional recovery of ischemically damaged rat livers was shown
using a combination of SCS followed by short term hypother-
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mic machine perfusion (9, 10). However, extended hypother-
mic machine perfusion can cause endothelial damage (11),
which may limit organ viability.
Normothermic extracorporeal liver perfusion (NELP)
has been suggested as a method to avoid the problems asso-
ciated with SCS and hypothermic perfusion (12-14). Near-
normothermic machine perfusion has been successfully used
in experimental kidney preservation (15-17), and recently nor-
mothermic perfusion was shown to be superior to SCS in the
preservation of DCD livers (13, 14, 18). A survival benefit after
transplantation of DCD livers preserved normothermically has
been demonstrated in one study using a porcine model (13).
The complexity and high cost of large animal models
limit the number of thorough studies that can be conducted,
making systematic characterization and optimization of
NELP difficult. To provide an alternative model that is more
amenable to research and development, we developed a
small-scale NELP system where rat livers can be successfully
transplanted after 6 hr of normothermic perfusion (19).
Herein, we investigated the potential of NELP to recover
warm ischemic livers. We show that rat livers that underwent
60 min of ex-vivo warm ischemia (34*C) and then preserved
by 5 hr of NELP could be successfully transplanted into syn-
geneic recipients. By contrast, recipients of similar livers
stored by SCS for 5 hr, and those transplanted directly with-
out having undergone preservation, did not survive.
EXPERIMENTAL PROCEDURES
Isolation of Donor Livers
Experiments were performed using male Lewis rats
weighing 250-300 g (Charles River Labs, Wilmington, MA).
The animals were maintained in accordance with National
Research Council guidelines and the experimental protocols
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were approved by the Subcommittee on Research Animal
Care, Massachusetts General Hospital. All animals were anes-
thetized with isoflurane using a Tech 4 vaporizer (Surgivet,
Waukesha, WI) under sterile conditions. The donor liver sur-
gery is described in detail elsewhere (19, 20).
Warm Ischemia Induction
After isolation from the donor, the liver was weighed
and placed in a temperature-controlled chamber filled with sa-
line and maintained at (34 0.1)*C for 1 hr. During this period
the portal vein (PV) and inferior vena cava (VC) were cuffed as
previously described (19).
Normothermic Liver Perfusion
The perfusate and dialysate comprised phenol red-free
Williams Medium E (Sigma Chemical, St. Louis, MO) sup-
plemented with 2 u/L insulin (Humulin, Eli Lily, Indianapo-
lis, IN), 100,000 u/L penicillin, 100 mg/L streptomycin sulfate
(Gibco, Invitrogen, Grand Island, NY), 0.292 g/L L-glutamine
(Gibco), 10 mg/L hydrocortisone (Solu-Cortef, Pharmacia &
Upjohn, Kalamazoo, MI), and 1000 u/L heparin (APP,
Schaumberg, IL). Fresh frozen rat plasma (25% v/v) and
erythrocytes (18-20% v/v) were collected earlier (19) and
added to the perfusate only. The total perfusate volume was
55 to 60 mL.
The perfusion system consisted of a primary liver per-
fusion circuit and a critical secondary dialysis circuit (19).
Briefly, the primary circuit included perfusate that recircu-
lated by means of a peristaltic pump through a jacketed per-
fusion chamber, a membrane oxygenator, a heat exchanger,
and a bubble trap. The oxygenator was gassed with a mixture
of 74% N2/21% 02/5% CO 2 and 100% 02 to maintain a con-
stant pH. A fraction of the perfusate was diverted to the sec-
ondary circuit through a hollow fiber dialyzer with a 2200
cm2 membrane area and a 30 kDa nominal molecular weight
cutoff (Spectrum Labs, Rancho Dominguez, CA) at a rate of 3
mL/min/g wet liver weight. The secondary circuit dialyzed the
perfusate by counter-current exposure to 450 mL of dialysate.
The volumes of perfusate and dialysate were kept constant by
varying the flow of dialysate through the dialyzer in the sec-
ondary circuit. Temperature within the system was main-
tained at 37.5*C.
After the warm ischemic period, the liver was flushed
with 10 mL of warm saline and immersed in perfusate in the
perfusion chamber. The liver was perfused at a constant flow
rate through the portal vein and effluent flowed freely from
the suprahepatic and inferior vena cava into the surrounding
medium. When the recipient hepatectomy was prepared, the
liver was disconnected from the circuit, rinsed in a bowl of
saline at room temperature, and weighed again before trans-
plantation. The operating parameters of the perfusion system
were as follows: flow rate, 1.84±0.05 mL/min/g; portal hy-
drostatic pressure, 12 to 16 cm H20 (8-12 mm Hg); hemat-
ocrit, 17.8%±0.8; inlet P0 2, 128.4±8.1 mm Hg; outlet P0 2,
47.9±1.7 mm Hg; inlet pCO2, 30.1±1.1 mm Hg; outlet
pCO 2: 34.6±1.6 mm Hg.
Analysis of Perfusate Levels of Metabolites and
Liver Enzymes
Perfusate samples (1 mL) were collected before placing
the liver in the perfusion system and hourly thereafter. For
each sample, 100 pL aliquots were immediately analyzed us-
ing a Piccolo comprehensive metabolic panel (Abaxis, Union
City, CA) for alanine aminotransferase (ALT), aspartate ami-
notransferase (AST), total bilirubin, electrolytes, and glucose.
The remainder was stored at - 80*C for later analysis. Dialy-
sate samples (1 mL) were collected at the same times and
stored at -80'C.
For analysis of the hepatic oxygen uptake rate (HOUR),
200 sL samples were taken from the PV and IVC of the liver
every 10 min for the first hour of the perfusion and every hour
subsequently. Samples were analyzed immediately using a
blood gas analyzer (Rapidlab, Chiron Diagnostics, Norwood,
MA). The total concentration of 02 (mL/dL) in the samples
was determined according to the formula:
[02]=1.39X [Hb] XFO 2Hb+0.00314XpO 2
where [Hb] is the hemoglobin concentration in g/dL, FO2Hb
is the fraction oxygenated hemoglobin, and P 0 2 is the partial
pressure of oxygen in mm Hg. HOUR was determined as
follows:
HOUR=(([O2]i-[02]o,)/100)x flowrate/weight of liver.
Bile was collected continuously in preweighed mi-
crofuge tubes that were exchanged every hour.
Recipient Surgery
The cuff technique developed by Kamada and Calne
(20-22) was implemented and is described in detail elsewhere
(19). All recipient surgery was carried out by the same micro-
surgeon (H.T.). The anhepatic phase of the procedure was
typically 13 to 15 min and did not exceed 17 min. Animals
were hydrated with 8 mL/kg of warm (37*C) lactated Ringer's
solution with 5% dextrose and 2 mL/kg of NaHCO 3 7%w/v
(Abbott, North Chicago, IL) by penile vein injection.
The animals were put in single clean cages, allowed to
recover from anesthesia under an infrared lamp for half an
hour, and subsequently returned to regular housing. The first
12 hr postoperatively animals were checked every 2 hr and
subsequently every 8 hr for 1 week.
Postoperative Blood Sampling
To determine the postoperative levels of AST, ALT, and
total bilirubin, 100 -200 pL of blood were drawn from the tail
vein under isoflurane anesthesia on postoperative days 1, 3, 5,
7, 14, 21, 28, and immediately analyzed using a Piccolo blood
chemistry analyzer. For these studies, n was more than or
equal to 4 for each group.
Simple Cold Storage
Warm ischemic livers (n=6) and freshly isolated livers
(n=6) were flushed with 20 mL of ice-cold (0*C) UW solu-
tion and placed on melting ice in a bowl containing UW so-
lution for the duration of the SCS period; these livers were not
perfused.
Diluted Whole Blood Reperfusion
For detailed evaluation of the graft response in the early
phase (0-2 hr) after transplantation, we used a diluted whole-
blood reperfusion model. This method was preferable as
manipulation of animals for sampling immediately after
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transplantation could further stress the animals, affect sur-
vival, and introduce artifactual findings. The reperfusion cir-
cuit was identical to the normothermic perfusion system, but
contained no secondary dialysis circuit. The livers were reper-
fused for 120 min and inflow (portal vein) and outflow (in-
frahepatic vena cava) sampling was performed every 15 min.
The operating conditions for the reperfusion system were
as follows: flow rate, 1.74±0.15 mL/min/g; hematocrit,
13.8±8.2; inlet P0 2, 263.5±111.9 mm Hg; outlet P0 2,
75.1 ±49.7 mm Hg; inlet pCO2, 40.4±14.9 mm Hg; outlet
pCO 2, 43.4±15.9 mm Hg.
Histology
Liver tissue slices were fixed in 10% formalin, embedded
in paraffin, sectioned, and stained with hematoxylin-eosin.
Apoptosis was evaluated through terminal deoxynucleotide
transferase-mediated dUTP nick-end labeling (TUNEL) stain-
ing (Roche, Indianapolis, IN).
Statistical Analysis
Data presented are mean ±SE. All statistical analysis for
differences performed with ANOVA at significance level of a
equal to 0.1.
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'3 60C
0
40
20
0
Transplantation - Volume 87, Number 2, January 27, 2009
RESULTS
Integrity and Function of Liver During Perfusion
ALT and AST activities as indicators of hepatocellular
damage are shown in Figure 1 (A and B); both AST and ALT
accumulated during the first 180 min of perfusion and then
decreased. These values were several folds higher than those
previously reported for freshly isolated livers not subjected to
any warm ischemia (19). Neither ALT nor AST were detected
in the dialysate (data not shown).
Bile secretion and oxygen consumption describe the
metabolic state of the liver. Bile was produced at a constant
rate throughout the perfusion (Fig. 1C). This rate was 40%
lower than that previously reported for freshly isolated livers.
The HOUR of warm ischemic livers declined rapidly during
the first 60 min of the perfusion and then remained stable
(Fig. 1D). This behavior was similar to that observed for
freshly isolated livers. The HOURs of the perfused warm isch-
emic and freshly isolated livers were similar in the plateau
region beyond 60 min.
The urea level in the perfusate showed a steady increase
from 4.20 mg/dL at t=0 to 8.60 mg/dL at t=300 min, indi-
cating a constant rate of urea production. This rate was con-
0 120 240 360
FIGURE 1. Function and integrity of warm
ischemic livers during normothermic perfu-
sion. (A) Asparate aminotransferase (AST)
and (B) alanine aminotransferase (ALT) lev-
els in perfusate samples collected hourly
from the primary circuit. (C) Total bile accu-
mulation normalized to wet liver weight. (D)
Oxygen uptake rate normalized to wet liver
weight. (E) Urea concentration in the perfus-
ate. Data shown are averages of six ischemic
livers ±standard error (SE). Values for the
warm ischemic livers are significantly lower
than the controls for bile and oxygen uptake,
and significantly higher for urea (P<0.01 by
analysis of variance) (Data for the control
group [normothermic perfusion of nonisch-
emic livers] are from Tolboom H, Pouw R,
Uygun K, et al. A model for normothermic
preservation of the rat liver. Tissue Eng 2007;
13(8): 2143). *Indicates statistical difference
compared with healthy perfused livers at
P<0. 1.
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sistently higher than that observed in perfused healthy livers
(Fig. 1E).
Figure 2 shows the histologic appearance of warm isch-
emic livers after 5 hr of NELP. Ischemic livers treated with
NELP show minimal to no damage compared with freshly
isolated livers preserved by SCS or NELP. In contrast, livers
subjected to 1 hr of warm ischemia and subsequently pre-
served by SCS show swelling of hepatocytes (indicated by the
arrows in the figure), widespread vacuolization, and destruc-
tion of liver architecture (as indicated by the asterisks).
GrouD I
Group 11
Groun III
.rni iV
100%
80%
X 60%
2'40%
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20%
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FIGURE 2. Microscopic appearance of livers after pres-
ervation. (A) Group I: Warm ischemic livers after 5 hr of
normothermic extracorporeal liver perfusion. (B) Group II:
Warm ischenic livers after 5 hr of static cold storage in
University of Wisconsin solution (arrows indicate cell swell-
ing and asterisks vacuolization and tissue destruction). (C)
Group III: Freshly isolated livers after 6 hr of normothermic
extracorporeal liver perfusion. (D) Group IV: Freshly iso-
lated livers after 6 hr of static cold storage in University of
Wisconsin solution. Bar=200 pm.
Survival After Transplantation
Warm ischemic livers were transplanted into recipient
rats after 5 hr of NELP (n= 13) or 5 hr of SCS in UW solution
at 0*C (n= 6). In addition, freshly isolated livers not subjected
to any warm ischemia were transplanted after 6 hr of SCS
(n=6) or NELP (n=11) and ischemic livers were trans-
planted directly without having undergone preservation
(n=9).
Transplantation of NELP-treated ischemic livers was
uneventful in all but one case, where bleeding at the anas-
tomosis occurred. All animals recovered from anesthesia
rapidly. The animal that bled during surgery died on day 4
postoperatively. The other recipient animals survived be-
yond 1 month and did not exhibit external signs of liver
failure, such as jaundice.
No surgical complications occurred during transplan-
tation of ischemic livers preserved by SCS and recipients re-
covered rapidly from anesthesia, but within 6 hr all developed
symptoms and died within 12 hr. Autopsy revealed patchy
livers and serous fluid in the abdomen.
All recipients of directly transplanted ischemic livers
died in a similar way within 24 hr postoperatively.
All controls that received freshly isolated livers pre-
served for 6 hr by SCS recovered rapidly from surgery and
survived beyond 1 month (Fig. 3).
Postoperative Liver Enzymes and Bilirubin
The levels of both AST and ALT (Fig. 4A and B) were
elevated on day 1 postoperatively similar to the levels found in
recipients of healthy cold stored livers. Overall, values of re-
cipients for healthy cold-stored livers and DCD livers showed
similar and normal levels implying successful transplanta-
tion. The AST levels were significantly lower for the perfused
warm ischemic livers as compared with the healthy cold-
stored livers on postoperative day 5. Both values were com-
parable with those observed in a hypothermic machine
perfusion study (5).
The total bilirubin level, an indicator of liver function,
was similar in both groups postoperatively and showed an
increasing trend (Fig. 4C). The increasing bilirubin value is
-e-Warm Ischemic + NELP
-4-Normal+-NELP
-4--Warm Ischemic - no storage
-- Warm Ischemic + Cold Storage
-a- Normal + Cold Storage
0 7 14 21 28
Post-Transplant Time (Days)
FIGURE 3. Survival curves of recipient rats after trans-
plantation of perfused warm ischemic livers, warm isch-
emic cold-stored livers, compared with healthy perfused
livers, and healthy cold-stored livers (Data for the
normal+normothernic extracorporeal liver perfusion
group are from Tolboom H, Pouw R, Uygun K, et al. A model
for normothermic preservation of the rat liver. Tissue Eng
2007; 13(8): 2143).
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FIGURE 4. Values of (A) asparate aminotransferase, (B) alanine aminotransferase, and (C) total bilirubin measured on
days 1, 3, 5, 7, 14, 21, and 28 after transplantation of perfused warm ischemic livers compared with healthy cold-stored
livers. (D, E) Comparison of the serum levels of albumin, total protein, glucose, and alkaline phosphatase within 1 week after
transplant. *Indicates statistical difference compared with cold-stored livers at P<0. 1.
within expected ranges and is likely an artifact of nonrearteri-
alization and ensuing histopathologically observable bile duct
proliferation (23). It is worth noting that the elevated biliru-
bin levels are reported (23) to normalize after 6 weeks and
survival is minimally affected. There was no statistical differ-
ence of bilirubin levels between the groups on any day.
The recipient serum analysis is displayed in Figure 4(D
and E). Albumin levels were similar for both SCS and WI-
NELP groups (1.52 and 1.46 mg/dL, respectively), though
lower than systemic levels we previously obtained in vivo
(1.91 ±0.23 g/dL; Izamis et al., submitted). The total protein
was higher in the SCS group (5.63 vs. 4.76 g/dL, both similar
to the in vivo levels of 4.96±0.64 g/dL), suggestive of immu-
noglobulin elevation. Glucose levels were similar and within
the normal in vivo range (241.64 ±119.81 mg/dL), as were the
electrolyte levels (results not shown). Alkaline phosphatase,
indicative of general tissue damage, was beyond the normal
rat values (208.54±66.019 U/L) for cold-stored organs
(472.75 U/L). NELP-treated ischemic livers were statistically
lower than healthy DCD livers (273.36 U/L) and well within
the normal range. These results are in agreement with slightly
increased ALT and AST levels in recipients of cold stored
organs, though the difference is statistically significant
only for day 5. These results overall indicate that the func-
tion of NELP-perfused DCD livers is slightly better than
cold-stored healthy organs. This could be due to avoiding
the cold injury (11) or ischemic preconditioning effects of
warm ischemia (24).
Short-Term Graft Function
To evaluate the short-term graft function posttrans-
plantation, we used a diluted whole-blood reperfusion
model. This was preferred to repetitive blood sampling
shortly after transplantation, as the animals would not toler-
ate well additional manipulations.
Figure 5 displays ALT and AST as markers of cellular
damage, bile secretion as a viability indicator, and liver oxy-
gen uptake rate as baseline indicator of metabolic activity.
ALT levels for WI and NELP group was lower than WI-only
and WI and SCS groups at all time points, and indifferent
from normal livers after the first 45 min. Similar trends were
observed for AST, although the difference between
WI+NELP and freshly isolated livers was statistically signifi-
cant at all time points except t=45min. These results suggest
that NELP improves early graft function and viability.
It was observed that bile secretion in the reperfusion
system was well correlated with the survival results (Fig. 5C).
Posttransplant bile secretion has been previously shown to be
strongly correlated with graft survival (25-27) and with cel-
lular ATP levels (28, 29). The average bile production during
reperfusion of normal livers and NELP-treated WI livers was
statistically not different (P= 0.21); secretion for both groups
was higher than the other two WI groups (P<<0.0 1). Further-
more, WI + SCS group showed lower bile secretion than WI-
only group. Overall these results were as anticipated: it is
known that substrate depletion causes reduction in bile syn-
thesis, and the degree of reduction is proportional to ischemic
injury (30).
As displayed in Figure 5(D), reperfusion results in ox-
ygen uptake rates that are different between groups. The av-
erage oxygen uptake was highest for the freshly isolated livers,
statistically higher than that of WI+NELP and WI+SCS
groups, but not different from 1 hr WI alone. There was no
difference between WI+NELP and WI+SCS groups. Inter-
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FIGURE 5. Reperfusion results:
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estingly the WI-only livers displayed oxygen uptakes compa-
rable with healthy livers. Although oxygen uptake can be con-
sidered a bottom-line figure for respiration and metabolism,
these results suggest that there is limited correlation between
survival and early oxygen uptake rates.
Figure 6 displays the TUNEL staining results at the end
of reperfusion. Apoptosis was absent in healthy and NELP-
treated ischemic livers, and limited in WI-only livers. By
comparison, WI+SCS group demonstrated significant stain-
ing. These results confirm that NELP is an effective method
for preservation of ischemic livers. However, the absence of
apoptosis in the WI-only livers that result in primary non-
function when transplanted, suggest that apoptosis is not a
determinant factor for graft survival.
DISCUSSION
We have demonstrated that livers subjected to 60 min
of ex-vivo warm ischemia can be resuscitated with NELP and
transplanted with excellent graft function and long-term sur-
vival of the recipient, comparable with that of recipients of
perfused fresh livers and fresh livers preserved with cold stor-
age. Animals that received ischemic livers that were preserved
with cold storage or experienced no storage time at all, died
within 24 hr of transplantation.
Diluted whole-blood reperfusion experiments were
performed to assess early graft function. It was observed that
function of NELP-treated ischemic livers matched that of
freshly isolated livers, whereas the function of untreated isch-
emic grafts was significantly worse. The transaminase levels
and bile trends in the reperfusion system correlated well with
our survival results. In addition, the results indicate that the
reperfusion system can be used to simulate liver transplanta-
tion for rapid optimization of NELP conditions.
Hypothermic machine perfusion provides the organ
with constant supply of oxygen and nutrients while waste is
FIGURE 6. Terminal deoxynucleotide tranferase-mediated
dUTP nick-end labeling of livers after preservation and
reperfusion. (A) Group I: Freshly isolated liver after reper-
fusion. (B) Group II: Warm ischemic livers after reperfu-
sion. (C) Group III: Warm ischemic livers after 5 hr of static
cold storage in University of Wisconsin solution after reper-
fusion. (D) Group IV: Warm ischemic livers after 5 hr of
Normothermic Extracorporeal Liver Perfusion followed by
reperfusion. Magnification X 10.
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removed. However, the basic approach to preservation still
relies on slowing down metabolic rates, and herein does not
differ from SCS. Under hypothermic conditions, a delicate
equilibrium exists between maintaining perfusate flow suffi-
cient to ensure adequate tissue oxygenation and damage of
the sinusoidal endothelium due to barotrauma and shear
stress that may limit it usefulness (31-33).
Normothermic machine perfusion is fundamentally
different from hypothermic perfusion because its aim is to
not only reestablish perfusion of the liver, but also closely
mimic the in vivo conditions and maintain the liver in a met-
abolically active state. The organ's metabolic activity can be
continuously monitored throughout the preservation period,
making it possible to assess its viability and function, provid-
ing potential markers that could be used to predict viability
after transplantation. Furthermore, once oxidative metabo-
lism has been sufficiently restored and intracellular energy
supplies have been replenished, induction of repair and even
regenerative processes might be possible. Other applications
that have been suggested for normothermic machine perfu-
sion include preconditioning, such as the induction of heat-
shock proteins, and immunomodulation, such as induction of
resistance against recurrent hepatitis C infection of the liver graft
and possibly the reversal of hepatic steatosis (34, 35).
Although previous NELP efforts have predominantly
used larger animal models, the rat was our model of choice to
keep our approach simple and inexpensive. Because the
blood supply of the rat liver is mostly venous (36, 37), we have
chosen to perfuse through the portal vein only, as usually
performed in the traditional isolated perfused rat liver sys-
tems (36, 38), which further helped to simplify the setup. For
the same reason, the orthotopic liver transplant without re-
construction of the hepatic artery was performed using the
cuff technique first described by Kamada and coworkers
(20, 21). By using an inbred strain of rats, issues associated
with immunoreactivity during perfusion and after trans-
plantation were avoided. A limitation of this approach is
the lack of rearterialization, which is known to introduce
certain artifacts, including histopathologically observable
biliary proliferation (23). The recipient rats in our studies
displayed the same complications (results not shown), and
the increased serum bilirubin, which is known to return to
normal levels after 6 weeks in this model (23); however,
survival was not affected by this phenomenon. This artifact
makes it difficult to identify other biliary complications, such as
biliary strictures, which is an important long-term issue with
DCD transplantation.
To model DCD, we subjected livers to ex-vivo warm
ischemia in a homeothermically controlled bath filled with
warm saline as previously described (5). The benefit of this
method is precise control of the ischemic time and tempera-
ture because the explantation of the organ occurred before
the period of ischemia. We have chosen 60 min as clinically
relevant time scale of prolonged ischemia. The temperature
of 34'C was chosen to simulate a degree of reduction of the
core temperature after cardiac arrest. Although we have also
tested the effect of warm ischemia before liver explantation
(39) we found that this approach introduces more variability
due to poor control of the temperature history of the liver and
variation of the duration of the donor surgery. Additionally,
we found that body-core temperature in the rat dropped
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much faster than what could be expected in a larger animal
model or in humans, reducing the impact of the ischemia. We
have chosen to heparinize animals before explantation for the
same reason of consistency.
During normothermic perfusion of the ischemic livers,
the initial peak in the release of both AST and ALT suggests
that hepatocellular damage occurred during the period of
warm ischemia but stopped on perfusion of the liver. Postop-
erative values of the AST and ALT were comparable, if not
lower than those of recipients of fresh livers preserved with
NELP or SCS for a similar period. The lower bile secretion of
the ischemic livers suggests that the damage sustained during
warm ischemia may affect the biliary epithelium more than
the hepatic parenchyma. Interestingly, the urea production of
the ischemic livers was higher than that of freshly resected
livers, which may reflect an increased nitrogen availability
caused by proteolysis secondary to cellular damage. The fact
that the oxygen uptake rate was similar to that of fresh livers
indicates that the machinery responsible for oxidative metab-
olism was largely intact and mitochondrial function main-
tained in warm ischemic livers.
One of the possible hypotheses to explain the beneficial
effect of NELP in reconditioning DCD organs is reduced ap-
optosis, which could be through reduced Kupffer cell activity
(due to presence of hydrocortisone in the perfusate) which is
known to be correlated with improved graft survival (9) or
ROS reduction (through glutathione which is present in
Williams E) which was also found to correlate with graft via-
bility (40). However, the TUNEL results of reperfused livers
demonstrate that there is no appreciable difference in apo-
ptosis between WI-only and WI+NELP groups. Although
both groups showed limited apoptosis, the survival of unper-
fused ischemic livers was zero. This result indicates that sup-
pression of Kupffer cells is an unlikely cause of survival in our
system. However, it is possible that other inflammatory
mechanisms not present in our model are involved. On the
other hand, the correlation between bile secretion and sur-
vival suggests that restoration of metabolic activity, perhaps
ATP levels and other metabolites, may play a role in the protec-
tive effects of NELP.
CONCLUSIONS
The goal of this study was to evaluate the possibility of
resuscitating livers after warm ischemia with normothermic
perfusion in a modified isolated perfused rat liver system. We
have shown that livers subjected to 1 hr of ex vivo warm
ischemia can be reclaimed using warm perfusion technology.
Posttransplant survival of rats that received these perfused
livers was far superior to that of animals that received isch-
emic livers that did not undergo any preservation, and those
preserved with traditional SCS. Our system provides an effec-
tive method to investigate the various aspects of warm perfu-
sion for preservation and resuscitation of the DCD liver
grafts, and a model to study liver metabolism (41). We envi-
sion that a similar, scaled-up version of our system could be
used in a clinical setting enabling the use of DCD livers for
transplantation.
In addition, this study establishes that the dilute whole-
blood reperfusion system can be used as a model simulating
rat liver transplantation, and transaminase levels and bile
synthesis are all adequate markers of viability.
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